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CHAPTER 1 
INTRODUCTION AND SUBJECT OF THESIS 
1.1 General introduction 
Major functions of the mature male gonad are the pro-
duction of gametes and steroid hormones. Extratesticular as 
well as intratesticular factors regulate these two male go-
nadal functions which are associated with two distinct cell 
compartments in the testis. It has been known for a long 
time that hypophysectomy is followed by gonadal atrophy and 
arrest of the spermatogenic process which only will proceed 
to a primary spermatocyte stage. The anterior pituitary 
gland appears to play an essential role in the regulation 
of the testis and systematic studies on the relationship 
between brain structures and the male gonad started in the 
late nineteen twenties and early thirties. The finding that 
testicular functions were controlled by the hypophysis sti-
mulated almost simultaneously experiments on the reverse 
issue, i.e. whether testicular products can affect the hy-
pophysis (Moore and Price, 1930). The connections between 
these systems are the anterior pituitary gonadotrophiC hor-
mones, luteinizing hormone (LH) and follicle-stimulating 
hormone (FSH). It is now well established that the major 
control of pituitary function resides in the hypothalamus, 
although other brain structures also are involved in the 
regulation of the pituitary gland (Szent.3.gothai et al. 
1968; Mess and Martini, 1968; Halasz, 1969). Hypothalamic 
gonadotrophin releasing factor (GnRF) , reaching the ante-
rior pituitary gland via a portal system, stimulates syn-
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thesis (Redding et al. 1972) and release (Schally et al. 
1968) of the hypophyseal gonadotrophins LH and FSH in spe-
cial gonadotroph cells. The many mutually dependent and 
complicated interactions between hypothalamus, hypophysis 
and testis at different functional levels are intriguing 
and make their study very attractive. 
1.2 Hypothalamic-pituitary unit 
The hypothalamus is an area in the diencephalon lying 
at the base of the brain ventral to the thalamus and for-
ming the floor and part of the lateral walls of the third 
ventricle. Anteriorly it is bounded by the optic chiasma 
and posteriorly by the mammillary bodies. The median emi-
nence is adjacent to the pituitary stalk that links the 
two structures of this unit. The anatomical basis for the 
hypothalamic regulation of the anterior pituitary gland was 
established by Green and Harris (1947) by demonstrating a 
neurovascular link between the hypothalamus and the anterior 
pituitary gland. This fact was conclusively substantia-
ted by the existence, the isolation and the synthesis of a 
specific hypothalamic decapeptide hormone GnRF by Schally 
and coworkers. Certain centres in the hypophysiotrophic 
area of the hypothalamus contain the GnRF producing neurons 
whose axons end at the capillary loops of the hypophyseal 
portal circulation. GnRF produced by these neurons under the 
influence of neurotransmitters {Schneider and Me Cann, 
1970; Wurtman, 1970; Kordon and Glowinski, 1972) is dis-
charged into the primary capillary plexus of the portal 
system. From this capillary bed, originating in the median 
eminence, GnRF is transported to the anterior pituitary 
gland. As a consequence of such transport distinct gonado-
troph cells in the anterior pituitary gland will secrete LH 
and FSH into the systemic circulation. Results suggesting 
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that stimulation of the adenylate-cyclase system and cyclic 
AMP may be involved in the action of GnRF on the anterior 
pituitary gland have recently been reviewed by Menon and 
Gunaga (1974). It is still disputed whether there exists 
only one releasing principle responsible for the production 
and release of both LH and FSH, but so far only one gonado-
trophin releasing hormone has been identified and synthe-
sized, which will promote synthesis (Redding et al. 1972) 
as well as release (Schally et al. 1968) of LH and FSH by 
the anterior pituitary gland in vivo and in vitro. In con-
trast to GnRF, the pituitary gonadotrophins appear to be 
species specific. The structure of these glycoproteins corn-
posed of two subunits designated the a- (or common) and the 
s- (or hormone specific subunits) (Pierce et al. 1971) I has 
been elucidated for a number of species (Pierce et al. 1971; 
Papkoff et al. 1971; Shorne and Parlow, 1974). It is gene-
rally believed that extrahypothalamic nervous structures 
such as the amygdala, cerebral cortex and hippocampus may 
influence the neurons that secrete GnRF (Szentagothai 
et al. 1968). Ablation of discrete areas of the central 
nervous system, hypothalamic and brain lesions and hypotha-
lamic deafferentiation, which partially or totally inter-
rupts the afferent pathways reaching the medial basal hypo-
thalamus, provide useful methods for studying the role 
played by extrahypothalarnic structures in regulating the 
action of the hypothalamic-pituitary-gonadal system. Cen-
tral nervous system mediators such as epinephrine, norepi-
nephrine, serotonin, dopamine and acetylcholine seem to be 
involved in transferring information from the extrahypo-
thalarnic centres to the hypothalamic nuclei (Ganong and 
Lorenzen, 1967; Kobayashi and Matsui, 1969; Fuxe and 
HOkfelt, 1969; Piva et al. 1969). Schneider and Me Cann 
(1969} and Martini (1973) showed that dopamine and acetyl-
choline respectively stimulate LH release in vitro when 
added to incubation media containing hypothalamic fragments 
and anterior pituitary tissue. In addition, signals of di-
verse origin such as pineal gland secretions (Fraschini, 
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1969), testicular secretions (Moore and Price, 1930; 
Bogdanove, 1964), prostaglandins (Saksena et al. 1973), 
light, stress and emotions all have been shown to affect 
the hypothalamic-pituitary unit with respect to discharge 
of gonadotrophins. Finally, Martini and coworkers have sug-
gested that complicated "short" loop feedback mechanisms 
regulate the secretion of LH (David ~· 1966) and FSH 
(Fraschini et al. 1968) and also the control of gonadotro-
phin releasing hormone {Motta, 1969). 
1.3 Testis 
Mature testicular tissue contains at least two diffe-
rent compartments: the interstitial compartment made up of 
connective tissue containing the Leydig cells, blood and 
lymph vessels and the non-vascularized tubular compartment 
containing as main components the Sertoli cells, forming a 
blood-testis barrier, and the germinal epithelium in diffe-
rent stages of spermatogenesis. It is now well recognized 
that the testis has binding sites with high affinity for 
labelled gonadotrophins (Castro et al. 1972; Means and 
Vaitukaitis, 1972; Catt et al. 1972; Leidenberger and 
Reichert, 1972), and is the main target organ for the gona-
dotrophic hormones LH and FSH. 
It has been shown that LH can stimulate testicular 
steroidogenesis in vivo and in vitro after stimulating tes-
ticular adenyl cyclase activity (Kuehl et al. 1970; 
Eik-Nes, 1971; Darrington et al. 1972) and after augmenting 
cyclic AMP production (Romrnerts et al. 1972). The intersti-
tial cell compartment is the predominant site for testoste-
rone production in the male gonad (Christensen and Mason, 
1965; Hall et al. 1969; Cooke et al. 1972). There is no 
agreement about the possible production of testosterone by 
the seminiferous tubules (Hall et al. 1969; Cooke et al. 
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1972; Basset al. 1973). Steroids can, however, be trans-
ported from the Leydig cells to the seminiferous tubules 
(van Doorn et al. 1974). Production and secretion in vivo 
of several steroids by the normal testis of different spe-
cies have been demonstrated by Eik-Nes (1970, 1971, 1972). 
Testosterone, however, appears to be quantitatively the 
main androgen steroid in systemic blood and is thought to 
be involved in the maintenance of the structural integrity 
of the accessory reproductive organs, in '1 long" loop feed-
back control of the gonadotrophins as well as in the sper-
matogenic process in the testis itself. It is, however, 
still not clear whether testosterone as such exerts these 
effects or following conversion to Sa-reduced androstane 
metabolites (or to oestrogens). 
The effects of FSH in the male gonad are less clear, 
but it has been shown that tritiated FSH will specifically 
bind to seminiferous tubular membranes (Means and 
Vaitukaitis, 1972). Furthermore, FSH will specifically sti-
mulate cyclic AMP production in seminiferous tubules 
(Darrington et al. 1972; Cooke et al. 1972). Activation of 
adenyl cyclase induced by binding of FSH to isolated semi-
niferous tubular membranes was shown to result in an incre-
ment of intracellular levels of cyclic AMP and in activa-
tion of protein kinase activity (Means, 1974). In hypophy-
sectomized rats, androgens (Walsh et al. 1934; Nelson 
et al. 1937; Ahmad et al. 1973) or LH (Steinberger, 1971) 
are capable of maintaining spermatogenesis when treatment 
is initiated immediately following hypophysectomy. But in 
long-term hypophysectomized animals showing testicular re-
gression neither LH nor testosterone given alone are capable 
of initiating spermatogenesis and FSH has to be administered 
with LH or androgen in order to fully restore spermatogenic 
activity (Steinberger, 1971). Recently, evidence has been 
published that the Sertoli cells are affected by FSH 
(Hansson et al. 1973). It appears that under influence of 
FSH the Sertoli cell secretes an androgen binding protein 
having high affinity for the testicular secretion products 
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testosterone and Sa-dihydrotestosterone (Vernon et al. 
1974). FSH administration in vivo to hypophysectomized rats 
results in increased levels of androgen binding protein in 
the testis (Hansson et al. 1973) and FSH also increased the 
androgen binding protein production by Sertoli cells in 
vitro (Fritz et al. 1974). Furthermore, it appears that the 
Sertoli cell is also an androgen target organ. It has been 
shown, that in the immature hypophysectomized rat androgen 
was capable of maintaining the secretion of androgen bin-
ding protein by the Sertoli cell, but after long-term re-
gression of the seminiferous tubular epithelium in such 
animals FSH was again required in addition to androgen for 
complete restoration of the androgen binding protein pro-
duction (Weddington et al. 1975). Finally, Odell et al. 
(1973) have postulated that FSH induces testicular sensiti-
vity to LH, and it has been suggested that this might be an 
important cause of sexual maturation in the immature male. 
1.4 Subject of thesis 
The anterior pituitary gonadotrophic hormones LH and 
FSH play an essential role in testis physiology. On the 
other hand, factors from the testis (Moore and Price, 1930, 
1932; Me Cullagh, 1932) appear to control these hypophyseal 
gonadotrophins via a feedback regulation mechanism, since 
removal of the testes results in drastically increased cir-
culating concentrations of these trophins (Gay and 
Bogdanove, 1969). It is not clear through which mechanism 
the male gonad regulates LH and FSH production and secre-
tion. Detailed investigation of the feedback control be-
tween testicular products and the pituitary gonadotrophic 
hormones has been hampered by the lack of specific and sen-
sitive analytical methods for quantification of testicular 
steroid hormones and pituitary gonadotrophins. The influence 
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of testicular and non-testicular steroid hormones on circu-
lating LH and FSH in the mature male rat is, however, a 
matter of considerable physiological importance and has 
been the main subject of the current investigation. The in-
troduction of sensitive assays for estimation of these go-
nadotrophins in blood and tissue made this study possible. 
Production in vivo and secretion of testicular 
steroids by the isolated testis (Eik-Nes, 1970, 1971, 1972) 
and metabolism in vitro of radioactive androgens in testi-
cular tissue (Folman et al. 1972; Rivarola and Podesta, 
1972; Folman et al. 1973; Sowell et al. 1974; P§rez Lloret 
and Weisz, 1974) have been studied over the past years and 
many testicular steroids and radioactive androgen metabo-
lites have been identified. It is not certain, whether all 
these metabolites occur also in the whole animal in vivo or 
bear on physiological functions at intragonadal or extrago-
nadal androgen target levels. The androgenicity and the 
possible influence of these various androgen metabolites on 
androgen sensitive organs are still poorly documented. In 
this respect, the aim of the present study was to assess in 
adult male animals the effect of steroid hormones, and es-
pecially of testicular steroids, on circulating concentra-
tions of the gonadotrophins LH and FSH which are essential 
for adequate function of the male gonad. Orchidectomized 
animals provide advantages to study the specificity of the 
effects of steroid hormones, because the influence of endo-
genous testicular products can be ruled out in this animal 
preparation. The androgenicity of the various compounds 
tested was evaluated by the classical bioassay test measu-
ring weights of accessory reproductive organs in castrated 
animals (Young and Cornell, 1963). Furthermore, the influ-
ence of androgenic and oestrogenic steroids on the release 
of LH and FSH induced by GnRF was investigated. In addition 
to the testis, the adrenal cortex is another source of 
oestrogenic and androgenic steroids. It was therefore 
deemed necessary to investigate the possible involvement of 
adrenal steroid hormones in the regulation of the hypotha-
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lamic-pituitary-testicular system. In order to elucidate 
which testicular tissue compartment produces the testicular 
factors involved in feedback control of LH and FSH, effects 
of testicular X-irradiation (destroying the germinal epi-
thelium in the tubular compartment) in adult male animals 
were studied. Under the different experimental conditions 
in this study, the functions of the hypothalamic-pituitary 
unit and the testis were Visualized by measuring blood serum 
concentrations of LH, FSH and testosterone. 
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CHAPTER 2 
ANALYTICAL METHODS FOR THE DETERMINATION OF TESTOSTERONE 
AND THE GONADOTROPHINS LH AND FSH 
2.1 Introduction 
Lack of reliable analytical methods for estimation of 
hormones influencing the hypothalamic-pituitary-testicular 
axis has been a crucial issue for many years. Specific, 
sensitive and reliable quantification of testosterone in 
systemic blood has only been possible since the nineteen 
sixties, and the available methods for estimation of this 
hormone in biological samples up to 1970 have been reviewed 
by van der Molen (1970). Quantitative determination of the 
gonadotrophins has for a long time only been possible with 
classical biological assays using the ovarian ascorbic acid 
depletion test (Parlow, 1961) for LH measurement and the 
human chorionic gonadotrophin augmentation test (Steelman 
and Pohley, 1953) for FSH measurement. Lack of sensitivity 
of the bioassay techniques prevented, however, estimation 
of these hypophyseal gonadotrophic hormones in blood 
samples of individual rats. The advent of radioactive 
labels of high specific activity and radioimmunoassay tech-
niques in this walk of endocrinological research is a sig-
nificant landmark and, nowadays new information and pro-
gress in this field mainly depend on data obtained with 
these newcomers to our technical armamentarium. 
P_rinciples, theoretical aspects, methodology and com-
puter data processing of radioimmunoassays have been des-
cribed extensively (see: Diczfalusy, 1969, 1970; Odell and 
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Daughaday, 1971; Zettner, 1973; Zettner and Duly, 1974; 
Skelley et al. 1973; Rodbard, 1974). Once the advantages of 
radioimmunoassay (high sensitivity and specificity of detec-
tion; simplicity and practicability) were recognized, these 
methods conquered many laboratories replacing many of the 
older analytical methods. The vast literature on this tech-
nology and its applications, which has appeared since the 
publication of Yalow and Berson (1959), gives a proper re-
flection of the impact of the technique. Radioimmunoassay 
methods have permitted sensitive quantification of a broad 
spectrum of hormonal and non-hormonal substances (for 
review see: Skelley et al. 1973) and have contributed to 
new and significant information that has promoted better 
knowledge of the general physiology. Application of radio-
immunoassay techniques for the estimation of testosterone 
and pituitary gonadotrophins in order to study biological 
relationships in the hypothalamic-pituitary-testicular axis 
has been explored and evaluated in the present investiga-
tion. 
2.2 Radioimmunoassay of testosterone 
2.2.1. method 
A rabbit antiserum was raised against testosterone-3-
(0-carboxyrnethyl)-oxime bovine serum albumin. This latter 
complex was synthesized after conversion of testosterone to 
testosterone-3-(0-carboxymethyl)-oxirne and coupling the 
latter to bovine serum albumin according to the method of 
Erlanger et al. (1957). Three months after the immunization 
procedure (Verjans et al. 1973) was initiated, an antiserum 
was obtained that was deemed suitable for measurement of 
testosterone. A flow sheet of the method in which this 
antiserum was used for testosterone quantification in blood 
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TABLE 2.2.1. 
Procedure for the radioimmunoassay of testosterone in blood 
plasma or serum or testicular tissue 
Blood plasma or serum Testicular tissue 
3 
- Add 30,000 dpm H-testos- 3 - Add 30,000 dprn H-testos-
terone to plasma or serum 
(50-500 "1) 
terone to tissue (10-100 rng} 
- Sonify tissue in water 
- Extract with 1,5 ml - Precipitate proteins with 
hexane:ether - 8:2 (v/v) acetone 
- Evaporate supernatant until 
only water remains 
- Extract water layer with 
3 rnl hexane:ether - 8:2 (v/v) 
Transfer organic layer to pre-eluted aluminium oxide 
column 
- Elute column with 1.6 ml hexane:ether - 8:2 (v/v) 
6 x 1.6 ml ethanol (0.45%) in hexane 
2 x 1.6 ml ethanol (0.95%) in hexane 
- Divide last eluates over two tubes 
- Evaporate solvents in each of the tubes 
- Add 250 ~1 of antibody solution and incubate at 4°C for 
16 h 
- Take SO ~1 for recovery estimation 
Add SOO ~1 of dextran-coated charcoal suspension 
- Incubate for 5 min at 4°C 
- Centrifuge for 10 min with 3,000 rpm 
- Take SOO ~1 of supernatant for counting of bound radio-
activity 
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plasma, serum or testicular tissue is shown in Table 2.2.1. 
In order to obtain the standard curve known standard 
amounts of testosterone were treated in the same fashion as 
the unknown samples. Purification of radioactive testoste-
rone, solvents for extraction and chromatography, prepara-
tion of aluminium oxide (A1 2o 3 ) micro-columns for chromato-
graphy, antibody buffer and dextran-coated charcoal suspen-
sion have been described by Verjans et al. (1973). 
2.2.2. results 
several methods for separation of antibody bound and 
free testosterone were compared and the dextran-coated 
charcoal method was found to be the most practical one 
(Verjans et al. 1973) and employed throughout the rest of 
the studies. 
The effects of the addition of increasing amounts of 
testosterone or of various other steroids to the binding of 
radioactive testosterone by the diluted antiserum are de-
picted in Fig. 2.2.1. 
s~-Dihydrotestosterone exhibits considerable cross 
reaction with this testosterone-3-(0-carboxymethyl)-oxime 
bovine serum albumin antiserum. It has been reported that 
this cross reaction of s~-dihydrotestosterone also occurs 
with several other antisera elicited against testosterone 
bovine serum albumin or testosterone thyroglobulin com-
plexes, irrespective of the site of coupling of these pro-
teins to the steroid via either the 1,7 (Kohen et al. 
1975), 3,11 or 17 (Bosch et al. 1974) position in testoste-
rone. The presence of Sa-dihydrotestosterone in human male 
and female blood plasma (Ito and Horton, 1970; Tremblay 
et al. 1970) and in rat serum (Coyotupa et al. 1973) and 
testicular tissue (Folman et al. 1972) has been demonstra-
ted. Therefore, inclusion of a chromatographic procedure on 
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FIG. 2.2.1. Displacement of tritiated testoste-
rone from testosterone antiserum (1:20,000 
diluted) by various steroids. 
Al 2o3 micro-columns separating testosterone from Sa-dihydro-
testosterone, should improve specificity of the described 
radioimmunoassay. We found, however, for rat testis tissue 
no differences between testosterone concentrations obtained 
with a gas-liquid chromatography procedure (Brownie et al. 
1964) and this radioimmunoassay method omitting the chroma-
tography step on the Al 2o 3 column (Verjans et al. 1973). 
This is in agreement with the observation that testicular 
tissue concentrations of Sa-dihydrotestosterone in mature 
rats are minute (Felman et al. 1972). Recovery of added 
tritiated testosterone after extraction from rat testicular 
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tissue (Table 2.2.1.) was 92 ~ 2 (S.D.)%. After extraction 
and Al 2o3 micro-column chromatography of blood plasma 
samples (Table 2.2.1.) a recovery of 67 ~ 8 (S.D.)% was 
obtained. Recovery of added tritiated testosterone after 
incubation with diluted antiserum (Table 2.2.1.) was 
90 + 5 (S .. D.) %. Results from accuracy testing of this 
method are given in Table 2.2.2. Mean blank values were 
TABLE 2.2.2. 
Accuracy of the estimation of testosterone by radioimmunoassay 
pg testosterone pg testosterone 
added to water n found {mean) 
50 47 
100 96 
150 152 
200 206 
300 260 
S.D. 
{in pgl 
8 
8 
35 
35 
~Coefficient of variation{%) " {S.D./mean x 100%) 
Coefficient:~: 
of 
variation 
3 3. 0 
8. 5 
8. 3 
5. 3 
17.0 
13.5 
% recovery 
94 
96 
;01 
10 3 
87 
low, varying from zero to four pg, and the sensitivity of 
the method was in the order of 25 pg. Data on the precision 
of the method as applied to human male blood plasma are 
summarized in Table 2.2.3. In addition, reliability of the 
described radioimmunoassay was evaluated by comparison of 
testosterone concentrations in the same samples of human 
blood plasma or rat testicular tissue assayed by a gas-
liquid chromatography method described by Brownie et al. 
(1964). For rat testis tissue samples a correlation coeffi-
cient of 0.95 (n=54) was found when the same samples were 
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TABLE 2.2.3. 
P~ecision of multiple estimations of testosterone in human male 
plasma pe~formed in four different assays using radioirrununoassay. 
Mean values fo~ each assay (intra-assay) and mean values calcu-
lated from the mean values obtained in the different assays 
(inte~-assay) are given 
Plasma 
M 1 
M 2 
M 3 
M 4 
M 5 
M 6 
Number of 
Testosterone 
(~,g/100 ml) 
Assay replicates Intra-assay Inter-assay 
means 2:_ S.D. 
(C.V.ll1) 
number in each 
assay 
2 
4 
2 
3 
4 
2 
4 
3 
4 
2 
6 
7 
8 
7 
7 
7 
6 
7 
8 
8 
8 
6 
7 
8 
7 
7 
7 
means 2:_ S.D. 
(C. V. :t) 
0.50 2:0.12 (24%) 0.49 2:0.03 (6%) 
0.45 2: 0.02 (5%) 
0.51 2: 0.06 (13%} 
0.48 2: 0.07 (14%} 
0.75 2:0.09 {12%) 0.73 2:_ 0.05 (7%) 
0.782:_0.10 (13%} 
0.72 2:0.09 {12%) 
0.66 2: 0.05 (7%) 
0.72 2:0.08 {10%) 0.69 2:0.04 (6%) 
0.71 2:_ 0.09 (13%) 
0.66 2:_ 0.07 (10%) 
0.65 .:!: 0.05 (7%} 
0.44 .:!: 0.03 (7%} 
0.43 .:!: 0.06 (14%) 
0.41.:!: 0.05 (13%) 
0.47 2: 0.04 (8%} 
0.58 2: 0.05 (9%) 
0.80 2: 0.10 (13%) 
0.44 2: 0.03 (7%) 
0.68 2:0.12 (17%) 
8 0.57 2: 0.06 {10%) 
4 
2 
3 
4 
7 
3 
8 
8 
8 
0.75 2: 0.03 (5%) 
0.49 0.41 2: 0.06 (15%) 
0.36.:!: 0.10 (28%) 
0.37.:!: 0.07 (19%) 
0.42.::: 0.06 {15%) 
:tCoefficient of variation (%) = (S.D./mean x 100%} 
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assayed with radioimmunoassay and gas-liquid chromatography. 
For human female plasma this value was 0.80 (n=36) and for 
human male plasma a correlation coefficient of 0.87 (n=92) 
could be determined. In a few assays for the determination 
of rat serum testosterone levels, thin layer chromatography 
on silicagel using the solvent system toluene:methanol -
9:1 (v/v) was employed in order to separate Sa-dihydrotes-
tosterone from testosterone. The results obtained for rat 
serum testosterone concentrations were essentially the 
same as those measured with the authentic method 
(Table 2.2.1.) not employing thin layer chromatography. 
2.2.3. discussion 
Accuracy and precision of the radioimmunological esti-
mation of testosterone are acceptable. Specificity of de-
tection of the procedure including Al 2o 3 micro-column chro-
matography appears to be satisfactory as reflected by the 
correlation coefficients found between testosterone concen-
trations in samples analysed with radioimmunological end-
point of detection and a technique based on gas-phase chro-
matography and electron capture as endpoint of detection. 
Data from other investigators show moreover that when tes-
tosterone is estimated in the same blood plasma samples by 
radioimmunoassay and gas-liquid chromatography (Collins 
et al. 1972), competitive protein binding (Furuyama et al. 
1970; Dessypris and Adlercreutz, 1972; Dufau et al. 1972) 
or double isotope derivative assay (Dufau et al. 1972) the 
measured testosterone concentrations are in agreement. It 
appears therefore reasonable to conclude that satisfactory 
assay of testosterone in human blood plasma (van der Molen 
et al. 1971) can be done with radioimmunoassay technique. 
In addition, the correlation found between testosterone 
concentrations by radioimmunoassay and gas-liquid chromato-
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graphy in the same rat testis tissue samples supports the 
validity of the radioimmunoassay method for testosterone 
estimations in tissues containing high concentrations of 
this hormone. Sensitivity of detection and practicability 
of the radioimmunoassay method offer, however, distinct 
advantages over other currently available techniques for 
testosterone determination and made the radioimmunoassay 
the method of choice in the present study. 
2.3 Radioimmunoassay of rat LH and rat FSH 
2.3.1. method and results 
The radioimmunoassay systems used for the estimation 
of rat LH and rat FSH have been published by Uilenbroek 
(1974). These techniques are essentially a modification of 
the radioimmunoassay system introduced by Niswender et al. 
(1968b) and utilize purified ovine gonadotrophin prepara-
tions for the immunization procedures and purified rat 
gonadotrophin preparations for radioiodination. The tech-
niques used in the present investigations are therefore 
referred to as "OR rat LH" radioimmunoassay and "OR rat 
FSH" radioimmunoassay according to the convention of 
Niswender et al. (1968a). Flow sheets of these methods are 
shown in Tables 2.3.1. and 2.3.2. 
Production of antisera, antiserum dilutions, buffer 
solutions, procedures for labelling of rat LH and rat FSH 
'th 125 d 'f' . 't f h l b ll d h w1 I an spec1 1c act1v1 y o t e a e e orrnones 
have been described in detail by Uilenbroek (1974). The 
purified rat LH and rat FSH preparations used as reference 
standards and for the labelling were obtained from The 
National Institute of Arthritis and Metabolic Diseases 
(NIAMD), Bethesda, Maryland, U.S.A. and the biological ac-
tivities of these preparations as measured by bioassay 
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TABLE 2.3.1. 
Procedure for the radioimmunoassay of LH in blood serum 
of male rats ("OR rat LH" system) 
- Standard series over the range 0-500 ng NIAMD rat LH RP-1 
- Blood serum samples (100 ~1) are adjusted to 500 ~1 with 
buffer 
- Add 200 ~1 of diluted rabbit anti-ovine LH-serum 
- Incubate for 24 h at 4°c 
- Add 100 ~1 of solution of 125 r-labelled NIAMD rat LH I-1 
(10,000 cpm) 
- Incubate for 72 h at 4°C 
- Add 200 ~1 of diluted donkey anti-rabbit y globulin serum 
- Incubate for 48 h at 4°C 
- Centrifuge for 20 min at 3,000 rpm and aspirate super-
natant 
- Wash precipitate with buffer 
- Centrifuge for 20 min at 3,000 rpm and aspirate super-
natant 
- Count precipitate for antibody bound radioactivity 
techniques are given in appendix paper 1. Rat serum samples 
were analysed using a constant volume of 100 ~1 throughout 
all assays for both LH and FSH and LH and FSH concentra-
tions were expressed on the basis of the widely used refe-
rence standard preparations NIAMD rat LH RP-1 and NIAMD 
rat FSH RP-1 respectively. 
Standard curves, specificity of antiserum, accuracy, 
precision and sensitivity of the "OR rat LH" and the 11 0R 
rat FSH" radioimmunoassays have been published in detail 
38 
w 
"' 
Tli.Bi..E 2, 3 , 3. 
Precision of estimation of LH in male rat serum samples (100 ~l) performed in different 
assays using the "OR rat LH" radioimmunoassay. Mean values for each assay (intra-assay) 
and mean values calculated from the mean values obtained in the different assays 
(inter-assay) are given 
Number Number of 
Serum of replicates 
assay per assay 
IV 1 5 
2 4 
3 4 
4 4 
v 1 5 
2 4 
3 4 
4 4 
5 4 
VI 1 4 
2 4 
3 4 
4 4 
XCoefficient of variation I% I ~ 
ng NIAMD rat LH RP-1/ml serum 
Intra-assay 
means + S.D. (C.V.:I:) 
906 + 189 ( 21%) 
1,029 + 171 ( 1 7%) 
917 + 41 14%1 
834 + 203 ( 24%} 
285 + 42 ( 15%) 
248 + 17 I 7% I 
170 + 5 13% I 
228 + 16 17% I 
280 + 18 16%1 
63 + 28 144%1 
89 + 12 113%1 
73 + 10 I 14%1 
101 + 6 I 6%1 
(S.D./mean x 100%) 
Inter-assay 
means+ S.D. (C.V.~) 
921 + 80 (9%) 
242 + 47 (19%} 
82 + 17 (21%) 
TABLE 2.3.2. 
Procedure for the radioimmunoassay of FSH in blood serum 
of male rats ("OR rat FSH" system) 
- Standard series over the range 0-200 ng NIAMD rat FSH RP-1 
- Blood serum samples (100 ~1) are adjusted to 500 ~1 with 
buffer 
- Add 200 ~1 of diluted rabbit anti-ovine FSH-serum 
- Incubate for 24 h at 4°C 
- Add 100 "l of solution of 125 r-labelled NIAMD rat FSH I-1 
(10, 000 cpm) 
- Incubate for 72 h at 4°C 
- Add 200 ul of diluted donkey anti-rabbit y globulin serum 
- Incubate for 48 h at 4°C 
- Centrifuge for 20 min at 3,000 rpm and aspirate super-
natant 
- Wash precipitate with buffer 
- Centrifuge for 20 min at 3,000 rpm and aspirate super-
natant 
- Count precipitate for antibody bound radioactivity 
by Uilenbroek (1974) and Welschen et al. (1975). Data on 
the precision of these radioimmunoassay systems as applied 
to multiple 100 ~1 samples of pooled serum obtained from 
adult male rats are summarized in Tables 2.3.3. and 2.3.4. 
samples with various concentrations of gonadotrophins were 
analysed in triplicate, quadruplicate or quintuplicate in 
different assays performed on different days. The coeffi-
cients of variation of the mean estimate in each individual 
assay, reflecting the intra-assay precision, varied from 
3 to 44% for LH (Table 2.3.3.) and from 2 to 17% for FSH 
(Table 2.3.4.). Mean values and standard deviations calcu-
lated from average values obtained in different assays, may 
give an impression about possible inter-assay variations. 
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TABLE 2.3.4. 
Precision of estimation of FSH in male rat serum samples (100 Wl) performed in different 
assays using the "OR rat FSH" radioimmunoassay. Mean values for each assay (intra-assay) 
and mean values calculated from the mean values obtained in the different assays 
(inter-assay) are given 
ng NIAMD rat FSH RP-1/ml serum 
Number Number of Intra-assay Inter-assay 
Serum of replicates means 2:. S.D. (C.V. :t:) means 2:. S.D. (C.V.*) 
assay per assay 
I 1 4 1-,243 .:t. 171 ( 14%) 1,209 + 152 (13%) 
2 4 1,198 + 140 (12%) 
3 3 1,432 .:t. 33 (2%) 
4 5 1,164 + 55 ( 5%) 
5 5 1,008 2:. 77 (8%) 
II 1 5 396 + 65 (16%) 455 + 40 (9%) 
2 5 478 + 44 (9%1 
3 5 480 + 36 (8%1 
4 3 467 + 78 ( 17%) 
III 1 4 323 + 25 (8% I 308 + 18 (6%) 
2 5 288 + 41 (14%) 
3 5 324 + 15 (5%1 
4 5 296 + 15 ( 5% I 
:t:Coefficient of variation (%1 
" 
(S.D./mean x 100%) 
For LH determination these latter coefficients of variation 
ranged from 9 to 21% and for FSH determination from 6 to 
13%. From the comparison of these intra-assay and inter-
assay coefficients of variation it appears that, in general, 
precision of the radioimmunoassay for rat FSH was slightly 
better than for rat LH. 
2. 3. 2. discussion 
The development of radioimmunoassay techniques for rat 
LH and rat FSH has made it possible to monitor gonadotro-
phin concentrations in serum of individual rats (Monroe 
et al. 1968; Niswender et al. 1968b; Daane and Parlow, 
1971). For the present study the heterologous "OR rat LH" 
and 11 0R rat FSH" radioimmunoassay systems have been used. 
Accuracy and precision of these systems appear to be in the 
same range as those of the widely used homologous "RR rat 
LH" and 11 RR rat FSH" radioimmunoassay systems supplied by 
the NIAMD (Seki et al. 1971), while the sensitivity of both 
assay systems employed is higher than that of the NIAMD 
kits (Uilenbroek, 1974; Welschen et al. 1975). The specifi-
city of the "OR rat LH and FSH" radioimmunoassays is similar 
to that of the highly specific NIAMD radioimmunoassays 
(Welschen et al. 1975). Slight interferences of serum com-
ponents in the rat FSH radioimmunoassay have been reported 
(Swerdlof£ et al. 1971; Seki et al. 1971; Uilenbroek, 1974). 
Therefore, it was deemed necessary to measure all serum 
samples at the same volume level of 100 ~1 in this radio-
immunoassay system. Furthermore, in order to avoid inter-
assay variations, only sample values analysed in the same 
assay have been compared in this study. 
All radioimmunoassay systems so far used for quantifi-
cation of gonadotrophin hormones may not necessarily measure 
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biologically active but rather immunologically active hor-
mones. Monroe et al. (1968) and Niswender et al. (1968b) 
have reported a good correlation between results of classi-
cal bioassay and radioimmunoassay for rat LH concentrations 
in pituitary extracts. Rat serum LH values estimated by 
radioimmunoassay, however, were found to be lower than 
those measured by bioassay (Monroe et al. 1968; Bogdanove 
et al. 1971). A satisfactory correlation between results of 
bioassay and radioimmunoassay has been found for FSH esti-
mation in rat pituitary extracts and rat serum samples 
(Daane and Parlow, 1971; Shahmanesh et al. 1975a). Diebel 
et al. (1973), however, reported marked discrepancies be-
tween rat pituitary FSH levels estimated by bioassay and 
radioimmunoassay. 
Recently, more sensitive bioassay techniques for mea-
surement of gonadotrophins have been introduced. These new 
techniques are based on the interaction of gonadotrophins 
with specific gonadotrophin receptors in testicular tissue. 
Reichert and Bhalla (1974) developed a radioligand recep-
tor-binding assay for measurement of human FSH employing 
homogenate of tubular elements of rat testes. Using testis 
homogenate of adult rats, Catt et al. (1972) introduced the 
radioligand receptor-binding assay for measurement of LH. 
Attempts to measure LH concentrations in rat serum with 
this latter method were, however, unsuccessful (Shahmanesh 
et al. 1975b). Dufau et al. {1974) described a sensitive 
bioassay in vitro for measurement of LH activity using 
collagenase-dispersed rat Leydig cells. Thus far, these 
newer receptor-binding techniques have not been applied for 
measurement of rat serum gonadotrophins. When LH concentra-
tions were measured in rat pituitary tissue (Shahmanesh 
et al. 1975b) or human blood plasma (Dufau et al. 1974) by 
these receptor-binding methods and by radioimmunoassay, the 
latter technique tended to give lower LH results. The dis-
crepancies observed were of quantitative rather than of 
qualitative nature. 
Over the last years increasing evidence has accumulated 
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that several hormone preparations having similar immunolo-
gical properties may differ widely in their biological po-
tency (Robyn et al. 1971). Furthermore, it has been esta-
blished that many protein and polypeptide hormones exist in 
more than one form, both in blood plasma and in tissues 
(Berson and Yalow, 1968i Rabinowitz et al. 1974). The com-
plexity of immunoreactive conformations of several peptide 
hormones in plasma and in tissue has recently been reviewed 
by Yalow (1974). It has been demonstrated that different 
molecular forms of FSH in rat (Diebel et al. 1973) and 
monkey (Peckham et al. 1973) pituitary tissues and in rat 
serum (Bogdanove et al. 1974a) and of LH in human blood 
plasma (Robertson et al. 1975; Loeber and Lequin, 1975) may 
exist. Heterogeneity of polypeptide hormones may therefore 
explain some of the discrepancies found between bioassay 
and radioimmunoassay potency estimates. After certain 
treatments, the structure of the polypeptide hormone mole-
cule could have been altered in such a way that either the 
immunological or the biological activity might have changed. 
In the male rat, it has been shown that long-term orchidec-
tomy alters the physicochemical characteristics of pituitary 
(Diebel et al. 1973) and serum (Bogdanove et al. 1974a) 
FSH. Exogenous androgen treatment of such rats could reverse 
this effect (Diebel et al. 1973; Bogdanove et al. 1974a,b). 
Such effects and changes have not been observed for rat 
pituitary LH (Bogdanove et al. 1974b). These observations 
might indicate a steroid regulated pleomorphism of rat FSH 
in long-term castrates (Diebel et al. 1973). There is, 
however, no reason to believe that the hypothalamic-
pituitary axis still responds in a normal way after long-
term castration (Schwartz and Me Cormack, 1972), and in the 
present study only short-term gonadectomized, adult male 
rats have been employed. 
Although these data indicate, that certain limitations 
may be associated with the use of radioimmunoassay of rat 
serum gonadotrophins, this should not detract from the fact 
that radioimmunoassay techniques actually offer the only 
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possibility to estimate gonadotrophin activity in blood 
serum of individual rats. Recognizing the limitations of 
measuring gonadotrophins by radioirnrnunoassays, it may be 
concluded, however, that these assays offer a useful 
approach to the solution of physiological problems, which 
previously were not accessible for direct investigations. 
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CHAPTER 3 
EXPERIMENTS WITH GONADECTOMIZED,ADULT MALE RATS 
3.1 Introduction 
The results of the effects of injecting a standard 
dose of 100 ~g/100 g b.w./day of various steroids during 
7 days on serum gonadotrophin levels and ventral prostate 
weights in orchidectomized, adult male rats (appendix 
paper 6) prompted us to investigate and compare the influ-
ence of lower doses of some potent androgens on serum gona-
dotrophins and weights of accessory reproductive organs. 
Furthermore, we have examined whether the observed positive 
feedback effects of androgens in castrates (appendix 
paper 6) are associated with the presence of a 36-hydroxy 
group in such steroids. 
The present chapter provides results on the effects of 
administering 6.25, 12.5, 25, 50 or 100 ~g/100 g b.w./day 
during 7 days of various androgens on weights of the ven-
tral prostate and seminal vesicles and on serum gonadotro-
phin concentrations in gonadectomized, adult male rats. In-
formation on the effects of injection during 7 days of 
100 ~g/100 g b.w./day of the various steroids, tested in 
the study of appendix paper 6, on weights of seminal vesi-
cles in castrates has also been included here. Furthermore, 
results are reported on the influence of administering 
50 ~g/100 g b.w./day during 7 days of various 36-hydroxy 
androstenes or androstanes on circulating gonadotrophin 
levels in castrates. Finally, we have studied the effect of 
exposure to ether anaesthesia during 2 min on serum levels 
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of LH, FSH and testosterone in gonadectomized male rats. 
In the Discussion section of this chapter, we have 
tried to evaluate our data on effects of steroids on circu-
lating gonadotrophins and weights of accessory reproductive 
organs in our experimental orchidectomized animal model 
(see also appendix papers 2, 3, 4, 6 and 7) in light of 
published information on: a) testicular steroid secretion 
in adult males, b) effects of castration on gonadotrophins, 
GnRF and circulating steroids and c) uptake and metabolism 
of steroids by the hypothalamic-pituitary axis. 
3.2 Animals 
Adult, male, Wistar rats (3 to 4 months old, body 
weights ranging from 250 to 330 g) were used. The animals 
were kept under constant light (14 h light and 10 h dark-
ness), temperature (19-21°C) and humidity conditions. Labo-
ratory rat chow and tap water were provided ad libitum. The 
animals were employed in experiments at least one week 
after arrival in the animal quarters. 
3.3 Experimental animal model and hormone treatments 
Rats were orchidectomized via the abdominal route under 
ether anaesthesia. Subcutaneous injections with various 
doses of different steroids or other compounds in sesame 
oil (0.04 ml oil/100 g body weight) were given immediately 
after surgery and continued daily during the next six days. 
Control castrated animals received sesame oil only (0.04 ml/ 
100 g b.w.). control normal animals were exposed to ether 
vapour for 10 min prior to the first injection with vehicle 
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only. The rats were injected each day between 11 a.m. and 
1 p.m. Twenty hours after the last injection, the animals 
were weighed, exposed to ether vapour in a jar for appro-
ximately 2 min and then immediately decapitated. Blood was 
collected from the trunk and allowed to clot overnight at 
4°C. Resulting blood serum was stored at -20°C until ana-
lysed for gonadotrophins and testosterone. Accessory repro-
ductive organs were removed immediately following sacrifice. 
After dissection the seminal vesicles (emptied) and ventral 
prostates were weighed. All steroids employed were pur-
chased from Steraloids (Pawling, New York, u.s.A.), unless 
otherwise stated in the appendix papers, and used without 
purification. Treatment with ACTH or dexamethasone was as 
indicated in appendix paper 4. Administration of gonado-
trophin releasing factor (GnRF) to animals pretreated with 
steroids, was as stated in appendix paper 7. Three or more 
rats were used for each treatment group. 
Each set of hormone treatments had its own controls 
both of castrated and normal rats. Owing to slight diffe-
rences in age and body weights of the various animal groups 
used during the entire period of all experiments (2~ years) 
and to inter-assay variations in the hormone determinations 1 
we have expressed some data relative to castrate control or 
normal control values. These latter informations were ob-
tained from animals of the same age and runned in the same 
experiment. 
Significance of differences between the absolute 
values of the relative weights of accessory reproductive 
organs (mg/100 g b.w.) and of serum testosterone and gona-
dotrophin levels (ng/ml) from the different treatment 
groups was determined using student's t-test unless other-
wise stated. 
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3.4 Results 
Serum gonadotrophins and testosterone 
Effect of exposure to ether vapour during 2 min on 
serum levels of LH, FSH and testosterone in gonadectomized 
male rats is shown in Table 3.4.1. One group of rats was 
TABLE 3, 4, 1. 
Effect of exposure to ether vapour during 2 min on mean 
(±S.D.) serum levels of LH, FSH and testosterone in gona-
dectomized, mature male rats (n=S) injected each day during 
7 days with 0.04 ml sesame oil/100 g b.w. 
Treatment 
ether 
no ether 
LH 
(ng/ml) 
373 + 79 
428 + 48 
FSH 
(ng/ml) 
1,287 + 184 
1,224 + 74 
testosterone 
(ng/ml) 
0.04 + 0.03 
0.03 + 0.03 
weighed, exposed to ether and then decapitated immediately 
after removal from the ether jar, the other group was first 
weighed and then immediately decapitated. In these castra-
ted rats ether anaesthesia did not significantly affect the 
blood serum parameters investigated (Table 3.4.1.). Effects 
of treating of castrates with ACTH or dexamethasone on cir-
culating hormone levels are summarized in appendix paper 4. 
Influence of increasing doses of 4-androstene-3,17-
dione, testosterone (appendix paper 3), 4-androstene-38, 
178-diol, Sa-dihydrotestosterone (Verjans and Eik-Nes, 
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1976), Sa-androstane-3a,17S-diol (Verjans and Eik-Nes, 
1976) or Sa-androstane-36,176-diol on serum concentrations 
of LH and FSH in gonadectomized rats are summarized in 
Tables 3.4.2. and 3.4.3. respectively. Injection of 2S ug/ 
100 g b.w./day of Sa-dihydrotestosterone or 5a-androstane-
3a,17S-diol during 7 days was sufficient to keep circula-
ting LH in castrated rats at values encountered in normal 
rats (P < O.OS). These Sa-reduced androstanes exhibited a 
higher potency than the other steroids used (Table 3.4.2.) 
in curbing augmentation of serum LH postorchiectomy. Admi-
nistration of relatively low doses of androgens to castra-
tes resulted in circulating LH levels higher than those 
found in castrate controls. This rise was significant 
(P < 0.05) following administration of 2S ug testosterone, 
50 ~g testosterone, 4-androstene-36,176-diol or 5a-andros-
tane-36,176-diol and 100 ug 4-androstene-36,176-diol. In 
order to prevent the increase in circulating FSH levels 
postgonadectomy, higher doses of Sa-reduced testosterone 
metabolites were required than for curbing the LH rise 
(Tables 3.4.1. and 3.4.2.). At the doses tried testosterone, 
4-androstene-3,17-dione, 4-androstene-36,176-diol or 5a-
androstane-36,176-diol were less effective in suppressing 
serum FSH than were Sa-dihydrotestosterone or 5a-androstane-
36,176-diol. Injection of low doses of the six androgens 
tested tended to elevate circulating FSH levels over cas-
trate control levels. This effect was significant (P < 0.05) 
after injection of 2S ~g 5a-androstane-36,176-diol and 
50 ~g of 4-androstene-36,176-diol or Sa-androstane-36,176-
diol (Table 3.4.3.). In addition, we observed that adminis-
tration of 50 ~g 4-androstene-36,17a-diol or 5-androstene-
36,176-diol resulted in significantly (P < O.OS) higher 
mean values of circulating LH and FSH levels than values in 
castrate control animals (Table 3.4.4.). Various steroids 
from the 4-androstene, S-androstene, Sa-androstane and 56-
androstane series were administered only in a dose of 
100 ~g/100 g b.w./day to gonadectomized rats and effects of 
these steroids on serum LH and FSH are given in appendix 
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TABLE 3.4.2. 
Effects of various doses (~g/100 g b.w./day for 7 days s.c.) of different steroids on serum LH levels 
(ng/ml) in gonadectomized, mature male rats. Mean levels + S.D. (n~J) are expressed as % of castrate 
control values (;100%) 
~ 4-androstene- testosterone 4-androstene- Sa-dihydro- Sa-androstane- Sa-androstane-e 3, 17-dione 38,178-diol testosterone 3a,l76-diol 3B, 178-diol 
oil 100 .!_ 20 100 + 17 100 .:!:_ 16 100 + 19 100 + 19 100 + 20 
6.25 110 + 35 101 + 13 140 .:!:_ 21 liB + 28 7 4 + 19 82 + 13 
12.5 132 + 43 98 + 11 143 :I: 26 120 + 30 54 + 14 97 + 18 
25.0 136 + 26 155 .:!::_ 20 160 .:!:_ 45 33 + ll 35 ' 8 143 + 18 
50,0 94 + 27 139 + 14 139 .!_ 8 6 ' 2 31 + 10 169 + 19 
100. 0 110 + 24 71 .!_ 10 153 .:!:_ 27 < 5 < 5 107 + 28 
normal, oil 18 ' 6 23 ' 5 20 .:!:_ 6 
"' 
6 22 ' 6 18 + 5 
--- -- - -
' 
-- ------ --------
"' 
"' 
TABLE 3.4,3, 
Effects of various doses {ug/100 g b.w./day for 7 days s.c.) of different steroids on serum FS!l levels 
{ng/ml) in gonadectomized, mature male rats. Mean levels~ S.D. {n~3) are expressed as % of castrate 
control values (=100%) 
~ 4-androstene- testosterone 4 androstene- So-dihydro- So androstane So androstane-e 3, 17-dione 36, 178-diol testosterone 3a,l7S-diol 3B ,176-dio1 
oil 100 + 12 100 .:!.: 20 100 2:. 16 100 2:. 18 100 ~ 18 100 .:::: 12 
6. 25 106 + 14 11S 2:. 9 104 2:. 12 112 .:!: 7 114.:!: 9 110 ~ 49 
12. s 123 + 12 127 .± 13 124 .:!: 21 121.:!: 17 117 + 8 108 .: ll 
2S.O 123 + 45 98 ± 13 131 2:. 10 108 ± 5 95 ~ 2 138 ± 9 
50,0 120 + 21 79 ± 16 14S .: l7 76 ± 11 89 + 10 147 ± 14 
100.0 106 + 16 63 2:. 14 107 2:. 20 36 .± 10 23 ± 3 96 .: 8 
normal, oil 29 + 8 28 ± 7 30 ± 7 31 ± 5 31 2:. 5 29 ~ 8 
TABLE 3.4.4. 
Effects of various 36-hydroxy androstenes or androstanes 
(50 "g/100 g b.w./day for 7 days s.c.) on mean (~S.D.) 
serum gonadotrophin levels (ng/ml) in gonadectomized, 
mature male rats (n=4) 
Serum LH Serum FSH 
Treatment (ng/mll (ng/ml) 
sesame oil 293 + 81 1,173 ~ 65 
50 
"g 4-androstene-3s,l7a-diol 557 + 23" 1,338 + so" 
50 
"g 5-androstene-3s,l7S-diol 537 + 55" 1,312 + 20" 
50 
"g 5a-androstan-3s-ol 378 + 135 1,057 + 90 
50 
"g 5a-androstan-3s-ol-17-one 430 + 74 1,322 + 170 
50 
"g ss-androstan-3s-ol-l7-one 366 + 211 1, 193 + 214 
normal, sesame oil 57 + 16 390 + 10 
"P < o.os, compared with castrate controls receiving 
vehicle only 
paper 6. Effects of oestrogens and oestrenes on these para-
meters are recorded in appendix papers 2 and 6. 
Weights of accessory reproductive organs 
Results of daily injections during 7 days with various 
androstenes, androstanes, oestratrienes and oestrenes in a 
dose of 100 ~g/100 g b.w. on ventral prostate weights in 
castrated male rats are given in appendix paper 6. Effects 
of oestrogen, ACTH or dexamethasone administration on 
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weights of accessory sex organs in castrates have been pre-
sented in appendix papers 2 and 4 respectively. Testoste-
rone, Sa-dihydrotestosterone and 5a-androstane-3a,l7S-diol 
were more potent in this respect than 4-androstene-3,17-
dione or 4-androstene-3S,l7S-diol since daily injection of 
as little as 6.25 ~g of these former androgens could pre-
vent ventral prostate weights to decrease to castrate con-
trol values (P < 0.01) (Table 3.4.5.). Administration of 
100 ~g of either testosterone, 4-androstene-3S,17S-diol, 
Sa-dihydrotestosterone or 5a-androstane-3a,17S-diol main-
tained weights of seminal vesicles in castrates at values 
measured in normal controls (P < 0.05), but injection of 
100 ~g 4-androstene-3,17-dione did not show this effect and 
5a-androstane-3S,17S-diol in the doses used had no effect 
on the weights of ventral prostates and seminal vesicles 
(Tables 3.4.5. and 3.4.6.). In addition to the data on 
weight of ventral prostate given in appendix paper 6, it 
was found that the weight changes of the seminal vesicles 
in general followed the pattern of weight changes of the 
ventral prostate subsequent to injection of various 
steroids in orchidectomized male rats. Administration of 
100 ~g of 5-androstene-3S,17S-diol but not of 5-androsten-
3S-ol-17-one was able to keep weights of seminal vesicles 
in castrates at values encountered in normal animals, 5S-
androstanes did not or only slightly affect weights of the 
seminal vesicles and prostates (appendix paper 6) in cas-
trates. In contrast to Ss-androstanes, their Sa-epimers 
showed high activity in preventing weight decrease of semi-
nal vesicles and ventral prostates (appendix paper 6) post-
gonadectomy. Given in a dose of 100 ~g/100 g b.w./day for 
7 days, Sa-androstane, Sa-androstan-3-one, 5a-androstane-
3a,l1S,17s-triol completely, and 5a-androstan-3a-ol-17-one, 
5a-androstan-3s-ol, Sa-androstan-17s-ol, Sa-androstane-3, 
17-dione partly, prevented the decrease in weight of the 
semina-l vesicles postcastration as compared with normal 
control rats. Administration of 5a-androstan-3a-ol, 5a-
androstane-3a,16a,17s-triol, 5a-androstan-3s-ol-17-one or 
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TABLE 3.4,5. 
Effects of various doses (~g/100 g b.w,/day for 7 days s.c.} of different steroids on weights of 
ventral prostates (mg/100 g b.w.) in gonadectomized, mature male rats. Mean data + S.D. (n~J) are 
expressed as % of normal control values (;100%) 
~ 4-androstene- testosterone 4-androstene- So.-dihydro- So-androstane- Sa-androstane-e 3,17-dione JS, 17e-diol testosterone 3a,l713-diGl 38, 178-diol 
oil 28+ 3 28 ~ 5 21 + 3 24 + 2 24 .!_ 2 28 .:1:_ 3 
6. 25 38 + 9 66 .!_ 12 41 + 14 59 + 5 62 + 9 24 .!_ 10 
12.5 38 + 15 73 + 12 49 .:!:_ 4 61 + 19 80 + 11 23 ::_ 2 
25.0 53 + 10 81 + 12 57 + 27 64 + 7 83 + 12 26 .!_ 6 
50.0 68 + 12 85 + 14 56 + 16 75 .! 15 87 + 13 26 .!_ 3 
100,0 73 + 14 96 + 5 104 .!_ 10 117 + 3 115 .!_ 31 3 5 .!_ 6 
normal, oil 100 .:!:_ 19 100 + 14 100 .!_ 25 100 2: 21 100 .:!:_ 21 l 00 .!_ 19 
--· -·- --
__ L_ 
"' 
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TABLE 3.4.6. 
Effects of various doses (ug/100 g b.w./day for 7 days s.c.) of different steroids on weights of 
seminal vesicles (mg/100 g b.w.) in gonadectomized, mature male rats. Mean data+ S.D. (n~3) are 
expressed as % of normal control values (=100%) 
~ 4-androstene- testosterone 4-androstene- Sa-dihydro- Sa-androstane- Sa-androstane-3,17-dione 36,178-diol testosterone 3a,l7tl-diol 36, 1713-diol e 
oil 55 + 3 43 + 6 43 :!: 9 59 + 5 59 :!: 5 55 + 3 
6. 25 60 + 17 60 + 17 52 .:!::. 5 76 + 10 67 :: 8 51 + 3 
12.5 59 :: 6 63 + 9 52 + 20 79 + 4 86 + 4 55 + 8 
25.0 60 .:!::. 17 71 + 17 53 :!:. 6 74 + 9 82 :::. 20 61 + 11 
so.c 61 + 16 7 4 + 13 61 :!:. 22 84 + 14 100 :!:. 8 57 + 12 
100.0 7 0 .:!:: 6 82 + 9 7 2 + 18 105 :!:. 12 106 + 6 59 :!:. 5 
normal, oil 100 .:!::. 18 100 + 24 100 + 15 100 :!:. 12 100 :::. 12 100 :!:. 18 
Sa-androstane-36 1 116,176-triol in the given dose could, 
however, not counteract this weight decrease following re-
moval of the testes. Effects of oestrogen treatment on 
accessory reproductive organ weights are given in appendix 
paper 2. The oestratrienes and oestrenes tested did not 
affect the decrease of ventral prostate weights in castra-
tes (appendix paper 6), but 5(10)-oestrene-3a,17S-diol, 
1,3,5(10)-oestratrien-3-ol, 1,3,5(10)-oestratriene-3,16a, 
178-triol and 1,3,5(10)-oestratriene-3,17a-diol adminis-
tered in a daily dose of 100 ~g/100 g b.w. for 7 days 
could partly curb decrement in seminal vesicles weights 
postcastration, 4-oestren-17s-ol-3-one, 5(10)-oestren-178-
ol-3-one and 1,3,5(10)-oestratrien-3-ol-17-one given in the 
same dose had only a small effect. Furthermore, administra-
tion of 4-pregnene-118,21-diol-3,20-dione, 5a-pregnane-17a, 
21-diol-3,20-dione, Sa-pregnan-3-one, Sa-pregnane-3,20-dione 
and 5o-cholestan-3o-ol (100 "g/100 g b.w./day for 7 days) 
had either no or minor effects on weight decrease of the 
seminal vesicles in castrates. Only treatment with dexame-
thasone (1 mg/day for 7 days) (appendix paper 4) or with 
compounds of the oestratriene series in a daily dose of 
100 ~g/100 g b.w. during 7 days reduced total body weight 
in castrates with respectively 15 to 25% and 10% compared 
with body weights of cas.trates treated with vehicle only. 
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3.5 General discussion 
A. hypothalamus-pituitary-testis system 
Testicular steroid secretion 
Biosynthesis and secretion of testicular steroids have 
recently been reviewed by Eik-Nes (1975). In the same 
review, Eik-Nes pointed out that most of the testicular 
steroids are delivered to the general circulation through 
the spermatic vein of the male gonad, since flow rate of the 
testicular lymph :is very low, and the quantitative signifi-
cance of lymphatic transport of androgens from the testis 
is small (Haltmeyer and Eik-Nes, 1974). Secretory mecha-
nisms of the testis and influence of testicular nerve 
fibers on secretion are largely unknown. In addition to the 
steroids synthesized via 4-ene intermediates (prevailing in 
rat testis) or via 5-ene intermediates, catabolites of tes-
tosterone such as oestradiol-178 (Eik-Nes, 1967) and 5a-
dihydrotestosterone (Felman et al. 1972) can also be secre-
ted by the male gonad. Recently, the presence of 5a-andros-
tane-3a,17S-diol and 5a-androstane-3S,l7S-diol was reported 
in the venous effluent of rabbit testes-epididymides per-
fused in vitro (Ewing et al. 1975). Mean secretion in sper-
matic vein blood of 5a-dihydrotestosterone, 5a-androstane-
3a,17S-diol and 5a-androstane-3S,17S-diol by this prepara-
tion was 0.8, 0.15 and 0.5 ~g/h respectively, which implied 
that testosterone constituted only 64% of the total mass of 
these four secreted androgens (Ewing et al. 1975). In dogs 
perip~eral plasma concentrations of Sa-dihydrotestosterone 
varied from 7 to 16% of those of testosterone (Felman 
et al. 1972}, while simultaneous measurement of plasma Sa-
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reduced testosterone metabolites in rabbits showed that 
mean concentrations of Sa-dihydrotestosterone, 5a-androsta-
ne-3a,17S-diol and Sa-androstane-3S,17S-diol were respec-
tively 0.49 1 0.17 and 0.24 ng per ml, which implies that in 
the peripheral blood of the rabbit testosterone accounts 
for only 53% of mean total mass of these four steroids 
(Schanbacher and Ewing, 1975). Testosterone production rate 
by the adult rat testes has been calculated to be in the 
order of 74 ~g/day and testicular production of oestradiol-
17S may be as little as 11 ng/day in the adult rat (de Jong 
et al. 1973), but only 20% of the minute circulating con-
centrations of oestradiol-178 originate from testicular 
secretion. Rat testicular tissue can convert radioactive 
testosterone to a variety of radioactive metabolites during 
incubations in vitro (Sowell et al. 1974; Lacroix et al. 
1975) , and contains measurable quantities of Sa-dihydrotes-
tosterone, 5a-androstane-3a,17S-diol (Podesta and Rivarola, 
1974) and oestradiol-l7S (de Jong et al. 1974). 
Uptake and metabolism of steroids by the hypothalamic-
pituitary system 
Testicular steroids can pass the blood-brain barrier 
since retention of labelled testosterone (Resko et al. 
1967), Sa-dihydrotestosterone (Perez-Palacios et al. 1973) 
or oestradiol-178 (Green et al. 1969) in the hypothalamic-
pituitary system can be recorded. Hypothalamic and hypophy-
seal tissue of adult male rats contain measurable quanti-
ties of testosterone and Sa-dihydrotestosterone (Robel 
et al. 1973). Moreover 1 it has been shown that the hypotha-
lamus and the pituitary gland may contain specific steroid 
receptor macromolecules, which are generally thought to be 
a prerequisite for steroid action at the target organ 
(Jensen and De Sombre, 1972). In the hypothalamus and hypo-
physis of male rats specific macromolecular binding prin-
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ciples have been demonstrated for oestradiol-178 (Kato 
et al. 1974; Kato, 1975), testosterone (Jouan et al. 1971, 
1973) and Sa-dihydrotestosterone (Kato and Onouchi, 
1973a,b). It has been shown that cytoplasmic binding prin-
ciples for either androgens (Naess et al. 1975) or oestro-
gens (Vreeburg et al. 1975) are also present in other 
brain regions. Specificity of "specific" receptors is limi-
ted and competition by other steroids does occur. The 
oestradiol-178 receptor proteins from anterior hypothalamus 
or pituitary cytosols show affinity for oestriol, oestrone 
and also for Sa-androstane-38,178-diol (Vreeburg et al. 
1975). Testosterone, 5a-androstane-3a,178-diol, Sa-andros-
tane-38,178-diol, oestradiol-178 and progesterone may com-
pete for binding to a specific cytoplasmic dihydrotestoste-
rone receptor from rat anterior hypophysis tissue 
(Thieulant et al. 1975). 
Steroid metabolizing enzymes, such as Sa-steroid re-
ductase {Rommerts and van der Molen, 1971; Massa et al. 
1972), 58-steroid reductase (Genot et al. 1975), 3a- and 
178-hydroxysteroid dehydrogenase (Rommerts and van der 
Molen, 1971) and 38-hydroxysteroid dehydrogenase (Genot 
et al. 1975) are present in hypothalamus and pituitary 
tissue of male rats and the anterior hypothalamus contains 
steroid aromatizing activity (Naftolin et al. 1972). 
Steroid ring A reduction appears to be the predominant 
pathway for androgen metabolism in neuroendocrine cells 
rather than steroid ring A aromatization (Naftolin and 
Ryan, 1975). Oestradiol-178 is probably not metabolized in 
hypothalamus and hypophysis (Kato and Villee, 1967; Kato, 
1975). Noma et al. (1975) have shown that also in the hypo-
thalamus Sa-reduction of testosterone to Sa-dihydrotestos-
terone is irreversible, whereas reduction of this latter 
androgen to Sa-androstane-3a,17S-diol is reversible, and 
either 5a-androstane-3a,178-diol or Sa-dihydrotestosterone 
cannot be converted to an oestrogen (Engel, 1973). 
The prevailing androgen in the peripheral circulation 
of normal male animals is testosterone (Eik-Nes, 1972) and 
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hypothalamic and pituitary tissue of mature male rats con-
tain higher concentrations of testosterone than of s~-di­
hydrotestosterone (Robel et al. 1973). Testosterone is thus 
probably the main precursor for formation of s~-reduced 
androstane metabolites and oestradiol-17S in the hypothala-
mic-pituitary system. 
Effects of gonadectomy on steroids, gonadotrophins and GnRF 
Within 2 h after castration of male anirnals, periphe-
ral levels of testosterone decrease to less than 4% of 
those seen in intact rats while circulating concentrations 
of s~-dihydrotestosterone are diminished to undetectable 
values at that interval following removal of the testes 
(Coyotupa et al. 1973). Testosterone, the prevailing andro-
gen in systemic blood of male animals (Eik-Nes, 1972), is 
probably the main precursor for formation of s~-reduced 
androstane metabolites and of oestradiol-17s. Hence, con-
centrations of these testosterone metabolites are likely to 
decrease in the peripheral circulation following gonadec-
tomy. While serum testosterone levels decrease (appendix 
paper 3), serum gonadotrophin levels will increase follo-
wing orchidectomy in adult male rats (appendix paper 2). 
These results are in agreement with previous observations 
in adult male rats that serum LH concentrations are drasti-
cally elevated as early as 8 h following gonadectomy and 
continue to increase over the ensuing days (Yamamoto et al. 
1970). These changes in plasma levels may partly reflect 
pituitary LH concentrations which fall initially, reaching 
their lowest value 4 days following castration, but subse-
quently rise again to levels encountered in normal rats at 
8 days following gonadectomy and then gradually increase 
over normal control values (Yamamoto et al. 1970). 
Drastic increases in serum FSH can be observed l day 
after castration (Steinberger and Chowdhury, 1974) and up 
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to 3,5,7,10, (appendix paper 2) 14 and 21 (Amatayakul et al. 
1971) days following gonadectomy these levels remain eleva-
ted but fairly constant. A progressive drop in pituitary 
FSH has been observed up to 72 h after castration 
(Steinberger and Chowdhury, 1974). Seven days following go-
nadectomy, pituitary FSH began to rise, to return to normal 
at 2 weeks after orchidectomy and to increase gradually 
thereafter (Steinberger and Duckett, 1966). 
The effects of castration on LH and FSH levels may be 
mediated via hypothalamic GnRF. The first two days follo-
wing gonadectomy serum and hypothalamic concentrations of 
GnRF appear to be raised, but a gradual decrease in hypo-
thalamic GnRF content has been recorded from 5 to 13 days 
following castration, while serum GnRF levels returned to 
normal control values in that same time period (Shin and 
Howitt, 1975). 
For hypertrophic pituitary glands from castrated male 
rats Me Cann (1974) has calculated drastic increases in 
daily secretion rates of LH and FSH and decreased turnover 
times for LH and FSH. All these data may reflect that remo-
val of male gonads results in an augmented release of gona-
dotrophins into the general circulation. In spite of the 
increased secretion rates of gonadotrophins, concentrations 
of gonadotrophins in pituitary tissue of male animals may 
still rise, and therefore, biosynthesis of pituitary gona-
dotrophins following gonadectomy must increase. This con-
clusion is supported by a report on augmented LH production 
in vitro by pituitary tissue from male castrates 
(Wakabayashi and Tamaoki, 1967). 
B. effects of administration of steroids on serum gonadotrophins in castrates 
-negative feedback-
Since removal of the testes from male animals results 
in changed production and secretion rates of gonadotrophins 
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and gonadotrophin releasing material, administration of 
testicular steroids to gonadectomized animals would be ex-
pected to counteract these effects. Our approach has been 
to start injection of the various steroids immediately 
after orchidectomy and to determine whether the steroids 
injected could curb the hypersecretion of gonadotrophins 
into the peripheral circulation. A period of daily injec-
tions during 7 days was chosen, because we found both a 
rather stable plateau of serum LH and FSH levels at 3,5 and 
7 days following castration (appendix paper 2) and an ade-
quate weight decrement of the accessory reproductive organs 
at that time (appendix paper 2). Other investigators have 
studied effects of steroid injections on circulating gona-
dotrophins in long-term castrates. Disadvantages associated 
with work in long-term castrates have been discussed in 
chapter 2. 
Experimental animal model 
The experimental animal model used suffers certain 
drawbacks. In experiments with rats stress conditions are 
practically unavoidable. The standard conditions used in 
our experiments have inevitably involved stress stimuli 
such as handling and manipulations of the rats during daily 
injections, use of ether anaesthesia during surgery and 
sacrifice, and serial blood sampling in the GnRF experi-
ments. These stress stimuli can influence circulating 
levels of LH and FSH (appendix paper 7; chapter 4), testos-
terone secretion (Bardin and Peterson, 1967} and testicular 
testosterone concentrations (Fariss et al. 1969). Using the 
present animal model, we could, however, not detect measu-
rable changes in serum LH, FSH and testosterone levels in 
castrates whether the animals were killed immediately or 
following exposure to ether anaesthesia during 2 min before 
sacrifice (Table 3.4.1.). Furthermore, serum gonadotrophin 
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and testosterone concentrations in castrated rats treated 
with ACTH or dexamethasone (appendix paper 4) or cortico-
sterone (appendix paper 6) and handled in the same standard 
fashion, were similar to those of control animals not trea-
ted with corticotrophin or one of these glucocorticoids 
during 7 days. Wasserman and Eik-Nes (1969) have shown, 
that the adrenal cortex of stressed dogs secreted substan-
tial amounts of 4-androstene-3,17-dione, a metabolic pre-
cursor of testosterone and oestradiol-17S (Samuels and 
Eik-Nes, 1968). Over the range investigated 4-androstene-
3,17-dione exhibits no effect on gonadotrophin levels in 
castrates (appendix paper 6, Tables 3.4.2. and 3.4.3.). 
Blood serum samples for determination of LH, FSH and tes-
tosterone were always obtained at the same time of the day 
in all our animals using the same stress conditions in 
order to withdraw this blood. We conclude from these data 
in our experimental animal model that the stress due to 
ether anaesthesia is not of paramount influence on circula-
ting gonadotrophins, and that steroid secretion of the 
adrenal gland does not play a significant role as regulator 
for circulating gonadotrophin concentrations in the adult, 
male rat. 
In the interpretation of the present results it has 
been assumed that: 1) the different steroids injected are 
released from the subcutaneous site of injection at the 
same rates and are undergoing metabolism at this site to 
the same (insignificant?) extent, 2) the various administe-
red steroids are cleared with approximately the same speed; 
however, one daily subcutaneous injection with steroid may 
result in variable concentrations of steroid and gonado-
trophins in the circulation over the ensuing period prior 
to the next injection (appendix paper 2; Hutchison and 
Goldman, 1975), 3) furthermore, we must assume that ciTcu-
lating gonadotrophins are true indicators of pituitary pro-
duction and secretion of these glycoprotein hormones. Even 
more important, the gonadotrophins will reach their target 
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tissues through the systemic blood, and the concentrations 
of gonadotrophins in blood should play an essential role 
for the processes involved in tissue regulation (Eik-Nes, 
197 5) • 
Circulating gonadotrophin concentrations are determi-
ned by rate of secretion and rate of disappearance. It 
seems likely that the clearance of endogenous FSH will be 
unaffected by circulating gonadal steroids (Bogdanove and 
Gay, 1969), since castration or steroid treatment does not 
appear to alter the capacity of the male rat to remove and/ 
or inactivate circulating exogenous FSH. Yamamoto et al. 
(1970) have concluded that the decay constant of LH is not 
appreciably influenced by removal of the gonads. Therefore, 
it may be assumed that steroids do not markedly influence 
the half-life of LH (approximately 30 min) and FSH (appro-
ximately 2 h) (Gay and Bogdanove, 1968). Bilateral nephrec-
tomy of castrated, adult male rats resulted, however, in 
decreased rates of LH and FSH clearance accompanied by 
quantitatively similar increases in serum levels of LH and 
FSH (Gay, 1974). It is interesting to note that these data 
from Gay's laboratory seem to cast doubt on the existence 
of short-loop feedback regulation by circulating gonado-
trophins at the hypothalamic-pituitary system in castrates 
(Gay, 1974). 
Our data (appendix papers 2 and 3) , and work done by 
Hutchison and Goldman (1975) show the same discrepancy be-
tween effects of administration of testosterone s.c. and 
testosterone propionate s.c. on serum gonadotrophins. The 
propionate derivative of testosterone given s.c. was more 
effective in suppressing serum gonadotrophins in castrates 
than "free" testosterone administered s.c. or i.v. 
(Hutchison and Goldman, 1975). Finally, neither continuous 
intravenous infusion {Hutchison and Goldman, 1975) nor sub-
cutaneous injections of testicular steroids may adequately 
simulate the fluctuations in plasma testosterone levels 
which can be detected in blood samples from the same rat 
obtained at different times of the day (Bartke et al. 1973). 
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A periodic release of LH but not of FSH has also been detec-
ted in long-term castrates (Gay and Sheth, 1973). 
In spite of these possible shortcomings of using 
"stressed" normal or castrated rats injected daily with 
different steroids, data from such experiments are of value 
on a comparative basis for an understanding of effects of 
steroids on regulation of circulating gonadotrophins. 
Results 
It is clear (Tables 3.4.2. and 3.4.3.; appendix 
papers 2, 3, 6 and 7; Verjans and Eik-Nes, 1976) that in-
jection of ring A reduced or ring A aromatized testosterone 
metabolites is more effective in preventing the rise of 
circulating gonadotrophin concentrations following gonadec-
tomy in male rats than testosterone or its metabolic pre-
cursors (Tables 3.4.2. and 3.4.3.; appendix papers 2, 3, 6 
and 7; Verjans and Eik-Nes, 1976). Serum LH concentrations 
were more sensitive to steroid suppression than serum FSH 
concentrations. From the compounds tested oestradiol-17S 
(appendix paper 7) or oestradiol benzoate (appendix 
paper 2) exhibited the highest potency in this respect. 
Aromatization of the A ring in steroids appeared, however, 
not to be a prerequisite in order to affect gonadotrophin 
levels in serum (appendix paper 2). Some of the disubsti-
tuted 3 or 17 keto and/or 3a or 17S hydroxyl Sa-reduced 
testosterone metabolites investigated showed high activity 
in regulating serum gonadotrophin levels in castrates (ap-
pendix paper 6), however, 3S or SS epimers of such com-
pounds exhibited no activity in this respect (appendix 
paper 6). A possible contribution of adrenal cortico-
steroids, androgens and oestrogens was found to be of minor, 
if any, importance in male rats (appendix paper 4) for re-
gulating circulating gonadotrophins. It was consistently 
69 
found that administration of low doses of androgens or 
oestrogens resulted in circulating gonadotrophin levels 
higher than those encountered in castrate control animals 
injected with vehicle only (appendix papers 2 and 3; 
Tables 3.4.2. and 3.4.3.). This effect was also observed 
following injection of relatively high doses of 38-hydroxy 
and 17 disubstituted androstenes or androstanes (appendix 
paper 6; Tables 3. 4. 2. , 3. 4. 3. and 3. 4. 4. ) . 
Subcutaneous administration of testosterone to castra-
tes resulting in serum testosterone levels not significantly 
different from those observed in intact rats, was not asso-
ciated with the expected drop of the high serum LH and FSH 
concentrations to values encountered in normal rats {appen-
dix paper 3). This finding was recently confirmed also for 
the immature, castrated male rat (Moger, 1975). This sug-
gests that besides testosterone other testicular products 
are involved in pituitary gonadotrophin regulation. These 
data also suggest that peripheral metabolism of testoste-
rone and metabolism of testosterone in androgen target or-
gans outside the testis do not promote the needed concen-
trations of potent suppressors for circulating LH and FSH 
to prevent the postcastration rise of serum gonadotrophin 
concentrations. Therefore, it is most likely that in the 
normal rat secretion products of the testis, such as tes-
tosterone and especially 5a-dihydrotestosterone, 5a-andro-
stane-3a,l7S-diol and oestradiol-178, are the main factors 
required for regulation of circulating LH and FSH. 
An "inhibin-like" factor isolated from bull seminal 
plasma has been shown to decrease selectively circulating 
FSH levels in castrates {Franchimont et al. 1975). We have 
indicated that such a testicular factor, probably of non-
interstitial cell origin, may partly control serum FSH con-
centrations in normal male rats {Verjans and Eik-Nes, 1976; 
appendix paper 5; chapter 4). 
The data discussed in this section may provide the 
biochemical base for a system where testicular products 
delivered into the general circulation affect the hypotha-
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lamic-pituitary axis. It appears feasible that testosterone, 
in combination with its Sa-reduced and/or ring A aromatized 
metabolites and together with "inhibin" can maintain phy-
siological balance between activities in the male gonad and 
activities in the hypothalamic-pituitary system. 
C. effects of gonadotrophin releasing factor 
-positive feedback-
The results on the effects of oestrogen and androgen 
on GnRF induced serum concentrations of gonadotrophins in 
castrates have been presented in appendix paper 7. Under 
the conditions of these experiments we have concluded that: 
1) The androgen and oestrogen might have acted at different 
sites in the male hypothalamic-pituitary axis with respect 
to regulation of circulating gonadotrophins, LH being more 
sensitive to steroid treatment than FSH. However, the pos-
sibility of effects of steroids at higher brain centres 
cannot be excluded. Effects of oestrogen (Davidson, 1969) 
or Sa-dihydrotestosterone (Feder, 1971) or combined treat-
ment with both steroids (Baum and Vreeburg, 1973) on mating 
behaviour in castrated male rats are well known. An animal 
model using systemic i.v. or s.c. steroid administration or 
steroid implants into the hypothalamic-pituitary area 
(Kingsley and Bogdanove, 1973; Smith and Davidson, 1974) 
will not provide decisive answers to this problem, because 
the administered or deposited steroid can reach many brain 
structures. 2) High doses of androgen administered to cas-
trates will inhibit pituitary release of gonadotrophins, 
while injection of low doses of androgen may stimulate GnRF 
resulting in pituitary release of gonadotrophins and in 
higher serum gonadotrophin levels than those of castrate 
controls {positive feedback). Not only release but also the 
production of gonadotrophins can be affected by steroids in 
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castrates. Testosterone propionate administered in very 
high doses to castrated male rats increased pituitary FSH 
but not pituitary LH stores (Gay and Bogdanove, 1969). 
3) Injection of low doses of oestradiol-17S to castrates 
may render the anterior pituitary gland more sensitive to 
GnRF, resulting in elevation of serum gonadotrophins over 
castrate control levels (positive feedback), while high 
doses of oestradiol-17S may inhibit hypothalamic production 
and/or secretion of GnRF. Very high doses of oestradiol 
benzoate are known to suppress LH and FSH concentrations in 
pituitaries of male castrate (Bogdanove et al. 1971) or 
normal rats (appendix paper 1). Positive feedback effects 
were also observed following administration of relatively 
high doses of 3S-hydroxy 17 disubstituted androstenes and 
androstanes to castrates (Table 3.4.4.). We are not aware 
of the presence of specific binding principles for these 
particular steroids in pituitary or hypothalamic tissues. 
However, we cannot exclude the possibility that these 
steroids exert their effects in castrates following metabo-
lic conversion or by their affinity for binding sites of 
known "specific" receptors. 
D. accessory reproductive organs and steroids 
Discussion of results 
Following removal of the male gonads the weights of 
accessory reproductive organs decreased concomitant with 
the decrease of circulating testosterone concentrations 
(appendix papers 2 and 6; Tables 3.4.5. and 3.4.6.). Admi-
nistration of several steroids can prevent this weight de-
crease in castrates (appendix papers 2 and 6; Tables 3.4.5. 
and 3.4.6.). In appendix paper 6 effects of administration 
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of a relatively high dose (100 "g/100 g b.w.jday during 
7 days) of various steroids on weights of the ventral pros-
tate in castrated, adult male rats have been compared and 
of 100 "g/100 g b.w. of 3 or discussed. The daily injection 
3S and 17 or 178 disubstituted (keto or hydroxyl) androste-
nes could entirely or partly prevent weight decrement of 
the accessory reproductive organs postgonadectomy. The re-
sults indicate a discrepancy between the effects of diffe-
rent androgens on the hypothalamic-pituitary axis and the 
biological potency on the processes governing growth of 
accessory reproductive organs. Representative compounds of 
the Sa-androstane, oestratriene and oestrene series also 
showed a remarkable discrepancy in their biological activi-
ty as judged by effects on weights of ventral prostate and 
seminal vesicles and on suppression of serum gonadotrophins. 
Like for regulation of serum gonadotrophins in castrates, 
Ss-reduction of testosterone and 3s-reduction of Sa-dihy-
drotestosterone resulted in loss of biological activity in 
the accessory sex organs, while 3a-reduction of Sa-dihydro-
testosterone did not alter the biological activity exhibi-
ted on the ventral prostate and seminal vesicles (Tables 
3.4.5. and 3.4.6.). Low doses of testosterone, Sa-dihydro-
testosterone, 5a-androstane-3a,l7B-diol, 4-androstene-36, 
17B-diol or 4-androstene-3,17-dione were more effective in 
curbing the decrease of prostate and seminal vesicles 
weights than in preventing the rise of serum gonadotrophins 
postorchiectomy. When circulating testosterone levels in 
castrated animals following s.c. injection of testosterone 
were comparable with those in normal rats, normal ventral 
prostate and seminal vesicles weights were observed in such 
animals, but these testosterone levels failed to suppress 
postcastration rise of serum LH and FSH (appendix paper 3; 
Tables 3.4.2. and 3.4.3.). We can, however, not exclude the 
possibility that this discrepancy in effects on gonadotro-
phins and accessory reproductive organ weights might be due 
to the use of daily injections of steroids, which may re-
sult in high peripheral steroid concentrations immediately 
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following injection with decreasing steroid levels prior to 
the next daily injection. The data obtained suggest that 
the effects of steroids on suppression of circulating gona-
dotrophins in castrates do not always correlate with the 
classical bioassay indicator for androgenicity, i.e. the 
effects of steroids on weight maintenance of seminal ve-
sicles and ventral prostate in such animals (Dorfman and 
Shipley, 1956; Young and Corner, 1963). 
Mechanism of effect of androgens in accessory reproduc-
tive organs 
5a-Dihydrotestosterone and 5a-androstane-3a,l7B-diol 
are at least as potent as testosterone in preventing weight 
decrease of the accessory sex organs (Tables 3.4.5. and 
3.4.6.), 5a-dihydrotestosterone propionate exhibited in 
this respect a higher potency than testosterone propionate 
(appendix paper 2). 4-Androstene-3,17-dione and 4-androste-
ne-3s117s-diol showed also high potencies (Tables 3.4.5. 
and 3.4.6.). Uptake (Hansson, 1971) and metabolism 
(Farnsworth and Brown, 1963) of androgens by accessory re-
productive organs have been reported. The concentration of 
cytoplasmic androgen receptor in the rat prostate has been 
shown to decrease following orchiectomy (Bruchovsky and 
Craven, 1975) and there is also extensive androgen metabo-
lism by the prostate (for review: Eik-Nes, 1976). 
Bruchovsky (1971) has shown that radioactive 5a-dihydro-
testosterone is the major metabolite in prostatic nuclei 
following intravenous injection of either radioactive tes-
tosterone, 5 0 -dihydrotestosterone, 50 -androstan-Ja-ol-17-
one, 5a-androstane-3a,17B-diol, 5a-androstane-3,17-dione, 
4-androstene-3,17-dione or 5-androsten-38-ol-17-one in 
castrated male rats. Moreover, 5a-dihydrotestosterone is 
the principal steroid bound to androgen receptor in the rat 
prostate following injection of radioactive testosterone 
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(Bruchovsky and Wilson, 1968). Administration of Sa-dihydro-
testosterone to castrates before prostatic atrophy had com-
menced, resulted in an increase of prostatic wet weight and 
stimulated secretory activity (Lesser and Bruchovsky, 1974). 
Recently, it has been shown that in rats and dogs the pros-
tate receives blood directly from the deferential vein 
(Pierrepoint et al. 1975). This blood has a high concentra-
tion of androgens (Pierrepoint et al. 1975). Finally, in 
the rat prostate and seminal vesicles the mean concentra-
tion of 5a-dihydrotestosterone is higher than that of tes-
tosterone (Robel et al. 1973). 
From these combined data it can be concluded that se-
cretion of testicular steroids in the mature rat is of pa-
ramount importance for adequate functioning and maintenance 
of ventral prostate and seminal vesicles physiology and 
that 5a-dihydrotestosterone is the main androgen in these 
organs. 4-Androstene-3S,17S-diol could have exerted a pos-
sible effect on the weights of the ventral prostate and se-
minal vesicles through its affinity to known steroid recep-
tors in these organs (Grover and Odell, 1975) or following 
conversion to testosterone or 5a-androstane-3S,17S-diol. 
The latter steroid has, however, no effect on these para-
meters in the doses tested (appendix paper 6; Tables 3.4.5. 
and 3.4.6.). Synergistic effects of prolactin and testoste-
rone on weight gain in the ventral prostate and in the se-
minal vesicles have been observed (Keenan and Thomas, 1975). 
Castration is associated with unchanged prolactin secretion 
rates (Me Cann, 1974), but we have not determined whether 
the steroid injections used in the current work will result 
in altered secretion rates of prolactin. Hence, it is not 
known whether prolactin has affected the effects of steroids 
on weights of accessory reproductive organs in our experi-
ments. 
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Effects of other compounds on accessory reproductive organs 
Several steroids from the pregnane, pregnene, choles-
tane and cholestene series do not affect the reduction of 
the weights of accessory reproductive organs in castrates 
{appendix paper 6). The C-21 metabolic precursors of tes-
tosterone also do not influence these parameters in hypo-
physectomized animals, indicating that conversion of these 
steroids to potent androgens is insignificant (Steinberger 
et al. 1975). Oestratrienes and oestrenes did not prevent 
the decrease of ventral prostate weight postorchiectomy but 
the oestratrienes tested could partly prevent the decrement 
of seminal vesicles weight in castrates (appendix paper 6). 
1,4-Diphenyl-butane-2,3-diol, a testicular secretion pro-
duct (Eik-Nes et al. 1967), followed in this respect the 
effects exhibited by the oestrogens on accessory sex organs 
(appendix paper 6). At variance with these findings is the 
fact that an oestradiol-178 receptor has been detected in 
the prostate of the rat but not in the seminal vesicles of 
this animal (van Beurden et al. 1974). 
E. summary of conclusions 
From the available information, it is difficult to 
conclude whether either Sa-dihydrotestosterone, or 5a-
androstane-3a,17S-diol, or both are the biologically active 
component(s) in the hypothalamic-pituitary system and/or 
the accessory reproductive organs. More definite answers 
may be obtained via the use of proper inhibitors for the 
3a-hydroxysteroid dehydrogenase enzyme activity, which in 
rat pituitary gland (Thien et al. 1975) and rat ventral 
prostate (Shimazaki et al. 1972) is mainly located in the 
cytosol fraction. Ratios between concentrations of testes-
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terone and Sa-dihydrotestosterone in hypothalamus and ante-
rior pituitary gland are much higher than for seminal ve-
sicles and prostate in the normal mature rat (Robel et al. 
1973). This might indicate that in accessory reproductive 
organs the metabolic conversion to the potent Sa-reduced 
testosterone metabolites is greater than in the hypothala-
mic-pituitary system. This difference might in part explain 
some of the discrepancies observed in gonadectomized male 
rats for the effects of steroids on LH and FSH in the peri-
pheral circulation and on the weights of accessory repro-
ductive organs. 
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CHAPTER 4 
EXPERIMENTS WITH NORMAL,ADULT MALE RATS 
4.1 Introduction 
The use of gonadectomized animals is frequently prefer-
red in studies concerning possible effects of steroids on 
the gonadotrophic function of the male hypothalamic-pitui-
tary axis, because the possible influence of endogenous 
steroids can be excluded as it has been shown that the con-
tribution of adrenal steroids in castrated male animals 
(appendix paper 4) is of minor, if any, importance in this 
respect. 
The suppressive effects of testosterone and oestradiol-
17S on circulating levels of LH and FSH in intact, adult 
male rats are well known. Few data are available concerning 
effects of administration of other steroids on these para-
meters in normal male rats. We were also interested to in-
vestigate the effect of administration of low doses of 
steroids to intact male rats, since we had observed a posi-
tive feedback effect of low doses of androgens on circula-
ting gonadotrophin concentrations in castrated rats (chap-
ter 3). These studies also offered the opportunity to eva-
luate the significance of the results with steroids (par-
ticularly with respect to specificity and doses needed) in 
orchidectomized 1 adult male rats. 
Furthermore 1 the effects of exposure to ether vapour 
during 2 min on serum LH 1 FSH and testosterone in normal 
rats were studied. The results of these experiments are 
discussed in light of data on intact 1 adult male rats pre-
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sented in the appendix papers 1,3 1 4,5 and 7. 
4.2 Animals 
Adult, male Wistar rats (3 to 4 months old, body 
weights ranging from 230 to 275 g) were employed. The ani-
mals were kept under constant light (14 h light and 10 h 
darkness), temperature (19-21°C) and humidity conditions. 
Laboratory rat chow and tap water were provided ad libitum. 
The animals were used in experiments at least one week 
after arrival in the animal quarters. 
4.3 Experimental animal model and hormone treatments 
Daily subcutaneous injections with various doses of 
different steroids in sesame oil (0.04 ml oil/100 g body 
weight) were given for a period of 7 days between 1 and 
2 p.m. Control animals received sesame oil only (0.04 ml/ 
100 g b.w.). Steroids were purchased from Steraloids 
(Pawling, New York, U.S.A.) and used without purification. 
Four or 5 animals were employed in each of the different 
treatment groups. Twenty hours after the last injection, 
the animals were weighed, exposed to ether vapour in a jar 
for approximately 2 min and then immediately decapitated. 
Blood was collected from the trunk and allowed to clot 
overnight at 4°C. Resulting blood serum was stored at -20°C 
until analysed for hormones. Testes and accessory reproduc-
tive organs were removed immediately after sacrifice. After 
dissection, testis, seminal vesicles (emptied) and ventral 
prostate were weighed. 
Treatment with ACTH or dexamethasone was as indicated 
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in appendix paper 4. Adrninistratio~ of gonadotrophin relea-
sing factor (GnRF) to rats pretreated with steroids was as 
stated in appendix paper 7. Bilateral, local X-irradiation 
of the testes of normal rats was as described in appendix 
paper 5. 
Significance of differences between data from the dif-
ferent treatment groups was determined using Student's t-
test unless otherwise stated. 
4.4 Results 
Serum gonadotrophins and testosterone 
Effects of exposure to ether vapour during 2 min on 
serum levels of LH, FSH and testosterone in normal male 
rats are shown in Table 4.3.1. One group of rats was 
TABLE 4. 3. l. 
Effect of exposure to ether vapour during 2 min on mean 
(~S.D.) serum levels of LH, FSH and testosterone in normal, 
mature male rats (n=5) injected each day during 7 days with 
0.04 ml sesame oil/100 g b.w. 
Treatment 
ether 
no ether 
LH 
(ng/ml) 
59 + 18 
78 + 18 
FSH 
(ng/ml) 
447 + 51" 
355 + 33 
testosterone 
(ng/ml) 
3.6 + 0.6 
3.4 + 0.5 
*p < 0.05, compared with animals not exposed to ether 
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weighed, exposed to ether and decapitated immediately after 
removal from the ether jar, the other group was first 
weighed and thenirnrnediately decapitated. No statistically 
significant differences in mean circulating testosterone 
and LH concentrations were found between animals killed 
with or without this type of ether anaesthesia 
(Table 4.3.1.). Mean levels of serum FSH rose significantly 
(P < 0.05) in rats exposed to ether when compared with ani-
mals not exposed to this anaesthetic. In appendix paper 4 
results of treatment with ACTH or dexamethasone on serum 
gonadotrophin and testosterone concentrations in normal, 
adult male rats are summarized and appendix paper 5 gives 
effects of local X-ray treatment of the testes on these 
TABLE 4.3.2. 
Effects of various steroids, administered s.c. in a daily 
dose of 50 ~g/100 g b.w. during 7 days, on mean (~S.D.) 
serum gonadotrophin levels in normal, mature male rats (n=4) 
Treatment 
progesterone 
4-androstene-3,17-dione 
4-androstene-3S,176-diol 
5-androstene-3S,17S-diol 
Sa-dihydrotestosterone 
Sa-androstane-3a,l76-diol 
Sa-androstane-36,178-diol 
oestradiol-l7a 
sesame oil 
Serum gonadotrophin concentrations 
(ng/ml) 
LH FSH 
52 + 19 480 + so 
83 + 18 448 + 103 
79 + 22 513 + 131 
78 + 14 428 ~ 111 
20 ~ 6* 315 + 46* 
26 + 7* 305 ~ 59* 
47 + 10 331 + 77 
16 + 4* 320 ~ 40* 
54 + 15 440 + 61 
* P < 0.05, compared with controls receiving vehicle only 
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parameters. Effects of oestrogen or testosterone administra-
tion on peripheral levels of blood serum testosterone and 
gonadotrophins in normal male rats are shown in appendix 
papers 1 and 3 respectively. Influence of injecting various 
steroids in a daily dose of SO ~g/100 g b.w. during 7 days 
on serum gonadotrophin levels in normal rats has been corn-
pared in Table 4.3.2. Significantly lower (P < O.OS) serum 
LH and FSH levels as compared with those of normal control 
rats were found following administration of SO ~g Sa-dihy-
drotestosterone, Sa-androstane-3a,176-diol or oestradiol-
17a (Table 4.3.2.). Given in the same dose, progesterone, 
4-androstene-3,17-dione, 4-androstene-36,176-diol, 
S-androstene-36,176-diol or Sa-androstane-36,176-diol had 
no significant effect on blood serum LH and FSH 
(Table 4.3.2.). Effects of injection of 25, 12.S or 6.2S ~g/ 
100 g b.w. of various androgens on mean serum LH and FSH 
concentrations in normal animals are summarized in 
Table 4.3.3. These doses did not have a significant effect 
on serum FSH concentrations, although some doses of 4-an-
drostene-36,176-diol and Sa-androstane-36,176-diol tended 
to augment serum FSH over control levels (Table 4.3.3.). 
Testosterone, Sa-dihydrotestosterone and Sa-androstane-3a, 
176-diol, when given in a dose of 25 ~g/100 g b.w. signifi-
cantly suppressed (P < 0,05) serum LH, but only a dose of 
12.5 ~g/100 g b.w. 5a-dihydrotestosterone could induce sta-
tistically lower (P < 0.05) LH levels as compared with nor-
mal control animals injected with oil only (Table 4.3.3.). 
Injection of 4-androstene-36,176-diol tended to elevate 
mean serum LH levels, but this increase was not statisti-
cally significant (Table 4.3.3.). 
Weights of reproductive organs 
Data on the effects of administration of ACTH or dexa-
methasone on weights of testes, seminal vesicles and ven-
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"" 
"" TABLE 4.3.3. 
Effects of various doses (~g/100 g b.w./day for 7 days s.c.} of different steroids on mean 
(~S.D.) serum gonadotrophin levels (ng/ml) in normal, mature male rats (n~4) 
Steroid 
testosterone 
4-androstene-36,176-diol 
Sa-dihydrotestosterone 
Sa-androstane-3a,l7B-diol 
Sa-androstane-38 1 178-diol 
Sesame oil 
Dose 
25,0 
l2. 5 
6.25 
25.0 
12.5 
6.25 
25.0 
12. 5 
6.25 
25.0 
l2 .s 
6.25 
25.0 
12. 5 
6.25 
serum gonadotrophin concentrations (ng/ml) 
LH FSH 
35 .:!:_ lO:t 349 .:!:. 70 
61 + 15 368 .:!:. 46 
69 .:!:. 14 3 9 4 .:: 47 
94 + 21 585 + 148 
69 .:!:. 15 523 .:!:. 187 
90 + 22 462 :!:_ 72 
27 + 7. 315 :!:. 74 
41 :!:. 2' 377 :!: 102 
56 :!:. 20 420 ,:1:: 57 
41 + 5• 3 23 :!:. 32 
58 :!: 25 527 :!:. 209 
66 + 34 514 :!::. 215 
6 4 .:!:_ 26 353 .:!:_ 112 
44 + 15 387 .:!:_ 140 
76 + 19 529 :!: 133 
64 .:!::. 14 397 .:!::. 57 
*p < 0,05, compared with controls receiving vehicle only 
tral prostates in normal rats are given in appendix paper 4 
and appendix paper l summarizes the influence of oestrogen 
treatment on these parameters. Changes in weights of repro-
ductive organs induced by local X-irradiation of the male 
gonads are summarized in appendix paper 5. The doses of 
testosterone employed in the study of appendix paper 3 and 
the doses of SO, 25, 12.5 or 6.25 "g/100 g b.w. of the 
steroids tested in the present study (Tables 4.3.2. and 
4.3.3.} did not significantly alter total body weight or 
weights of the testes, seminal vesicles and ventral pros-
tates compared with normal control rats injected with 
sesame oil only. 
4.5 General discussion 
Discussion of results 
Our data demonstrate that several steroids can lower 
circulating LH and FSH concentrations in normal male rats 
when given subcutaneously for several days. Ring A Sa-
reduced or ring A aromatized metabolites of testosterone 
had a high potency in this respect {Tables 4.3.3. and 
4.3.2.; appendix papers 1 and 7), which is compatible with 
the findings reported for gonadectomized rats (chapter 3). 
For depression of circulating gonadotrophins in normal male 
rats lower doses of androgens were required than in castra-
tes, whereas oestrogens were more effective in castrated 
than in normal male rats with regard to lowering blood 
serum gonadotrophins (appendix paper 7). In both type of 
animals serum LH appeared more sensitive to steroid treat-
ment than serum FSH. Of all steroids tested, oestrogen ex-
hibited the highest potency in suppressing circulating LH 
and FSH levels (appendix papers 1 and 7). In appendix 
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paper 7, the effects of oestradiol-178 or Sa-dihydrotesto-
sterone pretreatment on GnRF induced serum levels of LH and 
FSH in normal rats have been described and discussed. It 
was concluded, that under our experimental conditions 
oestradiol-178 exerts its effects on the hypothalamic-
pituitary axis in a way different from that of the non-
aromatizable Sa-dihydrotestosterone. 
Discussion of experimental animal model 
Our intact animal model suffers the same experimental 
shortcomings (i.e. handling, manipulation, anaesthesia, 
daily s.c. steroid injections) as the castrate animal model. 
Furthermore, effects of ether anaesthesia appear to be more 
serious in normal than in orchidectomized rats. Exposure to 
ether during 2 min induced a slight, but significant eleva-
tion of serum FSH levels, but did not significantly affect 
serum levels of testosterone and LH (Table 4.3.1.). Depres-
sive effects of anaesthesia (Eik-Nes, 1962; Bardin and 
Peterson, 1967) on testicular androgen secretion are well 
known and a drastic decrease in testicular testosterone con-
centrations has been reported for rats sacrificed 2 min 
following ether anaesthesia (Fariss et al. 1969). Increased 
serum LH and FSH levels have been found 10 min following 
short exposure to ether vapour (Krulich et al. 1974). These 
data on the effects of ether anaesthesia point to direct, 
rapid effects of this anaesthetic on the male gonad. We 
have sampled blood for measurement of serum testosterone, 
LH and FSH using the same stress condition in all our ani-
mals. Moreover, administration of ACTH did not result in 
significant changes in serum testosterone, LH and FSH 
levels in normal male rats (appendix paper 4). If the 
stress condition connected with our experimental set up 
were of paramount importance for circulating gonadotrophins, 
one would expect that ACTH treated rats, subjected already 
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to the stress stimuli of the standard procedure of handling 
and ether anaesthesia, should have shown different concen-
trations of such trophins in blood serum compared to rats 
not subjected to ACTH injections. Dexamethasone treatment 
of normal mature rats had no influence on circulating tes-
tosterone and LH concentrations (appendix paper 4), and 
adrenalectomy does not significantly affect plasma testoste-
rone levels in such animals (Frankel et al. 1975) indicating 
that the adrenal cortex does not significantly contribute 
to peripheral testosterone concentrations. We, therefore, 
do not believe that in our experiments effects of the stress 
conditions form a serious complication for comparing effects 
of different treatments on circulating LH and FSH levels in 
normal animals. Furthermore, under these conditions secre-
tions from the adrenal gland do not appear to contribute 
appreciably to secretions from the testis in regulating cir-
culating gonadotrophins (appendix paper 4). 
Regulation of FSH 
Dexamethasone injection during 7 days resulted in 
slightly elevated serum FSH levels in normal rats. This 
might be due to a deleterious effect of this corticoid on 
the germinal epithelium in the seminiferous tubules of the 
testes as has been reported for cortisone {Albert, 1961). 
Depletion of germinal epithelium in seminiferous tubu-
les of rats by chemical agents (Gomes et al. 1973; Debeljuk 
et al. 1973) or local testicular X-irradiation (Verjans and 
Eik-Nes, 1976; appendix paper 5) results in an elevation of 
serum FSH levels. It is believed, that a factor of non-
interstitial cell origin may participate in the regulation 
of FSH in addition to circulating steroids from testicular 
origi~ (Verjans and Eik-Nes, 1976}. 11 FSH depressing acti-
vity" is present in ram rete testis fluid (Setchell, 1974) 
in bull seminal plasma (Franchimont et al. 1975a) and bull 
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spermatozoa (Lugaro et al. 1974) and it is speculated that 
this FSH suppressing material, called "inhibin", may origi-
nate from the germinal epithelium in the testis (Franchimont 
et al. l975b). To which cell type(s) in the germinal epi-
thelium "inhibin" is related and whether it can be delivered 
into the peripheral blood is not yet clear. Effects of bi-
lateral testicular X-irradiation on serum LH and testoste-
rone levels have been discussed in appendix paper 5 
(Verjans and Eik-Nes, 1976a) and effects of this treatment 
on testis histology have recently been reviewed by oakberg 
(1975). Finally, data on GnRF induced serum LH and FSH 
levels in X-ray treated rats suggest that "inhibin" possi-
bly acts on the anterior hypophysis by modulating pituitary 
release of FSH (appendix papers 5 and 7). 
Mechanism of action of administered steroids in normal rats 
It was already discussed in chapter 3, that testicular 
Sa-reduced testosterone metabolites in addition to "inhi-
bin'', testosterone and possibly oestradiol-176 are essen-
tial for maintaining the endocrine balance between testis 
and hypothalamic-pituitary axis by inhibiting pituitary 
release of gonadotrophins. Therefore, the total output of 
testicular secretion products delivered through the sperma-
tic vein blood to the target organs can in all likelihood 
account for -the lower levels of gonadotrophins in normal, 
adult male rats as compared with the high levels of such 
trophins in castrates. In addition, we found that removal 
of one testis from mature male rats resulted in slightly 
increased serum levels of LH and FSH and slightly elevated 
weights of the remaining testis at 7 and 14 days after hemi-
gonadectomy. However, at 21 and 28 days after this opera-
tion, these parameters were indistinguishable from those of 
normal control animals of the same age. Other parameters 
investigated like serum testosterone concentrations, total 
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body weight, ventral prostate and seminal vesicles weights 
were not significantly changed at 7, 14, 21 and 28 days 
following hemi-castration when compared with control ani-
mals of the same age (Verjans and Eik-Nes, l976b). These 
data indicate that eventually one testis is able to main-
tain the endocrine balance in the hypothalamic-pituitary-
testicular system. Synergism of the steroids injected and 
the potent testicular secretion products present in the pe-
ripheral circulation may explain the suppression of circu-
lating gonadotrophins in normal rats as observed in the 
present study (Tables 4.3.2. and 4.3.3.). These data pro-
vide additional evidence for the specificity of the effects 
observed with these compounds in castrates (chapter 3), and 
biochemical support for these data with regard to possible 
metabolic conversion and binding to "specific" receptor 
protein, has been quoted (chapter 3). Furthermore, increases 
in serum testosterone (appendix paper 3) and serum oestra-
diol-17S (de Jong et al. 1975) concentrations have been 
found following administration of testosterone and oestra-
diol-176 respectively to normal rats. In normal rats, no 
distinct positive feedback effects of androgens in the 
doses tested were observed in contrast to castrated rats. 
It might be that the suppressive effect of circulating tes-
ticular products on gonadotrophins in normal rats has pre-
vailed over possible positive feedback effects of the ad-
ministered androgens. 
Effects of steroids of non-testicular origin in normal 
and castrated male rats may result either from metabolic 
conversion to potent steroids in the circulation or in the 
target organ(s), or these compounds could act per se by 
binding to known receptors for the potent testicular 
steroids. This latter affinity has been shown for the 
oestradiol-17S and Sa-dihydrotestosterone receptor from the 
hypophysis (chapter 3) and also 4-androstene-3S,l7S-diol 
and 5-androstene-36,176-diol can compete in this respect 
with Sa-dihydrotestosterone in the prostate (Grover and 
Odell, 1975). 
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Effects of steroids administered to normal rats 
Dose dependent effects of administered androgen on 
spermatogenesis are well known. Low doses of testosterone 
suppress circulating gonadotrophin concentrations (appendix 
paper 3) and androgen production by the Leydig cells, re-
sulting in atrophy of the germinal epithelium. It has been 
shown that treatment of normal men with moderate doses of 
testosterone propionate decreased testicular testosterone 
concentrations, while plasma LH levels were reduced and 
plasma testosterone levels were elevated (Morse et al. 
1973). Administration of very high doses of testosterone 
can, however, maintain high intratesticular testosterone 
levels and hence prevent atrophy of the germinal epithelium 
in spite of suppressed gonadotrophin levels. Concomitant 
with these dose dependent effects of testosterone on sperma-
togenesis, dose dependent effects of testosterone can be 
observed on ventral prostate weight (Walsh and Swerdloff, 
1973), testicular weight and testicular ABP content 
(Weddington et al. 19761. 
Oestrogen exhibits in this respect a pattern different 
from testosterone or its Sa-reduced metabolites. Oestrogen 
depresses pituitary and serum levels of LH and FSH and tes-
ticular and serum testosterone concentrations (appendix 
paper 1), which causes arrest of spermatogenesis and atro-
phy of accessory reproductive organs. In addition to hypo-
thalamic-hypophyseal mediated effects of oestrogens in male 
animals, direct effects of oestrogen on testicular testoste-
rone formation can be recorded (Samuels et al. 1969). More-
over, it has been observed that the interstitial tissue of 
the testis contains a specific oestradiol-178 binding prin-
ciple (Brinkmann et al. 1972). Very low doses of oestrogen, 
administered to normal rats, tended to elevate serum FSH 
over control levels (appendix paper l). It might be that 
this effect is mediated by the same mechanism as proposed 
for augmented FSH levels in castrated males given low doses 
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of oestrogen {appendix paper 7). One may, however, argue 
whether the minute concentrations of circulating and testi-
cular oestradiol-l7S per se can serve a physiological pur-
pose in male animals. Interestingly, it has been reported 
that Sa-dihydrotestosterone can inhibit the initial rate of 
formation of the oestradiol-178-receptor complex in the an-
terior pituitary gland {Korach and Muldoon, 197S), probably 
indicating that in the normal animal many complex regula-
tory effects - combinations of different hormones and recep-
tors at the target organ level - are in operation. 
Summary 
It has been discussed that Sa-dihydrotestosterone is a 
true androgen and may be the principal androgen in the an-
drogen target organs studied (Verjans and Eik-Nes, 1976a). 
Whether the androgenicity exhibited by 5a-androstane-3a,17B-
diol can be ascribed to its conversion to Sa-dihydrotestos-
terone is not yet solved, but De Moor et al. {1975) have 
indicated that this metabolic conversion at the target tis-
sue level may be an important factor in the responsiveness 
of several organs to Sa-androstane-3a,176-diol. The data 
presented emphasize that Sa-steroid reductase and 3a-hydro-
xysteroid dehydrogenase activities are of paramount impor-
tance in the target organs investigated in the present 
study, and it is clear that Sa-reduced ring A metabolites 
of testosterone exert major functions in androgen sensitive 
target organs. Surprisingly, 3S-reduction of Sa-dihydrotestos-
terone results in inactivation at both target organ levels 
tested. Finally, one may ask about the possible role of 
testosterone in androgen target organs. Is it merely requi-
red as a prehormone for the active metabolites? 
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SUMMARY AND CONCLUSIONS 
The endocrine and spermatogenic functions of the tes-
tes in the adult male animal are regulated and maintained 
by the gonadotrophins LH (luteinizing hormone) and FSH 
(follicle stimulating hormone) which are secreted by the 
anterior pituitary gland under the influence of GnRF (gona-
dotrophin releasing factor) from the hypothalamus. Products 
from the testis seem to control the gonadotrophic function 
of the hypothalamic-pituitary unit since removal of the 
male gonads results in increased peripheral concentrations 
of LH and FSH. 
The current thesis deals with a study concerning the 
effects of steroids, particularly those of testicular ori-
gin, on blood serum parameters reflecting the gonadotrophic 
functions of the hypothalamic-pituitary axis and on the en-
docrine function of the testis in the adult male rat. The 
introduction of sensitive radioimmunoassay techniques for 
the measurement of serum concentrations of LH, FSH and tes-
tosterone (chapter 2) made this investigation possible. The 
following aspects have been investigated: 
I. Effects of steroids on circulating levels of LH, FSH 
and testosterone in normal (appendix papers 1 and 3; 
chapter 4) or orchidectomized (appendix papers 2, 3 
and 6; chapter 3) adult male rats. The latter animal 
model offers the possibility to investigate specific 
effects of steroids without interference from endoge-
nous testicular factors. 
II. The influence of testicular secretion products on GnRF 
induced serum levels of LH and FSH in the normal in-
tact or castrated animal (appendix papers 2 and 7) . 
III. The possible involvement of adrenal steroid hormones 
in the regulation of the hypothalamic-pituitary-testi-
cular system (appendix paper 4). 
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IV. The effect of local X-irradiation of the male gonads 
on parameters reflecting activity of the hypothalamic-
pituitary-testicular system (appendix paper 5). 
From the experiments on effects of s.c. administered ste-
roids on circulating concentrations of LH, FSH and testoste-
rone in normal or gonadectomized, adult male rats 
(chapters 3 and 4; appendix papers 1, 2, 3 and 6) and on 
the basis of published data on testicular steroid secretion 
and on uptake and metabolism of steroids in the hypothala-
mic-pituitary unit, it has been concluded that: 
1. The level of circulating testosterone per se cannot ac-
count for the concentrations of serum gonadotrophins in 
normal, mature male rats as compared with castrated, ma-
ture male rats. Other testicular factors must be invol-
ved in maintaining the endocrine balance between the ma-
ture male gonad and the hypothalamic-pituitary unit. 
2. Sa-Reduced or ring A aromatized metabolites of testoste-
rone are more effective than testosterone or its metabo-
lic precursors in preventing the rise of serum gonado-
trophin levels postgonadectomy, circulating LH being 
more sensitive to steroid treatment than FSH. Steroid 
specific properties have been observed in this respect, 
since only the Sa-, but not Ss-reduced disubstituted me-
tabolites of testosterone are active. Moreover, the 
orientation of the hydroxyl group at C-3 in Sa-reduced 
testosterone metabolites influences the activity of the 
steroid in suppressing circulating gonadotrophins. 
3. Aromatization of ring A in steroids is not a prerequi-
site for affecting circulating gonadotrophins in the 
male rat. 
4. Testicular secretion products can cause the depressed 
serum gonadotrophin levels in normal male rats as com-
pared to levels in orchidectomized animals. Data obtai-
ned from hemi-gonadectomized, adult male rats indicate 
that the secretory activity of only one testis is suffi-
cient to maintain the endocrine balance in the hypotha-
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lamic-pituitary-testicular system in adult male rats. 
5. Administration of low doses of steroids can result in 
elevated serum gonadotrophin levels in castrated rats 
(positive feedback). 
6. There is not always a close correlation between the ef-
fects of steroids on processes at the hypothalamic-pi-
tuitary and the accessory reproductive organ level. Sa-
Dihydrotestosterone, however, may be the principal an-
drogen in these different androgen target organs. 
From the experiments on the effects of steroids on GnRF in-
duced serum gonadotrophin levels in castrated or normal, 
adult male rats, it has been concluded that: 
7. Steroids can alter pituitary sensitivity to GnRF. Andro-
gens inhibit and oestradiol-17S enhances pituitary re-
lease of gonadotrophins in response to exogenous GnRF. 
8. Oestrogens and androgens may act at different sites in 
the male hypothalamic-pituitary unit with respect to re-
gulation of pituitary release of gonadotrophins. Depen-
ding on the dose of administered oestrogens or androgens 
this unit may be affected in different ways. 
From the experiments concerning the potential involvement 
of adrenocortical steroids in the control of pituitary go-
nadotrophins, it has been concluded that: 
9. Secretions from the adrenal gland do not appreciably in-
fluence the effects of secretions from the testis on the 
control of pituitary release of gonadotrophins in adult 
male rats. 
Experiments with rats in which the germinal epithelium in 
the seminiferous tubules was depleted by local testicular 
X-irradiation, indicated that: 
10. Serum FSH concentrations in the mature male rat are 
partly regulated by testicular steroids and partly by an 
unknown factor ( 11 inhibin") from seminiferous tubules in 
the testis. 
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SAMENVATTING EN CONCLUSIES 
De endocriene en spermatogene functies van de testi-
kels in de volwassen mannelijke rat worden gereguleerd en 
instandgehouden door de gonadotrofe hormonen LH (luteinise-
rend hormoon) en FSH (follikel stirnulerend horrnoon), welke 
door de hypofyse-voorkwab worden gesecerneerd onder invloed 
van GnRF (gonadotrofine releasing factor). Steroidhorrnonen 
gesecerneerd door de testikels blijken op hun beurt deze 
gonadotrofe hypothalamus-hypofyse activiteit te kunnen be-
invloeden, aangezien verwijdering van de gonaden resulteert 
in sterk verhoogde serumspiegels van LH en FSH. 
In dit proefschrift worden de resultaten beschreven 
van een onderzoek over de invloed van steroiden, en voorna-
melijk die welke door de volwassen testikel worden gesecer-
neerd, op serum LH en FSH concentraties, als parameters 
voor de gonadotrofe activiteit van het hypothalamus-hypofyse 
systeem, en op serum testosteron concentraties, als parame-
ter voor de endocriene functie van de testikels. Voor de 
bepaling van de lage concentraties van de betreffende hor-
monen, was het noodzakelijk om nieuwe gevoelige radioimmu-
nologische technieken te evalueren (hoofdstuk 2) . De vol-
gende aspecten van de interactie tussen steroiden en het 
hypothalamus-hypofyse-testis systeem in volwassen mannelij-
ke ratten zijn bestudeerd: 
I. De invloed van steroiden op serum concentraties van 
LH, FSH en testosteron bij zowel normale (appendix ar-
tikelen 1 en 3; hoofdstuk 4) als gecastreerde (appen-
dix artikelen 2, 3 en 6; hoofdstuk 3) volwassen manne-
lijke ratten. Laatstgenoemd model biedt het voordeel 
de effecten van de steroiden te kunnen bestuderen zon-
der invloed van endogene testikulaire producten. 
II. De invloed van testikulaire steroiden op serum concen-
traties van LH en FSH na intraveneuze injectie van 
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GnRF in intacte of gecastreerde proefdieren (appendix 
artikelen 2 en 7). 
III. De invloed van bijnierschorssteroiden op de regulatie 
van het hypothalamus-hypofyse-testis systeem (appendix 
artikel 4). 
IV. Het effect van rOntgenbestraling van de mannelijke go-
naden op de activiteit van het hypothalamus-hypofyse-
testis systeem (appendix artikel 5). 
De volgende conclusies zijn gebaseerd op de resultaten van 
de experimenten beschreven in de hoofdstukken 3 en 4 en in 
de appendix artikelen 1, 2, 3 en 6 en op grand van gepubli-
ceerde gegevens over steroid secretie door de testikel, en 
over opname en metabolisme van steroiden in het hypothala-
mus-hypofyse systeem: 
1. De concentratie van testosteron in de perifere circula-
tie kan niet alleen verantwoordelijk zijn voor de ver-
laagde concentraties van LH en FSH in perifeer bleed van 
volwassen mannelijke ratten vergeleken met gecastreerde 
volwassen mannelijke ratten. Naast testosteron moeten 
andere factoren uit de testis betrokken zijn bij de hor-
monale balans tussen de testis en het hypothalamus-hypo-
fyse systeem van de volwassen rat. 
2. De toename van de concentraties van gonadotrofinen in 
serum na verwijdering van de gonaden wordt effectiever 
geremd door subcutane injectie van Sa-gereduceerde of 
ring A gearomatizeerde metabolieten van testosteron dan 
door testosteron of metabole precursors van testosteron. 
Serum LH spiegels tonen een grotere gevoeligheid voor 
steroidtoediening dan serum FSH spiegels. Het effect van 
de toegediende steroiden op gonadotrofine spiegels in 
bleed wordt belnvloed door specifieke isornere eigenschap-
pen van de steroiden; in dit verband is gebleken, dat 
alleen de Sa-, maar niet de SB-gereduceerde digesubsti-
tueerde metabolieten van testosteron een negatieve terug-
koppeling uitoefenen op de gonadotrofinen. Bovendien 
heeft de orientatie van de hydroxylgroep in de C-3 posi-
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tie van androstaan steroiden een invloed op de activiteit 
in dit opzicht. 
3. Aromatizering van de A-ring in steroiden is niet noodza-
kelijk veer het effect op LH en FSH. 
4. Door de testikels uitgescheiden producten zijn verant-
woordelijk voor de verlaagde serum LH en FSH spiegels in 
norrnale ratten vergeleken met gecastreerde ratten. De 
secretie van slechts een testis is voldoende om het hor-
rnonale evenwicht in het hypothalarnus-hypofyse-testis 
systeern te handhaven. 
5. Naast een negatieve terugkoppeling kunnen steroiden, in 
lage doseringen, ook een positieve terugkoppeling uit-
oefenen op de hypofysaire secretie van gonadotrofinen 
in gecastreerde mannelijke ratten. 
6. Fysiologische effecten van steroiden op de secundaire 
rnannelijke geslachtsorganen correleren niet altijd met 
die op de terugkoppeling in het hypothalarnus-hypofyse 
systeem. Het is evenwel mogelijk dat Sa-dihydrotestoste-
ron het voornaamste androgeen is in deze androgeengevoe-
lige doelwitorganen. 
Op grand van de resultaten van de experimenten betreffende 
de invloed van GnRF op serum LH en FSH concentraties in 
proefdieren voorbehandeld met steroiden van testikulaire 
oorsprong, werden de volgende conclusies getrokken: 
7. Steroidhorrnonen kunnen de gevoeligheid van de hypofyse 
voor exogeen GnRF belnvloeden. Androgenen rernrnen en 
oestradiol-l7S bevordert de hypofysaire secretie van g.o-
nadotrofinen in dit opzicht. 
8. Oestrogenen en androgenen kunnen hun effect op de regu-
latie van gonadotrofinen wellicht uitoefenen op meer dan 
een plaats in het hypothalamus-hypofyse systeem. Afhan-
kelijk van de dosering belnvloeden ze dit systeem wel-
licht op verschillende wijze. 
Uit de resultaten van de experimenten over de mogelijke rol 
van bijnierschorssteroiden bij de regulatie van het hypo-
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thalamus-hypofyse-testis systeem is de volgende conclusie 
getrokken: 
9. Secretieproducten van de bijnier hebben geen significante 
invloed op het effect van testikulaire secretieproducten 
op de regulatie van de hypofysaire secretie van gonado-
trofinen in de volwassen mannelijke rat. 
Uit de resultaten van de experimenten met ratten, waarbij 
het kiemepitheel in de serninifere tubuli ernstig werd be-
schadigd door middel van rOntgenbestraling van de gonaden, 
is geconcludeerd: 
10. Serum FSH spiegels in de volwassen rnannelijke rat worden 
behalve door testikulaire steroiden gedeeltelijk ook ge-
reguleerd door een (onbekende) factor ( 11 inhibine") uit 
de seminifere tubuli in de testikel. 
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ABSTRACT 
The effects of subcutaneous administration of oestradiol benzoate (EB) 
on the weights of sex organs and on levels of testosterone and gonado-
trophins in normal adult male rats have been studied. Doses of EB 
varied from 0.01 to 100 pg and were administered daily for seven days. 
Administraticn of 100 fAg EB resulted in suppression of pituitary LH, 
while serum LH levels were already decreased after treatment with 
EB ;;-;; I pg. Pituitary and serum FSH levels were suppressed after 
administration of 100 and 10 pg EB respectively. Testicular tissue and 
serum levels of testosterone decreased after treatment with amounts of 
EB ~ 1 pg. These decreased androgen levels were also reflected in a 
concomitant decrease in the weights of the ventral prostate and seminal 
vesicles. A decrease in the weight of the testes was obtained following 
a dose of EB ~ 10 .ug. 
It is now established, that oestradiol-17 j3 is synthesized and secreted by human, 
monkey, dog and rat testes (Kelch et al. 1972; Eik-Nes !967; de ]ong et al. 
1973). However, its physiological role in the male is still uncertain, although 
it has been proposed as a regulator of pituitary gonadotrophin secretion. The 
influence of oestradiol-17 p on the hypothalamic-pituitary axis in the male rat 
has mainly been studied following gonadectomy. In order tn suppress the high 
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levels of circulating gonadotrophins after gonadectomy to those found in nor-
mal adult male rats (Gay & Dever 1971; Swerdloff & Walsh 1973; Swerdloff 
et al. 1973; Kalra et al. 1973; Verjans et al. 1974) lower daily doses of oestra-
diol-17j3 or ·oestradiol benzoate were required than of androgens. These ob-
servations might suggest a role for circulating oestradiol-17 j3 in the feedback 
regulation of pituitary gonadotrophins (Walsh et al. 1973). 
Recently, however, there have been several reports showing that administra-
tion of oestradi·ol-17 j3 to intact male rats caused a decrease in circulating 
testosterone levels but not, as might be expected, a decrease in circulating 
LH and FSH levels (Danutra et al. 1973; Mallampati & johnson 1973). 
These observations can be explained if there were a direct effect of oestra-
diol-17 j3 on testicular testosterone secretion or if, besides LH or FSH, other 
factors regulate the secretion of testicular testosterone. Since most of these 
studies have been carried out with supraphysiological amounts of administered 
oestradiol-! 7 j3, the present study was undertaken to determine the lowest dose 
of administered oestradiol benzoate that could bring about changes in levels 
of testosterone in serum and in testis tissue of adult male rats. In addition 
pituitary and serum LH and FSH have been measured together with the weights 
of seminal vesicles, ventral prostates and testes. 
MATERIALS AND METHODS 
Animals 
Adult male Wistar rats (3-4 months old) with a body weight of 225-250 g were 
used in this study. The animals were kept under controlled light (14 hours light and 
10 hours darkness) and temperature (20-22°C) conditions. Laboratory chow and tap 
water were provided ad libitum. 
Daily subcutaneous injections with various doses of EB in 0.1 ml sesame oil were 
given for a period of seven days. Control animals received 0.1 ml vehicle only. Six 
animals were used in each of the different treatment groups. After decapitation of 
the animals on day 8 blood samples were wllected and allowed to clot overnight 
at 4°C. Serum was stored at -20°C until assayed for testosterone and gonadotrophins. 
Testes, ventral prostate and seminal vesicles were dissected and weighed. Testes were 
stored frozen at -20°C until further processed. The pituitary glands were :removed 
and kept frozen at -20°C in 1 ml 0.9 «fo sodium chloride solution until thawed and 
homogenized. The homogenate was diluted to 4 ml with saline and centrifuged at 
3000 rpm for 25 min. The supernatant was further diluted with saline and assayed 
for gonadotrophins. 
Radioimmunoassay methods 
Gonadotrophin levels were measured using double antibody radioimmunoassays. 
Antisera against ovine LH and ovine FSH were obtained by immunizing rabbits with 
NIH-LH-S17 and NIH-FSH-S9. For both radioimmunoassays the procedures as de-
scribed by Niswender et al. (1968) were followed. Sensitivity, accuracy and specificity 
of both radioimmunoassays have been published (Welschen et al. 1974, in press). Serum 
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Table I. 
Mean levels (±so) of serum and pituitary gonadotrophins in adult male rats treated with various doses of EB per day for seven days. 
Treatment I 
Serum LH 
(ng*/ml) 
Control, sesame oil 23.8 ± 12.9 (6) 
0.01 l'g EB 11.0 ± 3.4 (6) 
0.1 ,ug EB 19.4 ± 6.4 (6) 
1 ,ug EB < 7.5 (4)'' '* 
10 pg EB < 7.5 (5)''''''' 
100 pg EB < 7.5 (6)'"''' 
Number of rats is given in parentheses. 
* NIAMD rat-LH RP-1. 
'"' NIAMD rat-FSH RP-1. 
**~ P < 0.05, compared with controls. 
I Serum FSH (ng'''*/ml) 
288 ± 47 (6) 
322 ± 83 (6) 
336 ± 51 (6) 
278 ± 80 (4) 
163 ± 23 (5)'"'''' 
155 ± 11 (6)"'''' 
Pituitary LH 
(mg;'/pituitary) 
0.271 ± 0.062 (6) 
0.274 ± 0.088 (6) 
0.291 ± 0.100 (6) 
0.201 ± 0.045 (5) 
0.237 ± 0.070 (5) 
0.190 ± 0.058 (5)'""' 
Pituitary FSH 
(mg"-"~/pituitary) 
0.140 ± 0.020 (6) 
0.148 ± 0.038 (6) 
0.145 ± 0.024 (6) 
0.111 ± 0.023 (5) 
0.102 ± 0.029 (5)'"''' 
0.084 ± 0.011 (5)'"''' 
samples were assayed in duplicate at two levels per assay and serum LH and FSH 
levels were expressed on basis of reference preparations NIAMD rat-LH RP-1 and 
NIAMD rat-FSH RP-1 respectively. Pituitary gland extracts were assayed in duplicate 
at two dilutions per assay and contents of gonadotrophins were expressed as mg of 
the respective reference preparation per hypophysis. Radioimmunoassay of testosterone 
in blood serum and testis tissue was performed as described previously (V erjans et al. 
1973). 
Determinations of total protein in testicular tissue were carried out according to 
the method of Lowry et al. (1951). Statistical significance of the obtained data was 
determined by Student's t-test. 
RESULTS 
Doses of I, 10 and 100 fhg EB per day respectively, significantly (P < 0.05) 
suppressed serum levels of LH compared with rats receiving vehicle only, 
while hypophyseal LH levels were decreased after daily administration of 
100 fhg EB (Table 1). The levels of FSH in both serum and pituitary gland 
exhibited a significant decrease (P < 0.05) in animals treated daily with 10 
or 100 fhg EB for 7 days. 
Table 2 shows effects of daily, subcutaneous administration of various 
doses of EB for 7 days on testosterone levels in serum and testicular tissue 
in normal adult male rats. Compared with the control group, a dose of I flg 
per day caused a significant lowering of serum as well as of testis tissue tes-
tosterone (P < 0.05). Serum and testicular tissue testosterone levels decreased 
further with increasing doses of EB. The effects of various doses of EB on 
weights of male sex organs are summarized in Table 3. Administration o.f 
Table 2. 
Mean levels (± sn) of serum and testis tissue testosterone in adult male" rats treated 
with various doses of EB per day for seven days. 
Serum Testis tissue 
Treatment Number of rats testosterone testosterone 
(ng/ml) (ng/mg protein) 
Control, sesame oil 6 2.3 ± 0.9 1.00 ± 0.35 
0.01 fhg EB 6 2.4 ± 2.6 0.68 ± 0.56 
0.1 ,ug EB 6 3.3 ± 1.3 0.97 ± 0.40 
,ug EB 5 0.1 ± 0.2'' 0.22 ± 0.12* 
10 ,ug EB 5 < 0.01" 0.06 ± 0.01" 
100 ,ug EB 6 < 0.01'' 0.08 ± 0.01 * 
* Significantly different (P < 0.05) from controls. 
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Table 3. 
Mean weights ( ± sn) of sex organs of adult male rats treated with various doses 
of EB per day for seven days. 
Treatment Testis (g) 
Control, sesame oil 1.50 ± 0.10 (12) 
0.01 l'g EB 1.47 ± 0.12 (12) 
0.1 l'g EB 1.56 ± 0.10 (12) 
l'g EB 1.49 ± 0.17 (10) 
10 l'g EB 1.40 ± 0.06 (10)'• 
100 l'g EB 1.30 ± 0.06 (10)" 
Number of organs is given in parentheses. 
:;. P < 0.05, compared with controls. 
Seminal vesicle Ventral prostate 
(mg) (mg) 
112 ± 20 (12) 312 ± 34 (6) 
98 ± 19 (12) 251 ± 28 (6)'" 
117 ± 18 (12) 332 ± 52 (6) 
72 ± 4 (10)'' 166 ± 30 (5)" 
59± 8 (Ia)" 94 ± 30 (5)'' 
68 ± 15 (12)" 99 ± 26 (5)" 
10 or 100 .,ug EB per day during 7 days resulted in a significant reduction 
in testicular weight (P < 0.05) compared with the control group and the seminal 
vesicle and ventral prostate weights were decreased using a daily dose of 1, 
10 or 100 l'g EB. 
DISCuSSION 
It is apparent from the present study, that administration of 1 Jlg per day of 
oestradiol benzoate decreases levels of both testosterone (Table 2) and LH 
(Table I) in serum. No effect on either hormone was observed with smaller 
amounts of EB. Thus it is possible that EB acts directly on the hypothalamic-
pituitary axis causing a decreased secretion of LH and consequently lower 
circulating levels of testosterone. FSH serum levels (Table 1) were also lowered 
by the administration of EB, but compared with the smallest doses required 
to suppress LH and testosterone, 10 times more or at least 10 Jl.g daily, were 
needed. Serum and pituitary FSH levels were suppressed by a daily dose of 
10 l'g EB for 7 days (Table 1), which probably reflects that production and 
release of FSH are more or less equally sensitive to EB administration. Mallam-
pati & johnson (1973) found, h<>wever, a lowering of pituitary FSH levels 
in adult male rats following a daily dose of only 0.5 pg EB for 4 days, while 
serum FSH levels did not differ significantly from control levels with this 
dose of EB. Debeljuk et al. (1972) reported suppression of serum FSH levels 
in intact adult male rats even following a single, subcutaneous injection of 
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20 \ug EB. A significant depression of pituitary LH levels in the present inves-
tigation was observed following daily administration of 100 p.g EB for 7 days, 
while serum LH levels were already suppressed by one hundredth of this dose 
(Table I). This might indicate that the pituitary release of LH is more sensi-
tive to oestrogen than the pituitary production of this hormone. Danutra et al. 
(1973) found, however, no significant change in plasma LH levels in adult, 
male rats after daily treatment with 100 1..1g oestradiol-17;5' for 10 days. Our 
data are also in disagreement with those reported by Mallampati & johnson 
(1973), who found unaltered serum LH levels after a daily dose of 50 f,lg EB 
for 4 days, but depressed pituitary LH levels by as little as 0.5 flg EB. Con-
tinuous intravenous infusion of oestradiol-17 j3 for 4 days in men suppressed 
equally both plasma LH and FSH levels (Sherins & Loriaux 1973). 
A daily dose of 1 pg EB, which significantly lowered testosterone levels 
in serum as well as in testis tissue, did not affect total testicular weight 
(Table 3), but I U ,ug EB for i days resulted in a significant weight decrease 
of the male gonad (Table 3). Changes in testicular weight parallel changes 
in serum FSH. Thus, the processes leading to production and secretion of 
testosterone are more sensitive to EB administration than those promoting 
growth of the testicular tissue. Mallampati & johnson (1973) observed no re-
duction in either testicular weights or serum FSH levels -of adult male rats 
following injection of a daily dose of 50 pg EB for 4 days. This discrepancy 
could be due to differences in duration of the EB treatment. Compared with 
weights of control organs, the relative weight decrease of the seminal vesicle 
after treatment with daily doses of 1. 10 or 100 }J.g EB for 7 days was less 
than that of the ventral prostate after such treatments (Table 3). This may 
reflect that the latter organ is more sensitive to the possible "anti-androgenic" 
effect of oestrogen and/or the decrease in circulating testosterone levels than 
the former. 
The interaction of testicular and adrenal oestrogens and androgens at the 
level of the hypothalamic-pituitary-gonadal axis for regulation of production 
and secretion of gonadotrophins via hypothalamic releasing factor(s), and the 
subsequent secretion pattern of steroids, is still not clear and will require 
further exploration. 
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ABSTRACT 
The influence of treatment with various doses of testosterone propionate, 
5a-dihydrotestosterone propionate or oestradiol benzoate on serum levels 
of LH and FSH (measured by radioimmunoassay) and on weights of 
ventral prostates and seminal vesicles was investigated in castrated, 
adult, male rats. For depression of the high, castrate levels of serum 
gonadotrophins with either of these steroid esters, the inhibition curves 
were different for LH and for FSH. Serum LH was kept at levels 
encountered in intact, adult, male rats by lower doses of steroid ester 
than was serum FSH. Oestradiol benzoate was the most potent sup-
pressor of the serum gonadotrophins among the steroid esters tested, 
testosterone propionate the least. Treatment with low doses of oestradiol 
benzoate, however, resulted in serum FSH levels significantly above those 
of castrates treated with vehicle only. Finally, administration of a 
synthetic LH-releasing factor to testosterone propionate, 5a-dihydro-
testosterone propionate or oestradiol benzoate treated. castrated, adult, 
male rats resulted in a further release of both LH and FSH. The latter 
effect was more pronounced in oestradiol benzoate treated castrates 
than in testosterone propionate or 5rt-dihydrotestosteronc propionate 
treated castrates. 
043 
Following gonadectomy in male rats, serum levels of LH and FSH will in-
crease rapidly (Gay & Bogdanove 1969; Gay & Dever 1971; Swerdloff et al. 
1972, 1973; Swerdloff & Walsh 1973; Dufy-Barbe & Franchimont 1972; Kalra 
et al. 1973). Administration of testicular steroids to such animals may be used 
to suppress serum levels of these gonadotrophins (Gay & Bogdanove 1969; 
Gay & Dever 1971; Swerdloff et al. 1972. 1973; Swerdloff & Walsh 1978; 
Dufy-Barbe & Franchimont 1972; Kalra et al. 1973). Testosterone is in this 
respect a potent suppressor, but little is known about the potency of other 
steroids, such as 5a-dihydrotestosterone and oestradiol which are also secreted 
by the testis. In order to study the relative effects of testicular steroids on 
serum levels of LH and FSH, we have examined the doses of testosterone 
propionate (TP), 5a-dihydrotestosterone propionate (5a-dhTP) or oestradiol 
benzoate (EB) to keep circulating LH and FSH in the castrated. adult, male 
rat at levels comparable with those found in intact male rats of the same age. 
Furthermore, we have investigated the effect of such substitution doses of 
testicular steroids on weights of accessory sex organs. 
The release of LH and FSH from the pituitary gland is mediated via the 
hypothalamus which secretes gonadotrophin releasing factor(s). It was sug-
gested (Naftolin et a/. 1972) that androgens act on the hypothalamus after 
being converted to oestradiol-17;1. Swerdloff et al. (1972), however, showed 
that 5a- dihydrotestosterone, which cannot be converted to oestradiol-17 fi, 
also inhibits LH and FSH secretion in castrated, adult, male rats. These in-
vestigators concluded that the androgens may act directly on the hypothalamic-
pituitary axis. It has been reported (Debeljuk et al. 1972) that in normal, adult, 
male rats treated with relatively high doses of TP the circulating levels of 
LH and FSH are lower than in EB treated animals following administration 
of a LH-releasing factor. Since no data exist on effects of steroids on LH 
and FSH release after injection of gonadotrophic releasing factor to castrated 
rats, serum levels of LH and FSH were determined in TP, 5a-dh TP or EB 
treated castrated rats subsequent to administration of a synthetic LH-releasing 
factor. 
M A T E R 1 A L S A N D ME T H 0 DS 
A nirnals 
Four months old male rats (R x U strain) weighing 350-450 g were used throughout 
the experiments. The animals were kept under controlled lighting (14 hours light and 
10 hours darkness) and temperature (20-22°C) conditions. Laboratory chow and tap 
water were provided ad libitum. 
Exfu:rimcnt /. - Animals were gonadectomized under light ether anaesthesia. Daily, 
subcutaneous injections of TP. 5fx-dhTP or ER in sesame oil (0.04 ml/100 g b. w.) 
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started immediately after operation and were continued for the next six days. These 
steroids were injected between 2 and 4 p.m. Control animals received sesame oil only 
(0.04 ml/100 g b. w.). Steroid esters were purchased from Steraloids, Pawling, New 
York. and were used without further purification. Twenty-four hours after the last 
injection of steroids, blood samples were drawn under ether anaesthesia by puncturing 
the ophthalmic venous plexus. If used 500 ng synthetic LH-releasing factor (Beckman, 
Palo Alto, California), dissolved in 0.1 ml 0.9 °/o sodium chloride solution, was 
administered via the jugular vein immediately thereafter. Control animals received 
0.1 ml 0.9 Ofo sodium chloride solution only via this route and 15 and 45 min after 
the injection of LH-releasing factor or saline, the anim1.ls were bled again by punc-
turing the ophthalmic venous plexus under light ether anaesthesia. The animals were 
then sacrificed with chloroform. the ventral prostate and seminal vesicles were dissected 
free and weighed. 
F.xfJcriment 1!. - In one group of gonadectomized animals treated with 5 ,11g SrL-
dhTP/100 g b. w./day for ten days, blood samples were taken under light ether 
;maesthesia between 2 and 3 p.m. three days after castration. Daily treatment with 
Sr1-dhTP was then continued and blood samples were drawn on day 5, i and 10 after 
removal of the gonads. As controls served castrated animals subjected to the same 
type of blood withdrawal but treated with sesame oil only (0.04 ml/100 g b. w.). ln 
each of these treatment groups four animals were used. Blood samples from experi-
ments 1 and II were allowed to clot overnight at 4°C. Serum was stored at ~20°C 
until assayed for gonadotrophins. 
Radioimmunoa,~say 
Serum levels of LH and FSH were measured using double antibody radioimrnuno-
assays. Antisera against ovine LH and ovine FSH were obtained by immunizing 
rabbits with NIH-LH-S I i or NIH-FSH-S9 (Drs. Uilenbroek and Dullaart. Depart-
ments of Endocrinology. Growth and Reproduction and Anatomy, Erasmus University, 
Rotterdam). For both radioimmunoassays the procedures as described by Niswendcr 
ct al. (1968) were followed. Sensitivity, accuracy and specificity of both radioimmuno-
assays have been described previously (Welsrhen et al. 1974, in press). In the radio-
immunoassay of rat LH. NIAMD rat LH 1-1 was used for the preparation of the 
iodinated derivative (Grcenwond et al. l%3). The biological activity of this pre-
paration was 1.0 unit NIH-LH-Sl: .. mg as measured by the ovarian ascorbic acid 
depletion test and the FSH contamination was less than 0.04 unit NIH-FSH-SI·mg as 
measured by the human chorionic gonadotrophin augmentation test. Iodination was 
performed with 11;1 (Philips-Duphar, Petten, The Netherlands). Serum LH levels were 
expressed on basis of a reference standard preparation (NIAMD rat LH RP-1) which 
had a biological acticity of 0.08 unit NIH-LH-SJ:mg and FSH contamination of 0.5!i 
unit NIH-FSH-Sl/mg. NIAMD rat FSH 1-1 with a biological acticity of 100 unit 
NIH-FSH-Si/mg and a LH contamination of !l:SS than 0.(Hl2 unit NIH-LH-SJ/mg-
was used for iodination with !2.~1 (Grccnw.>ood ('[ al. 19K3) in the radioimmunoassay 
of rat FSH. Serum FSH levels were expressed on basis of a reference preparation 
NIAMD rat FSH RP-1 with a biological activity of 2.l unit NIH-FSH-Sl mg and a 
LH contamination of 0.02 unit NIH-LH-S!·'mg. All serum samples from one single 
experiment were assayed in duplicate at two levels per assay in order to eliminate 
inter-assay variations. Statistical significance of the obtained data was determined 
by Student's 1-test. 
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Effe<'t of treatment with various doses of testosterone proj;ionate/100 g b. w./day during 
seven days on levels of serum FSH and LH in castrated, adult, male rats. Mean 
data ± SEM from three animals are shown. Open bars: FSH; Cross bars: LH. 
RESULTS 
Effect of treatment wit It .1·tcroid esters on serum levels of LH and FSH 
The effects o.f daily administration of various doses of TP, 5a-dhTP or EB 
on serum levels of LH and FSH in castrated, adult, male rats are depicted in 
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Figs. l-8. Treatment with 20 ,ug TP during 7 days gave suppression of cir-
culating LH to levels below those found in castrated controls (P < 0.001). 
but not significantly different from the concentrations found in intact controls. 
For suppression of FSH to levels not significantly different from those of 
intact control animals. 35 ,ag TP was required. 5a-dhTP in a dose of 5pg 
gave significant suppression of LH below castrate levels (P < 0.005) with 
no significant lowering of FSH. Twice this dose of 5rx-dhTP gave FSH levels 
significantly lower than those of castrates (P < 0.001) and not significantly 
higher than those of intact controls (P < 0.10). A dose of 2.5 l'g 5a-dhTP 
caused no significant elevation in serum FSH over castrate control levels 
(P < 0.10). 
Treatment with 0.8 ,ug EB lowered serum LH levels to those of intact control 
rats and a dose of 0.5 ,ug EB suppressed serum LH significantly (P < 0.01) 
compared to intact control animals. Serum FSH. ho-wever. was not significantly 
higher in the former group of rats than in intact controls (P > 0.10). Ad-
ministration of 0.01 or 0.05 ,ug EB elevated serum FSH significantly above 
castrate C"ontrol levels (P < 0.001 and P < 0.005 respectively). Figs . ..J. and 5 
depict LH and FSH serum levels respectively in a longitudinal study on 
castrated, adult, male rats given daily injections of sesame oil containing 
5 ,11g 5o-dhTP. 
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Fig. 4. 
Levels of serum LH in castrated, adult, male rats in a longitudinal study. Mean 
data± SEM from four animals are shown. Solid line: castrated animals treated daily 
with 5 ,ug 5a-dihydrotestosterone propionate/100 g b. w. (subcutaneous) for ten days; 
dotted line: castrated animals treated daily with sesame oil (subcutaneous) only for 
ten days. 
Table 1. 
Effect of different doses of testosterone propionate (.ug/100 g b. w./day for seven days) 
on organ weights (mg/100 g b. w.) in castrated, adult, male rats (n = 3). 
Treatment 
Ventral prostate Seminal vesicles 
(mean ± SD) (mean± sn) 
Intact, controls 73.7 ± 6.4x 82.2 ± 5.9x 
Castrate, sesame oil 21.7 ± 4.0'" 40.3 ± 1.5'' 
Castrate. 25 ,ug TP 74.6 ± 12.0x 62.4 ± 7 }ix'~ 
Castrate. 30 ,ug TP 82.5 ± 5.8x 81.6 ± 17.8x 
Castrate. 35 JA-g TP 88.0 ± I0.9x 98.1 ± 4.4x':· 
* Mean significantly different (P < 0.05 one sided) from mean of intact controls. 
x Mean significantly different (P < 0.02) from mean of castrated animals treated with 
sesame oil. 
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Fig. 5. 
Levels of serum FSH in castrated, adult. male rats m a longitudinal study. Mean 
data ± SEM from four animals are .shown. Soli-d line: castrated animals treated daily 
with 5 pg 5a-dihydrotestosterone propionate/100 g b. w. (subcutaneous) for ten days; 
dotted line: castrated animals treated daily with sesame oil (subcutaneous) only for 
ten days. 
Table 2. 
Effect of different doses of Sa-dihydroteslosterone fJropionate Ct~g/100 g b. w./day fur 
seven days) on organ weights (mg/100 g b. w.) in castrated, adult, male rats (n = S). 
Treatment 
Intact. controls 
Castrate, ~esame oil 
Castrate. 2.5 ,ug 5u~dhTP 
Castrate, 5 ,11g 5a-dhTP 
Castrate. 7..5 ,ug 5o:-dhTP 
Castrate, 10 pg 5a-dhTP 
Castrate, 20 ,ug 5a~dhTP 
Castrate, 30 fig 5a~dhTP 
Ventral prostate 
(mean ± so) 
68.1 ± 7.3x 
26.0 ± 5.7* 
41..1 ± 6.Jx'f 
41.7 ± 7.9':· 
51.5 ± 9.4x 
72.9 ± 7.2x 
:)8.0 ± iL'1x 
69 .. 5 ± 2.2x 
Seminal vesicles 
(mean ± so) 
73.9 ± 7.5X 
42.2 ± 4.0'~ 
51.5 ± 6.4'. 
58.6 ± 7.3x 
67.8 ± 9.JX 
74.3 ± 17 .6x 
81.7 ± 1J.Ox 
77.3 ± 7 .9x 
* Mean significantly different (P < O.O:"J one sided) from mean of intact controls. 
x Mean significantly different (P < 0.05) from mean of castrated animals treated with 
sesame oil. 
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Table 3. 
Effect of different doses of oestradiol bn1zoatc (pg/100 g h. w./day for seven days) on 
organ weights (mg/100 g b. w.) in castrated, adult, male rats (n = 3). 
Treatment 
Intact, controls 
Castrate, sesame oil 
Castrate, 0.01 ,11g EB 
Castrate, 0.05 J'g EB 
Castrate, 0.10 ,ug EB 
Castrate. 0.50 ,II g EB 
Ventral prostate 
(mean ± so) 
68.1 ± 7.3x 
26.0 ± 5.7'"'" 
24.2 ± 5.·1'"'" 
25.5 ± 2.5':· 
24.2 ± 2.S':· 
28.6 ± 6.4':-
Seminc.l vesicles 
(mean± so) 
7.3.9 ± 7.5x 
41.2 ± 4.0']-
.?4.8 ± 2.5x':· 
:)6.1 ± 3.Qx'"<" 
60.7 ± 6.4x 
6.S.O ± 3.5x 
'"'" Mean significantly different (P < 0.05 nne sided) from mean of intact controls. 
x Mean significantly different (P < O.Cll) from mean of castrated animals treated with 
sesame oil. 
Five days after castration there was a significant difference in serum LH 
between castrated animals receiving sesame oil and 5 pg 5a-dhTP in this 
vehicle (P < 0.05), while the level of serum LH in the castrates after treat-
ment with 5 flg 511-dhTP was not significantly higher than the intact control 
level (P > 0.1 0). The FSH levels were not significantly different between 
castrates administered sesame oil or 5 pg 5u-dhTP in sesame oil during this 
longitudinal study. 
Effects of steroid esters on weights of accessory sex organs 
The effects of various doses of TP. 5a-dhTP or EB on ventral prostate 
and seminal vesicles weights are summarized in Tables 1~8. When given by 
daily injections, less 5a-dhTP than TP was required to maintain normal 
ventral prostate and seminal vesicles weights in castrated, adult. male rats. 
Administration of~ 0.01 ,ug EB prevented the weight decrease of the seminal 
vesicles as observed in castrated rats. although the weights were slightly de-
creased when compared to intact controls. The weights of the ventral prostate 
in animals treated with either amount of EB. even with 0.5 pg, were however. 
not significantly different from those of control castrates. 
Ef[ccls of synlhctir LH-rdeasing fw1or in TP, ,)u-dhTP, or EB treated, 
caslruted, adult, malr rats 
Table 4 shows levels of serum LH and FSH following intravenous injection 
of 500 ng synthetic LH-releasing factor in castrated rats treated during the 
7 preceding days with 40 ,ug TP. IU ,ug .S(f-dhTP or 1 pg EB per day. 15 min 
(j!)() 
Table 4. 
Effect of 500 ng ~ynthetic LH-releasing factor (LH-RF) on serum LH and FSH levels 
in intact, adult, male rats and castrated, adult, male rats, treated for seven days 
with either sesame oiL 40 ,ug testosterone propionate/100gb. w./day, 10 jJ.g 5a-dihydro-
testosterone propionate/tOO g b. w.Jday or I fA.g oestradiol benzoate/100' g b. w./day. 
A single injection of LH-RF was given on day 8 at 3 p.m. Effect of injecting 
saline in intact, adult, male rats is also shown. Blood samples were drawn immediately 
before and 15 and 45 min after injection of saline or saline containing LH-RF. Three 
or more animals were used per experiment. 
ng NIAMD rat ng NIAMD rat 
Treatment LH RP-1/ml serum FSH RP-1./ml serum 
(mean ± so) {mean± so) 
Intact contTols 80 ± 19 378 ± 42 
15 min after 500 ng LH-RF 209 ± 38 463 ± 42 
45 min after 500 ng LH-RF 108 ± 37 487 ± 49 
15 min after saline 7S± 4 378 ± 9 
45 min after saline 64 ± 17 371 ± 13 
Control castrates, sesame oil 220 ± 15 958 ± 67 
15 min after 500 ng LH-RF 364 ± 184 1107 ± 99 
45 min after 500 ng LH-RF 303±113 1189 ± 123 
Castrates, 40 ;1g TP 31 ± 5 406 ± 7S 
15 min after-500 ng LH-RF S9 ± 19 464 ± 151 
45 min after 500 ng LH-RF 59 ± 13 465 ± 50 
Castrates, 10 jJ.g 5a-dhTP n. d.'~ 508 ± 64 
15 min after 500 ng LH-RF 111± 19 642 ± 20 
45 min after 500 ng LH-RF 48 ± 24 673 ± 91 
Castrates, 1 ,ug EB 21 ± 2 470 ± 63 
15 min after 500 ng LH-RF 399 ± 23 992±115 
45 min after 500 ng LH-RF 242 ± 11 843 ± 295 
'~ n. d.: not detectable. 
after injection of this LH-releasing factor (dissolved in saline) there was a 
significant increase (P < 0.025) in serum FSH and LH levels, compared with 
the levels found before injections ·of this LH-releasing factor. However, no 
significant increase occurred in serum LH and FSH in castrates given saline 
only and in serum FSH in castrates treated with 40 !tg TP for the 7 previous 
days. 
DISCUSSION 
The data presented show the effects of daily injections of TP, 5rJ-dhTP or 
EB on serum levels of LH and FSH and on weights of ventral prostates and 
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seminal vesicles in castrated, adult, male rats. Castration resulted in elevated 
gonadotrophin levels (Figs. 1~8). To prevent this rise of serum LH levels, 
20 l'g TP, 5 pg 5a-dhTP or 0.3 pg EB per I 00 g body weight had to be ad-
ministered subcutaneously in daily injections for 7 days (Figs. 1-3). Larger 
doses of these steroids had to be given in order to curb the rise of serum FSH: 
35 JAg TP, 20 pg 5a-dhTP or 0.5 l'g EB (Figs. 1-3). The doses of TP and 
5a-dhTP required to maintain normal weights of ventral prostates and seminal 
vesicles after castration were slightly higher than those effecting normal LH 
after castration (Tables l and 2, Figs. I and 2). If the same amount of androgen 
reaches the target organs following daily administration of either TP or 
5a-dhTP in sesame oil. 5a-dhTP appears to be more potent than TP in in-
hibiting secretion of gonadotrophins after castration and in keeping ventral 
prostate and seminal vesicles weights of castrated rats equal to those of intact 
controls (Figs. 1 and 2, Tables I and 2). However. the suppression curves for 
serum LH and FSH by steroid esters are not parallel (Figs. 1-.1). Other in-
vestigators (Gay & Bogdanove 1969; Swerdloff et al. 1972. 1973: Swerdloff 
& Walsh 1978; Dufy-Barbe & Franrhimont 1972: Kalra et al. 1973; Mallamputi 
& johnson 1973) who have studied the problem of steroid effects on the pi-
tuitary-hypothalamic system have used other time schedules with regard to 
duration of steroid treatment and interval after castration such treatment 
was started. The results obtained in the current work are in agreement with 
those previously reported, although smaller doses of steroid esters were re-
quired in our investigation to keep normal serum LH and FSH levels in 
castrates. Since 5u-dihydrotestosterone cannot be converted to oestradiol-17 ("J. 
the current work and also the data of Swrrdloff el al. (1972) indicate that the 
androgens must not necessarily be metabolized to oestrogens in order to inhibit 
pituitary production of gonadotrophins. The doses of 5a-dhTP or 5a-dihydro-
testosterone used in the present investigation and by Swerdloff et al. (1972) 
are high. however. compared to the production in vitro of 5f!-dihydrotestos-
terone by the rat testis (Fo!man eta!. 1972). Moreover. in neither investigation 
the proof has been delivered that Sa-dihydrotestosterone is the "active form" 
of this androgen at the tissue organization tested. Low doses of EB gave a 
significant increase in serum FSH over castrate levels possibly indicating a 
stimulat·ory feedback mechanism. if circulating gonadotrophins are true indi-
cations of pituitary production and secretion of these hormones. However. 
it must he kept in mind that the clearance rates may differ for the different 
.:;teroids, employed in our work and that the use of one daily. subcutaneous 
injection of a stero~d ester may result in a variable concentration of that steroid 
in circulating blood over the ensuing 24 hours. This is indeed the case when TP 
is administered subcutaneously to castrated rats (unpublished observations). 
Therefore. we have used a strict time scheme of daily steroid injections and 
in the longitudinal study (Figs. 4 and 5) levels of serum LH and FSH on day 5. 
7 and I 0 after castration in the adult, male rats treated with 5 _ug 5a-dhTP 
are rather similar. 
Administration of LH-releasing factor caused an increase in serum LH 
and FSH levels in castrated, adult. male rats treated with steroid esters 
(Table 4). Using the same dose of this LH-releasing principle higher serum 
levels of FSH and LH were obtained in castrates treated with EB than in 
castrates treated with either TP or Sa-dhTP (Table 4). In normal, male rats 
treated with relatively high doses of TP the circulating levels of LH and FSH 
are lower than in EB treated animals following administration of a LH-releasing 
factor (Debeljuk et al. 1972). Circulating levels of LH and FSH in the castrates 
are affected in a different way by the steroid treatments, which might have 
influenced the hypothalamic secretion of releasing factor(s) and/or modified 
the sensitivity of the pituitary gland to hypothalamic regulators. The nature 
and the dose of the steroid employed may play an important role in both 
aspects. The sensitivity to administration of LH releasing factor appeared to 
be higher in EB treated castrates than in TP or 5a-dhTP treated castrates. 
The oestrogen-androgen interaction at the level of the hypothalamic-pituitary 
axis may still remain the topic of much debate. Since it is known that Cl\J-steroid 
Sr1-reductase activity will increase in the adrenal gland (Maynard & Cameron 
197.3) and in the hypophysis (Kniewald & Milkovic 1978) following castration. 
it is of interest to measure circulating levels of LH and FSH in adrenalecto-
mized, gonadectomized male rats. 
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ABSTRACT 
Serum levels of LH, FSH and testosterone were measured by radio-
immunoassay in intact and castrated, adult, male rats after testosterone 
was administered subcutaneously for seven days in doses ranging from 
25 to 200 pg per 100 g body weight per day. Such treatment increased 
circulating testosterone both in intact and castrated rats, but its effects 
on serum gonadotrophins were different in these animal groups. All doses 
of testosterone suppressed serum LH and FSH in the normal rat. In the 
castrates, treatment with the lowest dose of testosterone resulted in serum 
LH levels significantly above the high castrate levels, while serum FSH 
tended to drop. Administration of the highest doses of testosterone did 
not depress serum LH and FSH in the castrates to those of intact, normal 
animals, though serum testosterone in these castrates was much higher 
than in normal, male rats. It is concluded, that the sensitivity of the hypo-
thalamic-pituitary system for daily, subcutaneous testosterone administra-
tion during seven days is not the same in the intact and castrated, adult, 
male rat b.nd that testicular factors different from testosterone may play 
a role in regulating production and/or secretion of gonadotrophins by the 
hypophysis in male animals. 
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A relationship between testosterone and circulating gonadotrophins is rather 
well documented in the adult, male rat. Following gonadectomy, circulating 
testosterone will decrease to very low, almost undetectable values (Coyotupa 
et al. 1973), while circulating LH and FSH will increase (Gay & Bogdanove 
1969; Swerdloff el al. 1972; Kalra et al. 1973; Verjans et al. 1974b). Adminis-
tration of supraphysiological doses of testosterone or testosterone propionate to 
such animals prevents the rise of serum gonadotrophins (Gay & Bogdanove 
I 969; Swerdloff et al. 1972; Kalra et al. I 97 3; V er jans et al. 197 4b ). It is, 
however, unclear at what site of the hypothalamic-pituitary axis testosterone 
or its metabolites exert this action. Recently, Kingsley & Bogdanove (1973) de-
monstrated that androgenic steroids can exert direct intrapituitary effects 
in vivo in orchidectomized rats. Using an animal model (gonadectomized. 
adult, male rat) high doses of 5a-dihydrotestosterone, 5a-dihydrotestosterone 
propionate or of oestradiol-17 (3 or oestradiol benzoate appeared to be even 
more potent than testosterone or testosterone propionate in preventing the in-
crease in serum gonadotrophins following castration (Swerdloff & Walsh 197 3; 
Kalra et al. 1973; Verjans et al. 1974b). Data on the dependency between cir-
culating testosterone and circulating gonadotrophins following exogenous ad-
ministration of testosterone are, however, lacking. The availability of radio-
immunoassay techniques for testosterone and the gonadotrophins prompted us 
to study this dependency in normal a11d castrated rats. 
MATERIAL AND METHODS 
Animals 
Adult. male Wistar rats (3-4 months old) were used. The animals were kept under 
controlled lighting (14 h light and 10 h darkness) and temperature (19-:21°C) con-
ditions. Laboratory chow and tap water were provided ad libitum. One group of ani-
mals (body weight ranging from 210 to 265 g) was gonadectomized under light ether 
anaesthesia, another group (body weight ranging from 290 to 330 g) was employed as 
intact animals. Daily subcutaneous injections with various doses of testosterone 
(Steraloids. Pawling, New York) in sesame oil (0.04 ml/100 g b. w.) were given for a 
period of seven days between l and 2 p.m. Steroid treatment of the gonadectomized 
animals started immediately after operation. 
Twenty hours after the last testosterone injection the rats were decapitated under 
light ether anaesthesia, blood samples were collected and allowed to clot overnight at 
4°C. Serum was stored at -20°C until assayed for testosterone and gonadotrophins. 
Radioimmunoassay methods 
Radioimmunoassay of testosterone in serum was performed as described previously 
for plasma (Verjans et al. l9i3), and serum LH and FSH were measured using double 
antibody radioimmunoassays (Welschen et al. 1975, in press). For both radioimmuno-
assays the procedures as published by Niswender et al. (1968) were followed. Iodination 
with 1:25J (Institut for Atomenergic, Kjeller. Norway) was performed according to 
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Greenwood et al. (1963). Serum LH and FSH concentrations were expressed on the 
basis of the reference preparations NIAMD rat-LH RP-1 and NIAMD rat-FSH RP-1 
respectively. Statistical significance of differences between data from the different 
animal groups was determined using Student's t-test. 
RESULTS 
Circulating testosterone was very low in castrated, adult, male rats seven days 
following castration (Table 1), and varied from zero to 0.37 ng per ml. Daily, 
subcutaneous administration of testosterone during seven days to intact and 
castrated, adult, male rats resulted in increased serum testosterone (Tables 1 
and 2). In intact animals injected with testosterone the concentration of this 
hormone in systemic blood seemed to depend on the amount of testosterone 
injected. Variation in circulating testosterone among the individual animals 
was, however, large, especially in castrates treated with large amounts of 
testosterone. 
All doses of testosterone used suppressed serum LH and FSH in intact 
animals compared with the control group receiving vehicle only (Table 2), 
Table 1. 
Mean levels ( ± standard error of the mean) of serum testosterone and serum gonado-
trophins in castrated, adult, male rats treated with various doses of 
testosterone/100 g b. w./day for seven days. 
Serum Serum LH Serum FSH 
Treatment Number of rats testosterone (ng/ml) (ng/ml) (ng/ml) 
Sesame oil 9 0.09 ± 0.03 249 ± 41 1153 ± 87 
9" 
-0 _ug 
testosterone 5 1.42 ± 0.34* 427 ± 60* 1099 ± 67 
50 ['g 
testosterone 5 3.99 ± 1.52* 360 ± 31 793 ± 91* 
100 ['g 
testosterone 5 42.24 ± 34.40 172 ± 43 776 ± 80'~ 
200 ['g 
testosterone 5 35.90 ± 21.79 137 ± 44 547 ± 80'~ 
'' P < 0.05, compared with castrated rats receiving sesame oil only. 
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Table 2. 
Mean levels ( ± standard error of the mean) of serum testosterone and serum gonado-
trophins in intact, adult, male rats treated with various doses of 
testosterone/100 g b. w./day for seven days. 
Serum Serum LH Serum FSH 
Treatment Number of rats testosterone (ng/ml) (ng/ml) (ng/ml) 
Sesame oil 9 4.14 ± 0.60 37 ± 4 317 ±31 
25 ~g 
testosterone 4 4.68 ± 0.79 < !0* 245 ± 6 
50 pg 
testosterone 4 9.59 ± 4.70 < 10''' 198 ± 14'' 
100 ,ug 
testosterone 4 20.89 ± 9.87*' < 10'' 192 ± 39'' 
* P < 0.05, compared with intact rats receiving sesame oil only. 
though the dose of 25 ltg testosterone gave no significant depression of serum 
FSH (P > 0.10). Daily treatment with 25 p.g testosterone for seven days sig-
nificantly (P < 0.01) increased serum LH in the castrates, but higher doses 
of testosterone did not significantly (P > 0.10) affect serum LH (Table 1). 
For circulating FSH levels to be significantly (P < 0.05) below those of castrate 
control, 50 p,g testosterone was sufficient in gonadectomized animals (Table 1). 
Testosterone treatment of the castrates with a daily dose of 50 f-lg for seven 
days resulted in circulating testosterone concentrations comparable with those 
encountered in intact, normal animals receiving vehicle only. Circulating 
gonadotrophins in the castrate group receiving this dose of testosterone were, 
however, still highly elevated compared with intact, control rats (Tables I 
and 2). 
DISCUSSION 
Circulating levels of testosterone in adult, male rats have been published be-
fore (Miyachi eta/. 1973; Bartke eta/. 1973; Robel et al. 1973; Kinwn & Liu 
1973) and after gonadectomy (Coyotupa et a/. 1973) and our data are in 
adequate agreement with those of other investigators. Daily subcutaneous ad-
ministration of testosterone for seven days resulted in elevation of serum 
levels of this testicular androgen in intact and castrated, adult, male rats 
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(Tables I and 2), but only the dose of 25 l'g testosterone produced significantly 
different (P < 0.01) serum testosterone levels between intact and castrated 
animals (Tables I and 2). The effects of testosterone administration on cir-
culating gonadotrophins depended on the type of animal used (Tables 1 and 2). 
In intact rats all the doses of testosterone employed suppressed circulating LH 
and FSH (Table 2). It has been shown that treatment of normal men with 
testosterone propionate decreased testicular testosterone concentrations while 
plasma levels of this hormone were elevated and plasma LH levels were re-
duced (Morse et al. 1973). Continuous intravenous infusion of testosterone for 
four days in men resulted in increased plasma testosterone and oestradiol-17 /3 
and decreased plasma LH and FSH (Sherins & Loriaux 1973). Thus, it is pos-
sible that depression of serum gonadotrophins in normal, adult, males fol-
lowing treatment with testosterone might be due both to an elevation of cir-
culating testosterone, and of oestradiol-17,{3. Since administration of oestradiol-
17 j3 or oestradiol benzoate will suppress both serum gonadotrophins and 
testosterone in men (Sherins & Loriaux 1973) and in intact, adult, male rats 
(Verjans et al. 1974a), circulating oestrogens are probably of significance for 
the regulation of circulating gonadotrophins in male animals. 
Gonadectomy of adult, male rats gave marked reduction of serum testoste-
rone levels seven days following operation (Table 1). Coyotupa et al. (1973) 
observed a decrease of circulating testosterone and a decline of circulating 5a-
dihydrotestosterone to undetectable values within 24 hours after removal of 
the testes in rats. In the presence of decreased circulating testosterone, and 
probably also of 5a-dihydrotestosterone, serum LH and FSH in the castrates 
were increased (Table 1). Both testosterone and 5a-dihydrotestosterone or their 
respective propionate esters are suppressors of circulating LH and FSH in in-
tact and castrated adult, male rats (Swerdloff et al. 1972; Naftolin & Feder 
1973; Zanisi et al. 1973; Verjans et al. 1974b), but oestradiol-17{3 or oestradiol 
benzoate, however, appear to be even more potent suppressors (Dufy-Barbe & 
Franchimont 1972; Swerdloff et al. 1972; Swerdloff & Walsh 1973; Kalra et al. 
197 3; V erjans et al. 197 4b ). A possible lack of circulating oestradiol-! 7 fl in 
castrated rats may contribute to the rise of serum gonadotrophins following 
gonadectomy, since the rat testis secretes both oestradiol-17 j3 (de ]ong et al. 
1973) and the precursors for this hormone. Circulating oestradiol-17 j3 is, how-
ever, in the low picogram range in normal, male rats and only 20 O/o of cir-
culating oestradiol-17 f3 stems from testicular secretion (de ]ong et al. 1973). 
Daily, subcutaneous administration of 25 f.lg testosterone to the castrates 
during seven days gave a significant increase in serum LH levels over castrate 
control levels (Table 1). Swerdloff & Walsh (1973) observed similar effects 
administering low doses of androgens or oestrogens to castrated, adult, male 
rats. In a previous publication (Verjans et a!. 1974b) we demonstrated that 
testosterone propionate in a daily dose of 20 pg per 100 g body weight for 
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seven days could prevent the nse of serum LH levels following castration. 
Using the subcutaneous route of administration the clearance rate of the ester 
compounds compared to that of the free compounds may differ, moreover, 
different strains of animals were utilized in these studies. The apparent dis-
crepancy in these data and the fact that low doses of testosterone can aug-
ment serum LH in castrated, adult rats warrant, however, further investiga-
tions. 
In castrated rats 50 flg testosterone per day during seven days produced 
circulating levels of testosterone comparable with those of intact, adult, male 
rats (Tables 1 and 2), although circulating gonadotrophin concentrations were 
still markedly elevated compared with intact control values (Tables 1 and 2). 
Circulating testosterone levels in castrated, adult, male, rats which were main-
tained by daily administration of testosterone during seven days (starting 
steroid treatment immediately after removal of the testes), apparently failed 
to affect serum gonadotrophin levels in the same way as comparable steroid 
levels after such steroid treatment in intact rats. It is therefore suggested 
that the sensitivity of the hypothalamic-pituitary system producing LH and 
FSH differs for daily, subcutaneous testosterone administration during seven 
days between intact and castrated, adult, male rats. Thus, in addition to 
testosterone other testicular factors can be involved in regulation of production 
and secretion of LH and FSH by the pituitary gland in male rats. 
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ABSTRACT 
Effect of intramuscular administration of ACTH or dexamethasone on 
blood serum levels of testosterone, LH and FSH was examined in intar.:t 
and castrated, adult. male rats. Six IU ACTH or l mg dexametha3one were 
given daily for 7 days. Corticotrophin treatment had no influence on cir-
culating testosterone, LH and FSH in intact or castrated male rats. 
Dexamethasone administration resulted in a slight elevation of serum fSH 
in intact animals but not in castrates. LH and testosterone remained 
normal in boi.h intact and castrated animals injected with dexamethasone. 
Under our wnditions of study the secretions from the adrenal gland 
appear to be insignificant for the regulation of pituitary secretion of 
gonadotrophins in the male rat. 
Testosterone, 5a-dihydrotestosterone and oestradiol-17 fJ are known secretory 
products of the testis having regulatory effects on the hypothalamic-pituitary 
axis in aduJt male rats. Gonadectomy in such animals results in very low 
circulating levels of testosterone and 5a-dihydrotestosterone (Coyotupa et al. 
197 3), while circulating LH and FSH will increase markedly (Gay & Bogdanove 
1969; Gay & Dever 1971; Swerdloff eta/. 1972, 1973; Dufy-Barbe & Franchi-
mont 1972: K alra et al. 197 3). Administration of these testicular steroids (or their 
propionate and benzoate ester derivatives) can prevent the rise of serum gonado-
trophins following castration. In this respect, oestradiol-17 fJ and 5u-dihydro-
testosterone are very potent (Swerdloff et al. 1973; Verjans et al. 1974). In 
addition to the testis, the adrenal cortex is a source of androgenic and oestrogenic 
steroids in various animal species (Dorfman & Ungar 1965). The contribution 
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of androgenic and oestrogenic steroids from the adrenal gland as potential 
regulators of circulating gonadotrophins has scarcely been investigated. Fur-
thermore, the possible effect of 11-oxygenated and 11-deoxygenated cortico-
steroids is unknown in this respect. \Ve have, therefore, studied effects of 
adrenal suppression and adrenal stimulation on the hypothalamic-pituitary-
testicular system in intact and castrated, adult, male rats by determining cir-
culating testosterone. LH and FSH levels in such animals by appropriate radio-
immunoassay techniques. 
MATERIAL AND METHODS 
Animals 
Adult, male, Wistar rats (3~4 months old) were used in the experiments. The animals 
were kept under controlled light (14 hours light and 10 hours darkness) and temperature 
{19~21 °C) conditions. Rat chow and tap water were provided ad libitum. 
Ex[Jerimcnt I.~ From a group of 18 animals with body weights varying from 225-250 g, 
9 animals were gonadectomized under light ether anaesthesia and the rest was used as 
intact animals. Five gonadectomized and S intact animals were injected with 1 mg 
dexamethasone sodium phosphate (Decadron@ phosphate, Merck Sharp & Dohme B. V., 
Haarlem, The Netherlands) in 0.25 ml buffer while 4 animals of each group were in-
jected with 0.25 ml 0.9 Ofo sodium chloride solution only. Daily. intramuscular injections 
were given for a period of 7 days. Treatment of the gonadectomized animals started 
immediately following surgery. 
Experiment 11.- From a group of 16 animals with body weights ranging from 380-
400 g, R animals were gonadectomized under light ether anaesthesia and the rest was 
employed as intact animals. Four gonadectomized and 4 intact animals were injected 
with 6 IU corticotrophin (Frederiksberg Chemiske Fabriker A!S, K0benhavn, Denmark) 
in 0.1 ml aqua dest. while 4 animals of each group were injected with 0.1 ml water only. 
Daily, intramuscular injections were given for a period of 7 days. Treatment of the 
gonadectomized animals started immediately following operation. Twenty hours after 
the last injection blood samples from experiment I and II were col!ected following 
decapitation of the animals under light ether anaesthesia. The blood was allowed to 
clot overnight at 4°C. Resulting blood serum was then stored at -2ncc until analysed 
for gonadotrophins and testosterone. Adrenal glands. testes, ventral prostate and 
seminal vesicles were dissected and weighed shortly after the animals were sacrificed. 
Radioimmunoassays 
Serum LH and FSH levels were measured using double antibody radioimmunoassays 
(VVdschen et al. 1975). For both radioimmunoassays the procedures as described by 
Niswender ct a!. (1968) were followed. Iodination with 125J {Institut for Atomenergi, 
Kjeller, Norway) was performed according to the method of Greenwood et a!. (1963). 
Serum samples from all experiments were assayed as duplicates in one assay and serum 
LH and FSH concentrations were expressed on the basis of reference preparations 
NIAMD RAT LH RP-1 and NIAMD RAT FSH RP-I respectively. Radioimmunoassay 
of testosterone in serum was performed as described previously for plasma (Verjans et 
al. 1973). Statistical significance of the differences between data from the different 
animal groups was determined using Student's !-test. 
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Table I. 
Mean ( ± ·so) organ weights (g) of intact and castrated, adult, male rats treated with 
1 mg Decadron® (Dex.) per day for 7 days. 
No. 
Treatment of Adrenals 
rats 
Intact, l mg Dex. 5 0.026 ± 0.003'' 
Intact, saline 4 0.059 ± 0.008 
Castrate, 1 mg Dex. 5 0.026 ± 0.004'''' 
Castrate, saline 4 0.056 ± 0.006 
* P < 0.001, compared with intact controls. 
'1-* P < 0.001, compared with castrate controls. 
Testis 
1.284 ± 0.070 
1.394 ± 0.089 
RESULTS 
Ventral Seminal 
Prostate vesicles 
0.189±0.014 0.062 ± 0.009 
0.120±0.010 0.075±0.013 
0.040 ± 0.010 0.037 ±0.004 
0.054 ± 0.008 0.035 ± 0.010 
Effects of treatment with ACTH or dexamethasone on organ weights 
The effects of daily, intramuscular administration of 1 mg dexamethasone or 
6 IU ACTH during 7 days on the weights of the adrenal glands, testis, ventral 
prostate and seminal vesicles in intact and castrated. adult, male rats have been 
summarized in Tables 1 and 2 respectively. Compared with control rats ACTH 
treatment during 7 days had no influence on body weight of either castrated 
or intact animals. Treatment with dexamethasone fo-r 7 days caused, however, 
reduction of body weight (15-25 Ofo) in both intact and castrated animals. 
We have, therefore expressed the organ weights as absolute values rather 
than relative to total body weight. Following castration the weights of the 
Table 2. 
Mean ( ± so) organ weights (g) of intact and castrated, adult, male rats treated with 
6 IU ACTH per day for 7 days. 
No. Ventral Seminal 
Treatment of Adrenals Testis Prostate Vesicles 
rats 
Intact, 6 IU ACTH 4 0.094 ± 0.010 1.640±0.221 0.257 ± 0.026 0.232 ± 0.018 
Intact, aqua dest. 4 0.069±0.016 1.591 ±0.109 0.246±0.034 0.216±0.018 
Castrate, 6 IU ACTH 4 0.091 ±0.012 0.091 ±0.023 0.111±0.014 
Castrate, aqua dest. 4 0.081 ± 0.008 0.108 ± 0.029 0.131 ± 0.022 
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accessory reproductive organs in the control animals fell, but no significant 
change was observed in the weights of the adrenal glands in these animals 
(Tables I and 2). Administration of I mg dexamethasone per day during 7 days 
resulted in a profound reduction in adrenal weight in intact (P < 0.001) and 
castrated (P < 0.001) animals (Table 1). Testicular weight, the weights of the 
ventral prostate and the seminal vesicles remained unchanged in intact animals 
following 7 days treatment with dexamethasone (Table 1). The weights of the 
latter two organs in castrated animals exhibited no change following dexa-
methasone treatment (Table 1 ). Corticotrophin treated intact and castrated, 
adult, male rats gained adrenal weight, these gains were, however, not statistic-
ally significant for intact (0.05 < P < 0.10) or castrated (0.20 < P < 0.25) 
animals compared with respective control rats (Table 2). Testicular weight and 
the weights of the accessory reproductive organs in both type of animals were 
not influenced by the treatment with ACTH (Table 2). 
Effects of treatment with ACTH or dexamethasone on serum levels 
of testosterone, LH and FSH 
The effects of daily, intramuscular administration of 6 IU ACTH or 1 mg 
dexamethasone for 7 days on serum levels of testosterone in intact and castrated, 
adult, male rats are depicted in Figs. 1 and 2 respectively. Seven days following 
castration circulating testosterone decreased to very low values, while circulat-
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Fig. 1. 
Effect of daily treatment with 6 lU ACTH for seven days on levels of serum testosterone 
in intact and castrated. adult, male rats. Mean data ± sn from four animals are shown. 
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Fig. 2. 
Effect of daily treatment with I mg Decadron® (Dex.) for seven days on levels of serum 
testosterone in intact and castrated, adult, male rats. Mean data ± so from four or more 
animals are shown. 
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Fig. 3. 
Serum levels of LH and fSH in intact and castrated, adult, male rats treated with 6 IU 
ACTH per day for seven days. Mean data ± so from four animals are shown. 
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Serum levels of LH and FSH in intact and castrated, adult, male rats treated with I mg 
Decadron® (Dex.) per day for seven days. Mean data ± SD from four 
or more animals are shown. 
ing LH and FSH (Figs. 3 and 4) showed a remarkable increment. Daily, intra-
muscular corticotrophin treatment during 7 days did not bring about changes 
in serum levels of testosterone, LH and FSH in intact or castrated, adult, male 
rats in comparison with respective control animals receiving water only (Figs. 1 
and 3). Incubation of 6 IU ACTH with diluted antiserum, however, revealed a 
slight cross-reaction of the ACTH preparation used with both the LH and the 
FSH antibodies. In experiment I serum FSH levels were somewhat higher than 
in experiment II (Figs. 3 and 4), which might be due to interassay-variations 
in the radioimmunoassay of serum FSH or to biological variation. Treatment 
with 1 mg dexamethasone per day for 7 days resulted in an increase in serum 
FSH levels in intact animals (P < 0.01) compared with the controls receiving 
saline only (Fig. 4). Such elevation was not observed in castrates following the 
same dose of dexamethasone (Fig. 4). The other serum parameters investigated 
were not influenced by dexamethasone treatment in either normal or castrated 
rats (Figs. 2 and 4). 
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DISCUSSION 
Seven days following gonadectomy low testosterone (Figs. 1 and 2) and elevated 
gonadotrophin levels (Figs. 3 and 4) were found in blood serum of adult male 
rats. These data compare well with those of others (Coyotupa et al. 1973; Gay 
& Bogdanove I969; Gay & Dever I97I; Swerdloff et al. I971) and with data 
previously reported by our laboratory (Verjans eta!. 1974, 1975). Daily, intra-
muscular administration of ACTH for 7 days was followed by adrenocortical 
hypertrophy in normal and castrated rats though this was not of significant, 
nature (Table 2). Corticotrophin treatment for 7 days did not influence the 
hypothalamic-pituitary-testicular system investigated (Figs. 1 and 3). This is 
consistent with the observation that the weights of the androgen-sensitive, male, 
accessory organs remained unchanged following ACTH treatment in both intact 
and castrated animals compared with respective controls (Table 2). It has been 
reported (Hudson et al. 1965) that the administration of ACTH to normal men 
will not change plasma testosterone levels. Beitins et al. (1973) found, however, 
significantly lower testosterone and 5a-dihydrotestosterone concentrations in 
plasma of normal young men with no change in serum LH levels after exogenous 
ACTH. Gay & Dever (I 97 I) showed that adrenalectomy in orchidectomized, 
mature, male rats produced no additional rise in serum levels of LH and FSH. 
Thus, the present data favour the suggestion that steroids of adrenocortical 
origin do not play a significant role as regulators for gonadotrophin secretion 
in male rats. Moreover, the amount of adrenocortical androgens and oestrogens 
j;ecreted in castrated male rats cannot substitute for the testicular steroids in 
their feedback action on the hypothalamic-pituitary axis. Finally, if the major 
effect of a continuous "stress" situation is via pituitary secretion of ACTH, 
the possibility is remote that such a "stress" form will influence the testicular 
system. 
Dexamethasone has a high glucocorticoid activity and will suppress ACTH 
secretion at a pituitary and/or hypothalamic level (Zimmermann & Critchlow 
1969). Suppression of adrenocortical function in our investigation was evident 
by the decreased adrenal weights of dexamethasone treated normal and castrated 
rats (Table 1). In the castrates, 1 mg dexamethasone per day for 7 days had no 
measurable effects on circulating testosterone (Fig. 2), LH or FSH (Fig. 4), nor 
did this glucocorticoid affect the falling ventral prostate and seminal vesicles 
weights (Table 1). Thus, in the present study the endocrine changes induced by 
castration were not influenced by the use of a large dose of a potent glucocorti-
coid. It has been shown that administration of a daily dose of 3 mg cortisone for 
15 days will cause a small weight decrease of the ventral prostate in castrated 
rats while a daily dose of 9 mg cortisone administered over the same period of 
time will not do so, both doses of cortisone were, however, found to induce 
growth of the seminal vesicles in such animals (TiJel! 1970). Cortisone, having 
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a weak androgenic effect when administered alone, can, however, counteract 
partially the growth of the male, accessory, reproductive organs induced by 
testosterone propionate administration in castrated, adrenalectomized rats (Tisell 
1972). Tveter & Aakvaag (1969) reported that cortico-sterone will reduce the 
uptake of [3H] testosterone by the prostatic lobes and the seminal vesicles. 
Simultaneous administration of cortisol augments the androgenic activity of 
testosterone propionate as measured by ability to increase the weights of the 
seminal vesicles and the ventral prostate in immature castrates (Klaiber et al. 
1968). These discrepancies could be due to differences in doses and duration of 
glucocorticoid treatment. 
In the normal rat, dexamethasone treatment for 7 days did not influence 
circulating testosterone and LH (Figs. 2 and 4). This was also· reflected by 
unchanged weights of the ventral prostate, seminal vesicles and testis in these 
animals (Table 1). Circulating FSH, however, exhibited a slight but significant 
elevation (Fig. 4) in the intact rat following dexamethasone treatment. It has 
been reported that cortisone exerts a deleterious effect on the germinal epi-
thelium of rats and mice (Albert 1961). Thus, in the doses given, dexamethasone 
could have a direct effect on the testicular tissue and change the production in 
this tissue of factors responsible for regulated secretion of FSH. Setchell & 
Sirinathsinghji (1972) have published on FSH depressing activity in rete testis 
fluid and Van Thiel et al. (1972) have suggested that factors produced in tbe 
germinal epithelium are involved in FSH feedback control in men. Our data 
could indicate that dexamethasone will lower testicular production of an un-
known factor controlling specifically FSH secretion in the male rat. Thus, a 
direct effect o.f large doses of dexamethasone on possible testicular factors, 
regulating serum FSH concentrations in normal rats, is possible. No data are, 
however, available on the effects of long-term treatment with dexamethasone on 
the pituitary-testicular system. Faiman & Winter (1971) have shown that admi-
nistration of a total dose of 3 mg dexamethasone to normal men will elevate 
plasma LH levels but not those of plasma FSH and testosterone. judd et al. 
(1973) reported, however, that a single dose of 2 mg dexamethasone did not 
block nocturnal rise of plasma testosterone in normal male subjects, a probable 
LH function. A total dose of 0.6 mg dexamethasone given on late dioestrus and 
early pro-oestrus will block ovulation in female rats, probably by inhibiting 
pituitary release of LH (Baldwin & Sawyer 1974). 
The present work using stimulation or suppression of adrenocortical function 
in gonadectomized, adult, male rats with long-term administration of supra-
pharmacological doses of ACTH or dexamethasone and the work of Gay & 
Dever (1971) using adrenalectomized, orchidectomized, mature, male rats reveal 
that the steroids of the adrenal cortex do not significantly affect circulating 
gonadotrophin concentrations in such animals. The contribution of adrenal 
corticosteroids, androgens and oestrogens to the testicular steroids in regulating 
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circulating gonadotrophin concentrations is likely to be of minor importance. 
Thus, only secretory products of the testes reaching target organs in the brain 
via the general circulation seem to be responsible for control of the gonado-
trophic function of the hypophyseal-hypothalamic system in adult male rats. 
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HYPOTHALAMIC - PITUITARY - TESTICULAR 
SYSTEM FOLLOWING TESTICULAR X-IRRADIATION~ 
By 
H.L. Verjans and K.B. Eik-Nes 
A short summary of some of the data in this paper will 
be published elsewhere (Verjans and Eik-Nes, 1975). 
1 
A B S T R A C T 
Testes of adult, male rats were exposed to a total dose of 
1,500 R of X-irradiation. Testicular weight decreased from 
day 8 after X-ray treatment. This decrease was, however, 
preceded by an increment of the testis weight on day 4 
following treatment. X-ray treatment of testes was associa-
ted with significant increases in serum FSH. Testicular 
irradiation had, however, no effect on ventral prostate and 
seminal vesicles weights. Serum testosterone increased only 
on day 1, 2 and 4 after irradiation, while serum LH levels 
tended to increase from day 8 postirradiation. These 
changes were not significant, however, when compared with 
non-irradiated controls. At 7,13 and 20 days following 
1,500 R of bilateral, testicular X-irradiation, the hypo-
thalamic-pituitary unit was still capable of responding to 
exogenous gonadotrophin releasing factor. Serum FSH may in 
male rats be regulated at least partly by circulating 
steroids of testicular origin and partly by an unknown fac-
tor of non-interstitial cell nature. 
I N T R 0 D U C T I 0 N 
Following gonadectomy circulating testosterone concen-
trations will decrease in adult, male rats (Coyotupa et al. 
1973; Verjans et al. 1975} while circulating LH and FSH 
concentrations will increase (Gay and Bogdanove 1969; 
Gay and Dever 1971; Swerdloff et al. 1972; Verjans et al. 
1974). Testosterone is considered being the hormone direc-
ting a feedback system between the hypothalamic-pituitary 
unit and the male gonad. Recent work, however, points out 
that metabolites of testosterone like Sa-dihydrotestoste-
2 
rone and Sa-androstane-3a,17S-diol are more potent than 
testosterone in curbing circulating LH and FSH concentra-
tions in gonadectomized, adult, male rats (Swerdloff et al. 
1972; Verjans et al. 1974; Eik-Nes 1974). Moreover, higher 
doses of Sa-reduced metabolites of testosterone are 
required for suppression of circulating FSH than for sup-
pressing circulating LH in such rats (Verjans et al. 1974; 
Eik-Nes 1974). The specific role and contribution of the 
different testis cell compartments in regulating production 
and/or secretion of gonadotrophins by the pituitary gland 
remain to be clarified. Local, testicular X-irradiation 
will destroy the germinal cells of the seminiferous tubules, 
leaving Sertoli and interstitial cells relatively unaffec-
ted (Fogg and Cowing, 1951; Shaver 1953; Schoen 1964). In 
order to study effect of the absence of proliferative ger-
minal epithelium on the hypothalamic-pituitary-testicular 
system, we have measured serum testosterone, LH and FSH 
levels in adult, male rats at different time intervals 
following local testicular X-irradiation with a dose of 
1,500 R. Furthermore, we have investigated effect of admi-
nistering a gonadotrophin releasing factor on circulating 
LH and FSH in rats exposed to testicular irradiation. 
M A T E R I A L S A N D M E T H 0 D S 
Animals 
Adult, male Wistar rats (3-4 months old) with body 
weights ranging from 300 to 350 g were used. The animals 
were kept under controlled light (14 hrs light, 10 hrs 
darkness) and temperature (19-21° C) conditions. Laboratory 
chow and tap water were provided ad libitum. 
3 
Experiment r. - Rats were anaesthesized with ether and 
without shielding the rest of the body, the scrotal area 
was exposed to irradiation by means of a medical X-ray 
machine operating at 200 kV with a setting of 20 rnA and a 
filter of 0.5 mrn Cu. The animals were subjected to a total 
dose of 1,500 R directed over a period of 10 min. At 1,2,4, 
8,13,20,26 and 52 days following irradiation, three or more 
animals were decapitated under light ether anaesthesia at 
9 a.m. Control animals of the same age were anaesthesized 
with ether for a period of 10 min and 4,8,13,20,26 and 
52 days following this treatment, three or more animals 
were also decapitated at 9 a.m. Blood samples of irradiated 
and control animals were collected and allowed to clot 
overnight at 4° c. Serum was stored at -20° C until ana-
lysed for testosterone and gonadotrophins. Testes, ventral 
prostate and seminal vesicles were dissected and weighed. 
Experiment II. - Twelve animals were irradiated as sta-
ted under experiment I. At 7, 13 and 20 days following 
irradiation, blood samples were drawn under light ether 
anaesthesia by puncturing the ophthalmic venous plexus. 
500 ng synthetic gonadotrophin releasing factor (GnRF, 
Abbott Laboratories, North Chicago, Illinois, U.S.A.) dis-
solved in 0.1 ml 0.9% sodium chloride solution were then 
administered via the jugular vein. Blood was obtained 15 
and 60 min after this injection from the ophthalmic venous 
plexus. Control, non-irradiated animals were treated in 
the same fashion but received 0.1 ml saline or 0.1 ml 
saline containing 500 ng GnRF via the jugular vein. Blood 
samples were withdrawn 15 and 60 min afterwards, and all 
blood specimens were handled as dicussed in experiment I. 
Radioimmunoassay methods 
Serum gonadotrophins were measured by double antibody 
radioimrnunoassays employing antisera raised against ovine 
4 
LH and ovine FSH by immunizing rabbits with NIH-LH-S17 and 
NIH-FSH-S9 respectively. NIAMD rat LH I-1 and NIAMD rat 
FSH I-1 were used for preparation of iodinated derivatives. 
Iodination was performed with 125 r (Institutt for Atom-
energi, Kjeller, Norway) according to Greenwood et al. 
(1963). For both radioimmunoassays the procedures described 
by Niswender et al. (1968) were followed. Sensitivity, 
accuracy and specificity of both radioimrnunoassays have 
been published (Welschen et al. 1975). Serum samples from 
individual rats were assayed in duplicate in one assay and 
serum LH and FSH levels expressed on the basis of standard 
reference preparations NIAMD rat LH RP-1 and NIAMD rat FSH 
RP-1 respectively. Serum testosterone levels were measured 
using a radioimmunoassay technique described previously 
(Verjans et al. 1973). Statistical significance of the dif-
ferences between data from the different animal groups was 
determined by Student's t-test. 
R E S U L T S 
Relative weights of testes and accessory, reproductive 
organs 
Relative weight (weight of organ/100 g of total body 
weight) of testes and accessory, reproductive organs at 
different days following exposure of testes to X-ray is 
depicted in Figs. 1 and 2 respectively. At 4 days after 
irradiation the relative testicular weight of irradiated 
animals was significantly higher (P<O.Ol) than testis 
weight of controls. A progressive decrease (P<O.Ol) of tes-
ticular weight and size was observed from 8 to 52 days 
postirradiation when relative testis weight was only 32% of 
that of control rats. From 4 to 52 days after testicular 
X-irradiation we observed some changes in the relative 
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Fig. 1. 
Relative testis weight (rng/100 g b.w.) in adult, male rats 
at different time intervals following testicular X-irradia-
tion with 1,500 R. Mean data+ S.E.M. (n ~ 6) are presented. 
weights of the male, accessory, reproductive organs 
(Fig. 2). These changes, however, were not of statistically 
significant nature {data not shown). 
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Serum levels of testosterone, LH and FSH 
Fig. 3 shows serum testosterone levels on various days 
after X-irradiation of testes. The first days after treat-
ment serum testosterone appeared slightly elevated compared 
to the other days. This elevation and the differences in 
serum testosterone between irradiated and non-irradiated 
animals from day 4 onwards were, however, not statistically 
significant. Circulating LH in irradiated and control ani-
mals did not change significantly throughout the period of 
study (Fig. 4), but serum FSH (Fig. 5) started to increase 
as early as 4 days postirradiation. Serum FSH levels in 
X-ray treated animals were significantly higher (P<O.OS) 
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52 
Serum levels of testosterone in adult, male rats at diffe-
rent time intervals following testicular X-irradiation 
with 1,500 R. Mean data+ S.D. from three or more animals 
are shown. 
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than in non-irradiated animals on day 8,13,20 and 26 after 
X-ray exposure. Circulating FSH levels on day 52 post-
irradiation were not significantly different from the 
levels in control animals. 
Effect of GnRF in X-ray treated adult, male rats 
Effects of intravenous administration of 500 ng synthe-
tic GnRF on circulating LH and FSH in control rats and rats 
at different intervals following testicular X-irradiation 
are summarized in Figs. 6 and 7. 15 min after injection of 
GnRF serum LH and FSH levels in non-irradiated control ani-
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Effect of intravenous injection of 500 ng GnRF on serum LH 
levels in adult, male rats at different days after testi-
cular X-irradiation with 1,500 R. Mean data+ S.E.M. (n;3) 
15 and 60 min following administration of GnRF (dissolved 
in saline) are expressed as % change from the basal level 
measured just before injection of GnRF. LH response in 
normal rats of the same age injected with 500 ng GnRF in 
saline or with saline only is also shown. 
mals were higher than the basal levels before administration 
of GnRF, and 60 min after GnRF, mean serum LH and FSH 
levels had returned to the preinjection range in these rats. 
15 min following administration of the standard dose of 
500 ng GnRF to rats exposed to testicular irradiation 7,13 
or 20 _days before, serum LH levels were increased (Fig. 6) 
but 60 min subsequent to GnRF injection these levels were 
those of normal animals. In these rats the elevated serum 
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Effect of intravenous injection of 500 ng GnRF on serum 
FSH levels in adult, male rats at different days after tes-
ticular X-irradiation with 1,500 R. Mean data~ S.E.M. 
(n~3) 15 and 60 min following administration of GnRF (dis-
solved in saline) are expressed as % change from the basal 
level measured just before injection of GnRF. FSH response 
in normal rats of the same age injected with 500 ng GnRF in 
saline or with saline only is also shown. 
FSH concentrations (Fig. 5) underwent further elevation 
15 min following 500 ng GnRF (Fig. 7). Compared to normal 
rats given the same dose of GnRF (Fig. 7), the FSH response 
to GnRF injection in rats 13 and 20 days after irradiation 
of the testes, showed either no decline or a slow decline 
between 15 and 60 min after GnRF (Fig. 7). 
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D I S C U S S I 0 N 
Damage of testicular tissue following total body or 
local, testicular exposure to ionizing X-irradiation has 
been described by many workers (Fogg and Cowing 1951; 
Shaver 1953; Oakberg 1955; Schoen 1964; Ellis and 
Van Kampen 1971). Interstitial cells and Sertoli cells are 
known to remain intact by histologic criteria following 
bilateral, testicular X-irradiation. Moreover, by such cri-
teria the germinal epithelium of the seminiferous tubules 
is not radioresistant and will be destroyed. The most 
radiosensitive cells in the tubular elements are thought to 
be type A1-A 4 spermatogonia, while type A0 spermatogonia 
will survive following 300 R of X-irradiation (Dym and 
Clermont 1970). When the supply of germinal cells is ex-
hausted following X-irradiation, mature sperm cells will 
disappear. The cycle of sperm maturation will thus be 
interrupted until regeneration occurs via type A spermato-
gonia which are resistant to X-ray destruction. This will 
lead to repopulation of the germinal epithelium in the 
seminiferous tubules. Schoen (1964) reported that bilateral, 
testicular X-irradiation decreased the tubule diameter and 
resulted in increased number of interstitial cells per 
tubule when evaluated 14 days post x-ray treatment. Our 
histologic findings (not shown) were in adequate agreement 
with the above observations. Moreover, decrease of size 
and weight of the male gonad (Fig. 1) was recorded from 
day 8 postirradiation. The first days after bilateral, 
testicular X-irradiation, circulating testosterone concen-
trations (Fig. 3) were slightly elevated compared to those 
measured later on. This was also reflected by an augmented 
testicular weight on day 4 preceding the decrease in tes-
ticular weight seen from day 8 postirradiation (Fig. 1). 
The changes in the relative weights of the accessory, re-
productive organs of X-ray treated rats {Fig. 2) appeared 
largely to follow the pattern observed for circulating 
13 
testosterone postirradiation {Fig. 3). Concomitantly with 
the decrease of circulating testosterone, circulating LH 
concentrations tended to increase (Fig. 4). None of the 
changes observed in the weights of the accessory, repro-
ductive organs, circulating testosterone or circulating LH 
concentrations, however, were statistically significant 
when compared with non-irradiated, control animals. Our 
data (Fig. 3) are compatible with the observation that 
X-irradiation of mice will initially increase testicular 
androgen production from radioactive precursors in vitro, 
but is followed later by diminished ability to synthesize 
such androgens (Ellis and Berliner 1963). Circulating 
levels of Sa-dihydrotestosterone and 5a-androstane-3a,l7s-
diol after irradiation were not measured in our work. Sa-
Steroid reductase activity is present in seminiferous 
tubules of adult rats (Rivarola and Podesta 1972; Folman 
et al. 1973). X-ray induced changes in these cells may have 
altered circulating concentrations of the Sa-reduced meta-
bolites of testosterone exerting potent activity on andro-
gen target tissues. The slight elevation of circulating LH 
concentrations post X-ray (Fig. 4) may result from testes 
failing to produce required amounts of androgens to keep 
circulating LH within normal range. The data presented 
(Figs. 2, 3 and 4), however, are indicative of that a 
functional, interstitial cell compartment exists following 
testicular X-irradiation. 
X-ray treatment of rat testes resulted in elevation of 
circulating FSH in these animals (Fig. 5). Swerdloff et al. 
(1971) showed that the relatively high levels of circula-
ting FSH in immature, male rats will fall with appearance 
of mature sperm in seminiferous tubules and that circula-
ting FSH will further decrease in sexually mature animals 
with normal spermatogenesis. In Klinefelter's syndrome, 
azoospermia and hypogonadism (Franchimont 1973), cryptor-
chidism (Swerdloff et al. 1971) and following treatment 
with antispermatogenic chemical agents (Gomes et al. 1973) 
graded degree of germinal epithelium damage is associated 
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with elevated circulating concentrations of FSH. Paulsen 
(1968) found that urinary FSH levels will increase follo-
wing X-irradiation of the testis prior to decrement in 
sperm count, and urinary FSH will decrease again to normal 
levels before the germinal epithelium is fully recovered. 
Recent reports demonstrate FSH depressing activity present 
in rete testis fluid (Setchell and Sirinathsinghji 1972) 
or associated with germinal epithelium of seminiferous 
tubules (Van Thiel et al. 1972). In the present study 
serum FSH levels were not as high as observed in castrated, 
adult, male rats (Verjans et al. 1974). Daily administra-
tion of testosterone for 7 days to castrated, adult, male 
rats, resulting in circulating testosterone concentrations 
found in normal, adult, male rats, will prevent serum FSH 
levels to rise to those of untreated castrates (Verjans 
et al. 1975). Also Sa-dihydrotestosterone and 5a-androstane-
3a,178-diol injections will suppress serum FSH levels in 
castrated rats (Verjans et al. 1974, Eik-Nes 1974). 
Therefore circulating FSH concentrations in the adult, 
male rat might be regulated at least partly by circulating 
androgen concentrations and partly by an unknown factor, 
probably produced by spermatogonial cells and/or Sertoli 
cells supporting such spermatogonia. From our data it is 
difficult to conclude whether increased circulating FSH 
following testicular X-irradiation has affected testicular 
function in the animals. Intravenous administration of FSH 
will not change testosterone concentrations in testicular, 
venous plasma of normal rats (de Jong et al. 1973). Fur-
thermore, Sertoli cell production of an androgen binding 
protein (Hagenas et al. 1974 ; Vernon et al. 1974) appears 
to depend on FSH {Hansson et al. 1973). The high serum FSH 
concentrations in our animals (Fig. 5) might have main-
tained proper levels of testosterone and/or Sa-reduced 
testosterone metabolite concentrations in the depleted tu-
bules _by augmenting androgen binding protein concentrations 
in these cells. 
Circulating LH and FSH following injection of a standard 
15 
dose of GnRF should evaluate the reserve capacity of the 
pituitary gland to secrete these trophins. Administration 
of GnRF {Figs. 6 and 7) causes a larger increase in circu-
lating LH than in circulating FSH both in normal and X-
irradiated rats. Moreover, in spite of the high control 
levels of both trophins before GnRF injection in the X-ray 
treated rats (Figs. 4 and 5), pituitary secretion of 
either trophin was not maximal since additional secretion 
of these trophins was promoted by exogenous hypothalamic 
releasing factor. The increment in circulating FSH and LH 
is smaller in male rats following X-ray treatment of the 
testes than following removal of these organs {Verjans 
et al. 1974). Thus, the effects of gonadectomy and of X-ray 
treatment of the testes on the feedback control at the hy-
pothalamic-pituitary level are different. The LH response 
measured 15 and 60 min after GnRF injection appears normal 
in the X-ray treated rats (Fig. 6). The response of FSH to 
GnRF in rats 13 and 20 days after irradiation of the tes-
tis shows a slower decline than in normal rats over a 
45 min observation period (Fig. 7}. The slower decrease of 
circulating FSH levels following injection of GnRF in rats 
13 and 20 days posttesticular irradiation, could be caused 
by pituitary tissue producing increased amounts of FSH in 
the absence of a physiological regulator for the secretion 
of this hormone. 
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EFFECTS OF ANDROSTENES, 5a-ANDROSTANES, 5S-
ANDROSTANES, OESTRENES AND OESTRATRIENES ON SERUM 
GONADOTROPHIN LEVELS AND VENTRAL PROSTATE WEIGHTS 
IN GONADECTOMIZED, ADULT MALE RATS 
By 
H.L. Verjans and K.B. Eik-Nes 
l 
A B S T R A C T 
The effects of subcutaneous administration of steroids from 
the androstene, Sa-androstane, 58-androstane, oestrene and 
oestratriene series on serum levels of LH and FSH and on 
ventral prostate weights were investigated in gonadecto-
mized, adult male rats. Each steroid was administered for 
seven days in a standard dose of 100 ~g per 100 g body 
weight per day. 3 Or 3a (but not 36) and 17 or 176 disub-
stituted Sa-androstanes were effective in suppressing 
either one or both serum gonadotrophins. SB-Androstanes and 
androstenes exhibited very little inhibitory effect in this 
respect. Potent suppression of serum gonadotrophins was 
observed following treatment with oestratrienes, the pre-
sence of only a phenolic A-ring in these oestrogens appea-
red sufficient for such suppression. 3 Or 36 and 17 or 176 
disubstituted androstenes could entirely or partly prevent 
ventral prostate weight decrease postgonadectomy 5a-
Androstane-3a,176-diol, 5a-androstane-3a,116,176-triol and 
Sa-androstan-178-ol-3-one were most potent, while 58-
androstanes and oestratrienes had no effect on this decre-
ment. Regulatory processes by steroids at the hypothalamic-
pituitary and at the ventral prostate level were not pa-
rallel. 
The results indicate, however, that 3 or 3a and 17 
disubstituted (keto or hydroxyl) sa-reduced testosterone 
metabolites, of which Sa-androstan-176-ol-3-one might be 
the principal one, are the main steroids directing andro-
genic regulation at both organ systems tested in the 
mature male rat. 
2 
I N T R 0 D U C T I 0 N 
Gonadectomy in mature male rats results in very low circu-
lating concentrations of 4-androsten-l?S-ol-3-one (testos-
terone) (Coyotupa et al. 1973; Verjans et al. 1975a) and 
Sa-androstan-178-ol-3-one (Sa-dihydrotestosterone) 
(Coyotupa et al. 1973) and elevated circulating concentra-
tions of the gonadotrophins LH and FSH (Gay and Bogdanove 
1969; Swerdloff et al. 1972; Dufy-Barbe and Franchimont 
1972; Verjans et al. 1974a). The accessory reproductive 
organs are known to undergo atrophy following castration. 
Secretory products of the testis are therefore believed to 
regulate circulating gonadotrophins and to maintain func-
tion of accessory reproductive organs. Administration of 
known testicular secretion products like testosterone or 
Sa-dihydrotestosterone to gonadectomized mature, male rats 
most effectively prevents the rise of serum gonadotrophins 
and the weight decrement of the accessory reproductive or-
gans (Swerdloff et al. 1973; Verjans et al. 1974a). Oestro-
gen treatment of castrated rats inhibits circulating gona-
dotrophin concentrations (Kalra et al. 1973; Swerdloff 
et al. 1973; Verjans e·t al. 1974a), and promotes growth of 
the seminal vesicles but not of the ventral prostate 
(Verjans et al. 1974a). It has moreover been demonstrated 
that Sa-dihydrotestosterone is more potent than testoste-
rone in curbing serum gonadotrophins in adult male rats 
(Swerdloff et al. 1972; Verjans et al. 1974a) and in pre-
venting weight decrement of the accessory reproductive or-
gans following gonadectomy (Verjans et al. 1974a). Testos-
terone the prevailing androgen in systemic blood is meta-
bolized extensively and Sa-reduction of this hormone might 
be necessary for androgen regulation of the hypothalamic-
pituitary system and for maintaining weight of accessory 
reproductive organs. These tissues contain Sa-steroid re-
ductase activity (Bruchovsky and Wilson 1968; Rommerts and 
3 
van der Molen 1971; Massa et al. 1972). Metabolism of sa-
reduced testosterone may, however, occur in these organs. 
Furthermore, Sa-reduction of testosterone is not the only 
metabolic route for this steroid. In light of these possi-
bilities and in order to assess steroid structure needed 
for "androgenic activity" in the hypothalamic-pituitary 
and the ventral prostate systems, we have studied the 
effect of administering a standard dose of various com-
pounds from the androstene, Sa-androstane, sa-androstane, 
oestrene and oestratriene series on serum levels of gona-
dotrophins and on weights of the ventral prostate in gona-
dectomized, mature male rats. 
M A T E R I A L S A N D M E T H 0 D S 
Adult male Wistar rats (3-4 months old) with body weights 
ranging from 2SO to 320 g were used. The animals were kept 
under controlled light (14 hrs light, 10 hrs darkness) and 
temperature (19-21°C) conditions. Rat chow and tap water 
were provided ad libitum. 
The animals were gonadectomized under light ether 
anaesthesia. Daily subcutaneous injections of the different 
compounds in sesame oil (0.04 ml/100 g b.w.) in a standard 
dose of 100 ~g/100 g b.w. were started immediately follo-
wing operation and continued for the next six days. Con-
trol intact and castrated animals received sesame oil only. 
Intact control animals were exposed to 10 min of light 
ether anaesthesia prior to the first injection with sesame 
oil. Injections were given between 11 a.m. and 1 p.m. 4-
Androstene-7a,178-diol-3-one and 4-androstene-178,19-diol-
3-one were a gift from Merck, Sharp & Dohme. 
The other steroids used were purchased from Steraloids. 
(=)1,4-Diphenyl-butane-2,3-diol was a gift of Dr. R. Neher. 
All compounds were used without purification. Twenty hours 
4 
after the last injection the rats were weighed and then de-
capitated under ether anaesthesia. Blood samples were col-
lected and allowed to clot overnight at 4°C. Resulting 
blood serum was stored at -20°C until analysed for serum 
LH and FSH levels by double antibody radioimmunoassay tech-
niques as previously described (Verjans et al. 1974a; 
Welschen et al. 1975). Serum LH and FSH concentrations were 
expressed on the basis of the reference preparations NIAMD 
rat LH RP-1 and NIAMD rat FSH RP-1 respectively. Only 
sample values from a single assay have been compared. Ven-
tral prostates were dissected and weighed shortly after the 
animals were sacrificed. 
RESULTS 
Effects of steroid treatments on serum gonadotrophin levels 
Gonadectomy results in a substantial rise of serum LH 
and FSH levels seven days post surgery (Tables 1-4). 
Table 1 shows effects of steroids from the androstene 
series on serum gonadotrophin levels. In the tested dose of 
100 ~g/100 g b.w./day for seven days only 4-androsten-176-
ol-3-one (testosterone) suppressed serum FSH below castrate 
control levels, while serum LH also tended to drop follo-
wing this treatment. Neither of the trophins reached intact 
control levels employing this dose of testosterone 
(Table l). 
Treatment with 4-androstene-3S,17S-diol or 4-androsten-
17a-ol-3-one augmented serum LH levels over castrate con-
trols given vehicle only, but did not affect circulating 
FSH. In Table 2 effects of different sa-androstanes on 
serum_ gonadotrophin levels in gonadectomized male rats are 
summarized. Serum LH levels in castrates were depressed by 
5a-androstan-3a-ol-17-one, Sa-androstane-3a,l7S-diol and 
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Table 1 
Effect of various androstenes (100 ~g/100 g b.w./day for seven days s.c.) on ventral pros-
tate weight (rng/100 g b.w.) and serum gonadotrophin levels (ng/ml) in gonadectomized, ma-
ture male rats. Mean data + S.D. (n?3) are expressed as % of castrate control values (=100%) 
Compound Ventral prostate 
4-androstene-3S,l7a-diol 97 ~ 27 
4-androstene-38,178-diol 363 ± 35 
4-androstene-3S,6B,l7B-triol 100 ± 10 
4-androstene-38,68-diol-17-one 75 ± 30 
4-androstene-68,178-diol-3-one 117 ± 22 
4-androstene-?a,l?S-diol-3-one 121 ± 17 
4-androstene-118,178-diol-3-one 194 ± 70 
4-androsten-l?a-ol-3-one 149 + 24 
4-androsten-178-ol-3-one 375 ± 30 
4-androstene-178,19-diol-3-one 78 ± 32 
4-androstene-3,17-dione 272 ~SO 
5-androstene-36,178-diol 230 ~ 10 
5-androsten-38-ol-17-one 172 + 13 
intact, sesame oil 
castrate, sesame oil 
350 + 12 
100 + 26 
serum LH 
114 + 31 
165 + 35 
104 + 31 
121 + 21 
95 + 39 
99 + 7 
86 + 40 
138 + 9 
60 + 33 
130 + 22 
134 + 19 
120 + 47 
133 + 82 
20 + 5 
100 + 18 
Serum FSH 
128 + 13 
9 6 + 12 
104 + 24 
122 + 10 
93 + ll 
107 + 15 
98 + 12 
109 + 42 
58 :!: 13 
90 :!: 10 
105 :!: 9 
114 + 15 
112 + 32 
27 + 6 
100 + 17 
Table 2 
Effect of various Sa-androstanes (100 ~g/100 g b.w.jday for seven days s.c.) on ventral 
prostate weight (mg/100 g b.w.) and serum gonadotrophin levels (ng/ml) in gonadectomized, 
mature male rats. Mean data + S.D. (n~3) are expressed as % of castrate control values 
(~100%) 
Compound Ventral prostate Serum LH Serum FSH 
Sa-androstane 218 + 48 124 + 3 90 + 23 
5a-androstan-3a-ol 118 + 3 87 + 36 91 + 18 
5a-androstan-3a-ol-17-one 260 + 5 58 + 9 84 + 13 
5a-androstane-3a,17S-diol 363 :!: 99 < 5 23 + 3 
5a-androstane-3a,11S,17S-triol 314 :!: 83 107 + 69 109 + 18 
5a-androstane-3a,16a,17S-triol 81 + 30 143 + 30 111 + 7 
-
Sa-androstan-38-ol 146 + 18 115 + 26 118 :!: 18 
5a-androstan-3S-ol-17-one 189 + 28 96+ 18 96 + 4 
5a-andiostane-3S,17S-diol 110 + 18 83 + 35 70 + 8 
5a-androstane-3S,11S,178-triol 116 + 32 117 + 59 108 + 9 
-
Sa-androstan-178-ol 205 + 45 86 + 33 84 + 7 
Sa-androstan-178-ol-3-one 369 + 10 < 5 36 + 10 
Sa-androstan-3-one 143 + 27 115 + 27 117 + 12 
-
Sa-androstane-3,17-dione 343 + 32 40 + 5 98 + 16 
intact, sesame oil 360 + 15 
-
22 + 6 31 :!: 5 
castrate, sesame oil 100 + 23 100 + 19 100 + 18 
Table 3 
Effect of various 58-androstanes (100 ~g/100 g b.w./day for seven days s.c.) on ventral 
prostate weight (mg/100 g b.w.) and serum gonadotrophin levels (ng/ml) in gonadectomized, 
mature male rats. Mean data + S.D. (n~3) are expressed as % of castrate control values 
(=100%) 
Compound Ventral prostate Serum LH Serum FSH 
sa-androstane 108 + 4 108 + 35 98 + 25 
5S-androstan-3a-ol 145 2: 29 109 + 49 89 + 9 
ss-androstan-3a-ol-17-one 121 + 28 80 + 25 98 + 8 
5S-androstane-3a,l7S-diol 90 + 29 86 + 30 70 + 15 
ss-androstan-178-ol 87 + 25 140 + 21 94 + 6 
ss-androstan-178-ol-3-one 149 + 25 104 + 12 95 + 9 
58-androstan-17-one 137 + 26 114 + 22 91 + 10 
intact, sesame oil 381 2: 40 25 + 7 33 + 5 
castrate, sesame oil 100 + 23 100 + 23 100 + 18 
Table 4 
Effect of various oestrenes and oestratrienes (100 ~g/100 g b.w./day for seven days s.c.) 
on ventral prostate weight (mg/100 g b.w.) and serum gonadotrophin levels (ng/rnl) in gona-
dectomized, mature male rats. Mean data~ S.D. (n~3) are expressed as % of castrate 
control values (=100%) 
Compound Ventral prostate Serum LH Serum FSH 
4-oestren-178-ol-3-one 177 + 55 88 + 21 107 + 15 
5(10)-oestrene-3a,l7S-diol 138 + 18 146 + 10 162 + 21 
5(10)-oestren-178-ol-3-one 140 + 27 19 + 11 84 + 17 
1,3,5(10)-oestratrien-3-ol 129 + 35 24 + 5 37 + 7 
1,3,5(10)-oestratrien-3-ol-17-one 108 + 6 l4 + 6 55 + 6 
-
1,3,5(10)-oestratrien~-3,16a,l7S-triol 141 + 12 14 + 1 36 + 4 
1,3,5(10)-oestratriene-3,17a-diol 94 + 39 26 + 9 42 + 19 
-
intact, sesame oil 350 + 12 25 + 7 31 :':_ 5 
castrate, sesame oil 100 + 25 100 + 23 100 + 18 
Sa-dihydrotestosterone. The steroids used from the 58-
androstane series had no effect on circulating gonadotro-
phins in this animal preparation at the dose used (Table 3). 
Table 4 demonstrates that all oestratrienes tested suppres-
sed serum gonadotrophins to levels comparable to those of 
intact, control animals, except for the 1,3,5(10)-oestra-
trien-3-ol-17-one effect on serum FSH. Of the oestrenes 
tried (Table 4) 4-oestren-178-ol-3-one exhibited no influ-
ence on the high serum gonadotrophin levels of gonadecto-
mized rats. The postcastration rise of serum LH, but not 
of serum FSH was prevented by 5(10)-oestren-178-ol-3-one 
injections. Administration of 5(10)-oestrene-3a,178-diol 
resulted in elevation of both serum LH and FSH over cas-
trate control levels (Table 4). In addition, treatment with 
a standard dose of 100 ~g/100 g b.w./day for seven days of 
4-pregnene-118,21-diol-3,20-dione, 5a-pregnane-17a,21-diol-
3,20-dione, Sa-pregnan-3-one, Sa-pregnane-3,20-dione, 5a-
cholestan-3a-ol, 58-cholestan-3a-ol or 1,4-diphenyl-butane-
2,3-diol did not depress serum LH and FSH levels in gona-
dectomized, adult male rats (data not shown) . 
Effects of steroid treatments on ventral prostate weights 
Significant decrement of ventral prostate weights could 
be recorded seven days postgonadectomy (Tables 1-4) . When 
administered in the daily standard dose of 100 ~g/100 g 
b.w. during seven days testosterone and 4-androstene-36, 
178-diol most adequately prevented this weight decrease 
(Table 1), and maintained prostatic weight at levels en-
countered in intact animals (Table 1). The 17a-epimers or 
the 66-hydroxylated derivatives of these steroids, however, 
showed no androgenic potency in this respect (Table 1). Of 
the compounds tested in this series (Table 1), some andro-
genic activity on the ventral prostate was exerted by 4-
androstene-3,17-dione, 5-androstene-38,176-diol and 5-
androsten-3 s-ol-17-one. 5 a-Androstane-3 a,l7 6-diol, 5 a-
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androstane-3a,11B,17B-triol, Sa-dihydrotestosterone and Sa-
androstane-3,17-dione maintained ventral prostate weights 
following castration at values found in intact animals, 
while Sa-androstane, Sa-androstan-3a-ol-17-one, Sa-andros-
tan-38-ol-17-one and Sa-androstan-178-ol were less effec-
tive (Table 2). Daily subcutaneous treatment (100 ~g/ 
100 g b.w. for seven days) with Sa-androstan-3a-ol, Sa-
androstane-3a,16a,17S-triol, Sa-androstan-38-ol, Sa-andros-
tane-38,178-diol, Sa-androstane-3S,118,17S-triol or Sa-
androstan-3-one had no effect on the falling ventral pros-
tate weights in castrated animals (Table 2) . Compounds from 
the 58-androstane series showed no androgenic action as 
evaluated by this bioassay method (Table 3). This was also 
the case for steroids of the oestrene and oestratriene 
series (Table 4). In addition, administration of 4-pregnene-
118,21-diol-3,20-dione, Sa-pregnane-17a,21-diol-3,20-dione, 
Sa-pregnan-3-one, Sa-pregnane-3,20-dione, Sa-cholestan-3a-
ol, SB-cholestan-3a-ol or 1,4-diphenyl-butane-2,3-diol 
(100 ~g/100 g b.w./day for seven days) could not counter-
act the decrement in ventral prostate weight following 
castration (data not shown). 
D I S C U S S I 0 N 
Provided that the steroids injected are released from the 
injection site at the same rate and are undergoing metabo-
lism at this site to the same extent, it is clear that 68-
hydroxylation, ?a-hydroxylation, 118-hydroxylation, 19-hy-
droxylation or 17 epimerization of 4-androsten-178-ol-3-one 
(testosterone) are associated with loss of androgenic acti-
vity at the hypothalamic-pituitary axis and in the ventral 
prostate (Table 1). Noteworthy is the fact that 4-andros-
tene-38,178-diol appears to elevate serum LH, but not 
serum FSH over castrate control levels {Table 1). This 
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positive feedback effect, affecting serum FSH levels too, 
can also be obtained employing lower doses of this com-
pound (unpublished data). 4-Androstene-3S,17S-diol exerts, 
however, potent androgenicity as evaluated by preventing 
weight decrement of the ventral prostate in castrated ani-
mals (Table 1). If this steroid were predominantly conver-
ted to testosterone in our experiments in vivo, one would 
expect to measure depression of circulating gonadotrophins 
(Table 1). If it were converted to Sa-androstane-3S,17S-
diol one would not expect to measure gain in ventral pros-
tatic weight (Table 2). We have, however, observed that 
administration of lower doses of Sa-androstane-3S,17S-diol 
than used in this work, results in positive feedback ef-
fects on circulating gonadotrophins in castrated male rats 
(unpublished data). Whether 4-androstene-3S,17S-diol has 
any physiological importance in regulating male reproduc-
tive function is unknown 1 but the results obtained warrant 
further exploration. As for testosterone, 17 epimerization 
or 6S-hydroxylation of 4-androstene-3S,17S-diol are asso-
ciated with loss of activity on the prostate (Table 1). 
Precursors of testosterone, such as 4-androstene-3 1 17-dione, 
5-androstene-3S,17S-diol or 5-androsten-3s-ol-17-one had no 
effect on serum gonadotrophins in the dose tested but the 
former two compounds were rather potent in preventing 
weight decrease of the ventral prostate postcastration 
(Table 1). Such data might indicate that the processes in-
volved in regulating the hypothalamic-pituitary unit and 
accessory reproductive organs by steroids are not parallel. 
Whether this difference resides at a receptor or at an or-
gan metabolic level remains for future work to decide. 
Steroids from the Sa-androstane series substituted with 
a 3a-hydroxyl or a 3-keto but containing a 17S-hydroxyl or 
a 17-keto group most effectively suppressed serum LH levels 
in gonadectomized rats and with the exception of Sa-andros-
tane-3,17-dione and Sa-androstan-3a-ol-17-one, also serum 
FSH levels (Table 2). In previously published work we have 
demonstrated that lower doses of Sa-dihydrotestosterone 
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or Sa-androstane-3a,176-diol are required for suppression 
of serum LH than for suppression of serum FSH in castrated, 
mature male rats (Verjans and Eik-Nes 1975b). Compounds of 
the Sa-androstane series without substitution or with only 
one substituent group in 3, 3a, 36 or 17S position and 36-
hydroxyl 17-disubstituted Sa-androstanes were unable to in-
fluence serum gonadotrophins in castrated rats (Table 2) . 
Of some interest is the observation that 11S- or 16a-hydro-
xylation of 5a-androstane-3a,17S-diol renders this compound 
inactive pertinent to gonadotrophin regulation (Table 2). 
Since the respective 56-epimers of the potent Sa-androsta-
nes failed to affect serum gonadotrophins (Table 3), Sa-
reduced testosterone metabolites substituted in 3 or 3a 
and 17 or 176 position are probably of importance for regu-
lating circulating gonadotrophins. Rat brain tissue of 
males contains Sa-steroid reductase as well as 3a- and 
176-hydroxysteroid dehydrogenase activity -(Rornmerts and 
van der Molen 1971). 
It is therefore possible that Sa-androstane-3a,176-diol, 
Sa-androstane-3,17-dione and 5a-androstan-3a-ol-17-one 
exert biological effects after being converted to Sa-dihy-
drotestosterone. The slightly higher potency of Sa-andros-
tane-3,17-dione than that of 5a-androstan-3a-ol-17-one in 
suppressing circulating LH levels might favor this sugges-
tion. Aromatization of ring A in steroids seems therefore 
not to be required in order to obtain such regulation, 
since Sa-androstanes cannot be converted to oestrogens in 
vertebrate animals. At the dose employed 36-hydroxylation 
of Sa-dihydrotestosterone is associated with no androgenic 
activity (Table 2), 36-hydroxysteroid dehydrogenase acti-
vity appears, however, to be low, because sa-androstane-
36,176-diol did not show negative feedback effects on cir-
culating gonadotrophins in the dose administered (Table 2). 
5a-Androstane-3a,176-diol, Sa-androstane-3a,11B,176-
triol,. Sa-androstane-3,17-dione and Sa-dihydrotestosterone 
exerted potent androgenicity as evaluated by weight of the 
ventral prostate (Table 2) . The presence of only one sub-
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stituent group in the Sa-androstane molecule, either in 3, 
3a or 36 position, decreased the androgenic activity as 
compared to Sa-androstane. Additional 17-keto substitution, 
however, increased this potency (Table 2). The influence of 
only a 176-hydroxy group of Sa-androstane appeared to be 
larger than substitution with only a 3a- or a 3S-hydroxyl 
group (Table 2). 3S-Epimerization of Sa-androstane-3a,l7S-
diol and of Sa-androstane-3a,ll6,17B-triol rendered these 
compounds completely inactive in maintaining ventral pros-
tate weights (Table 2). And, unlike liS-hydroxylation, 16a-
hydroxylation of Sa-androstane-3a,l7s-diol drastically de-
creased the potency of the compound in this respect 
(Table 2) . These observations might indicate differences 
in the regulatory processes for the two organs evaluated. 
The SS-androstanes tested lost the biological activity 
exhibited by their respective Sa-epimers (Table 3}. 
Bruchovsky (1971) showed that radioactive Sa-dihydrotestos-
terone was the major metabolite in prostatic nuclei follo-
wing intravenous injection of radioactive testosterone, sa-
dihydrotestosterone, Sa-androstan-3a-ol-17-one, Sa-andros-
tane-3a,l76-diol, Sa-androstane-3,17-dione, 4-androstene-
3,17-dione or 5-androsten-36-ol-17-one in castrated male 
rats. The experiments of Bruchovsky (1971) show that all 
relevant enzyme activities for conversion of these compounds 
to Sa-dihydrotestosterone are present in the rat. Further-
more, Sa-dihydrotestosterone was the principal steroid 
bound to androgen receptor in the rat prostate following 
administration of radioactive testosterone (Bruchovsky and 
Wilson 1968). Our data (Tables 1 and 2) corroborate 
these findings since in no case significant biological ac-
tivity of 56-androstanes (Table 3) was observed. 
Evaluating the effects of the oestratrienes (Table 4), 
we extended our previous findings that oestrogen will exert 
potent influence on circulating LH and FSH levels in intact 
and castrated, adult male rats (Verjans et al. 1974a, 
1974b). The current results indicate that the presence of 
only a phenolic A-ring is sufficient to afflict serum gena-
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dotrophin levels in gonadectomized animals, which seems to 
reduce the importance of 17a- or 17S-hydroxyl substitution 
in such molecules in order to be effective. 
In addition, we found that administration of 5,6,7,8-
tetra-hydro-8-naphthol (100 "g/100 g b.w./day given s.c. 
for seven days) did not mimic the effects exerted by oestro-
gens on serum gonadotrophins (unpublished data) . This could 
indicate that the presence of the C- and D-ring in the 
oestrogens is necessary for depressing circulating gonado-
trophins in the animal preparation used. The oestratrienes 
and oestrenes did not affect the falling ventral prostate 
weights in castrated male rats (Table 4), but 1,3,5(10)-
oestratrien-3-ol, 1,3,5(10)-oestratriene-3,16a,17S-triol, 
1,3,5(10)-oestratriene~3,17a-diol and 5(10)-oestrene-3a, 
176-diol could partly prevent the decrement of seminal 
vesicles weights in such animals (unpublished data) . Unlike 
4-oestren-176-ol-3-one, 5(10)-oestren-176-ol-3-one exerted 
potent activity at least on serum LH (Table 4). It might be 
that this shift in the double binding creates a structure 
more resembling the aromatic structure in the A-ring of 
physiological oestrogens. It should be noted that 5(10)-
oestrene-3a,17B-diol has a positive feedback action on both 
serum gonadotrophins (Table 4). Treatment with pregnanes 
and cholestanes had no effect on the parameters investiga-
ted, while 1,4-diphenyl-butane-2,3-diol, which is present 
in the testis from mature rats (Neher 1963) and is also 
secreted into the spermatic venous blood of the gonadotro-
phic stimulated dog (Eik-Nes et al. 1967), exhibited only 
some activity in preventing the seminal vesicles weight 
decrease in castrates (unpublished data). The failure of 
4-pregnene-116,21-diol-3,20-dione (corticosterone) to 
affect serum gonadotrophins and the falling ventral pros-
tate weight in castrates is in accordance with previously 
published work (Verjans and Eik-Nes 1975c) in which we 
showeO that dexamethasone treatment did not affect these 
parameters in castrates. Thus adrenocortical steroids are 
not of major importance in regulating circulating ganado-
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trophin levels and ventral prostate growth. 
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SERUM LH AND FSH LEVELS FOLLOWING INTRAVENOUS 
INJECTION OF A GONADOTROPHIN RELEASING PRINCIPLE 
IN NORMAL AND GONADECTOMIZED, ADULT MALE RATS 
TREATED WITH OESTRADIOL-l7B OR 5a-DIHYDROTESTOS-
TERONE 
By 
H.L. Verjans and K.B. Eik-Nes 
l 
A B S T R A C T 
Effect of intravenous administration of a synthetic gonado-
trophin releasing factor (GnRF) on circulating LH and FSH 
concentrations was investigated in normal and gonadecto-
mized, adult male rats injected subcutaneously each day 
during seven days with various doses of oestradiol-17S or 
Sa-dihydrotestosterone in sesame oil. Higher increase in 
serum LH and FSH levels subsequent to intravenously ad-
ministered GnRF was observed in castrated control animals 
than in intact control animals, though this increment was 
not of significant nature for serum FSH. Pretreatment of 
normal and gonadectomized rats with oestradiol-176 resulted 
in an augmented response of serum LH and FSH concentrations 
to GnRF i.v. Pretreatment of normal and gonadectomized rats 
with Sa-dihydrotestosterone diminished serum LH and FSH 
response following administration of the same amount of 
GnRF. For these steroids to affect the response pattern of 
serum LH and FSH to GnRF i.v., higher doses were required 
in normal than in gonadectomized animals. The data indicate 
that oestrogen and androgen may act at different sites in 
the male hypothalamic-pituitary axis with respect to regu-
lation of pituitary gonadotrophins. 
I N T R 0 D U C T I 0 N 
Synthesis and release of the gonadotrophins LH and FSH from 
the anterior pituitary gland are mediated by releasing 
material produced in the hypothalamus (for review: Schally 
et al. 1973a) and circulating gonadotrophins regulate and 
maintain testicular functions in the adult male animal. 
Testicular steroids have, in turn, been shown to influence 
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circulating concentrations of the gonadotrophins in normal 
and gonadectomized, adult male rats. Oestradiol-17S, Sa-
dihydrotestosterone, 5a-androstane-3a,17S-diol exhibit 
higher potency than testosterone in preventing the drastic 
increase of serum LH and FSH concentrations following gona-
dectomy in adult male rats (Verjans and Eik-Nes 1975a}. In 
these experiments circulating LH appeared more sensitive to 
steroid treatment than circulating FSH. It has been demon-
strated that testicular steroids can modulate the response 
in vivo to exogenous GnRF in intact (Debeljuk et al. 1972; 
Debeljuk et al. 1974; Hopkinson et al. 1974; Galloway et al. 
1974) and orchidectomized, adult male animals (Debeljuk 
et al. 1973; Debeljuk et al. 1974; Pelletier 1974; Smith 
and Davidson 1974; Verjans et al. 1974a). Modulatory 
effects of steroid hormones on GnRF induced release of go-
nadotrophins in vitro by pituitary tissue from male animals 
have also been reported (Schally et al. 1973b; Spona 1974; 
Kao and Weisz 1975). We have studied the effect of treat-
ment with an oestrogen or a non-aromatizable androgen on 
GnRF induced levels of LH and FSH in the blood serum of 
normal and gonadectomized, adult male rats in order to 
assess the modulatory effect of these steroids on gonado-
trophin response in an experimental animal model which has 
been characterized in previously published work (Verjans 
et al. 1974a,b; Verjans et al. 1975; Verjans and Eik-Nes 
197Sa,b). 
M A T E R I A L S A N D M E T H 0 D S 
Animals 
Adult, male Wistar rats .(3-4 months old) were used. The 
animals were kept under controlled light (14 hrs light and 
10 hrs darkness) and temperature (19-21°C) conditions. 
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Laboratory chow and tap water were provided ad libitum. 
Experiment I. - From fifteen rats of the same age (body 
weights ranging from 260 to 290 g) blood samples (1.2 -
1.5 ml) we_re drawn around 9 a.m. by puncturing the ophthal-
mic venous plexus under ether anaesthesia. Synthetic gona-
dotrophin releasing factor {GnRF, Abbott Laboratories, 
North Chicago, Illinois, U.S.A.) in doses of 1,000, SOD, 
250 or 50 ng, dissolved in 0.1 ml 0.9% sodium chloride so-
lution, was then injected via the jugular vein under ether 
anaesthesia. Control animals received 0.1 ml saline only 
via this route. Fifteen min after such injection, approxi-
mately 1.5 ml blood was removed by puncturing the ophthal-
mic venous plexus under ether anaesthesia. All injections 
were given to groups of three rats. 
Experiment II. - One group of animals with body weights 
varying from 310 to 370 g was gonadectomized (Verjans et al. 
1974a), another group of the same age with body weights 
ranging from 335 to 380 g was employed as intact animals. 
Daily subcutaneous injections with various doses of oestra-
diol-176 {Steraloids, Pawling, New York, U.S.A.) in sesame 
oil (0.04 rnl oil/100 g b.w.) were given for a period of 
seven days between 1 and 2 p.m. to both animal groups. Con-
trol intact and control castrate animals received sesame 
oil only (0.04 ml/100 g b.w./day for seven days). All 
intact animals were exposed to 10 min of ether anaesthesia 
prior to the first injection with sesame oil or sesame oil 
containing oestradiol-17S. Oestrogen treatment of the or-
chidectomized rats started immediately following surgery. 
Twenty hours after the last injection, blood samples 
(1.2- 1.5 ml) were obtained at 9 a.m. by puncturing the 
ophthalmic venous plexus under ether anaesthesia. Then 
500 ng GnRF in 0,1 ml saline was administered via the jugu-
lar vein (see above). Intact and gonadectomized animals, 
injected with sesame oil for the seven preceding days, 
received as control 0.1 ml saline only via this route. 
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Fifteen min following administration of saline or saline 
containing 500 ng GnRF, all animals were bled again (appro-
ximately 1.5 ml) by puncturing the ophthalmic venous plexus 
under ether anaesthesia. Three or more rats were used for 
each treatment group. 
Experiment III. - One group of animals with body weights 
ranging from 260 to 290 g was castrated, another group of 
rats of the same age with body weights varying from 260 to 
275 g was employed as intact animals. Daily subcutaneous 
treatment of intact and orchidectomized animals with 
various doses of 5a-dihydrotestosterone (Steraloids, 
Pawling, New York 1 U.S.A.) in sesame oil or with this 
vehicle only and injection of GnRF followed the protocol 
used in experiment II. Three or more rats were used for 
each treatment group. 
Radioimmunoassay methods for blood serum LH and FSH concen-
trations 
All blood samples from the three experiments were 
allowed to clot overnight at 4°C. Resulting blood serum was 
stored at -20°C until analysed for serum LH and FSH by 
double antibody radioimmunoassay techniques as previously 
described (Verjans et al. 1974a; Welschen et al. 1975). 
Serum LH and FSH concentrations were expressed on the basis 
of the reference preparations NIAMD rat LH RP-1 and NIAMD 
rat FSH RP-1 respectively. Serum samples from each experi-
ment were measured in duplicate at the same volume level in 
a single assay and only sample values thus obtained have 
been compared. Significance of differences between the go-
nadotrophin responses following intravenous administration 
of GnRF in the different animal groups was determined using 
Duncan's new multiple-range test (Duncan 1955). In all ex-
periments changes in blood serum levels of LH and FSH were 
calculated by subtracting the resting gonadotrophin levels 
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(measured just before administration of GnRF or saline) 
from the gonadotrophin levels determined 15 min after in-
jection of GnRF or saline. Whenever circulating LH concen-
trations were depressed to undetectable values following 
steroid treatment, we used an LH level of 7 ng/ml serum 
(the detection limit of the radioimmunoassay employed) in 
order to calculate the LH response following GnRF i.v. 
R E S U L T S 
Normal rats 
Effects of intravenous administration of increasing 
doses of synthetic GnRF on circulating levels of LH and FSH 
in intact, adult male rats measured 15 min following intra-
venous injection of the gonadotrophin releasing principle 
are shown in Table 1. GnRF augmented both serum LH and FSH 
in a dose-dependent way, 500 ng GnRF i.v. appeared to give 
adequate stimulation of both trophins (Table 1) and was 
used as the standard dose for the rest of the study. Intra-
venous injection of saline tended to reduce the resting go-
nadotrophin levels (Table 1). 
Oestradiol treated rats 
Daily treatment of intact rats with 5 ~g or 0.5 ~g 
oestradiol/100 g b.w. for seven days depressed circulating 
LH to undetectable levels and mean circulating FSH to res-
pectively 64% ± 17 (S.D.) and 92% ± 39 (S.D.) of intact 
control levels (100% ~ 9 (S.D.)). Administration of 0.05 ~g 
oestradiol resulted in circulating FSH levels slightly 
higher than those of intact control animals injected with 
sesame oil only. In gonadectomized rats treatment with 5 ~g 
oestradiol reduced circulating LH to undetectable levels, 
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Table 1 
Effect of various doses of intravenously administered 
synthetic GnRF on serum LH and FSH levels in intact, adult 
male rats (n=3) 
Treatment 
1,000 ng GnRF 
500 ng GnRF 
250 ng GnRF 
50 ng GnRF 
saline 
Difference (mean~ S.D.) between 
serum levels of LH and FSH measured 
before and 15 min after injection of 
0.1 ml saline or 0.1 ml saline con-
taining GnRF 
LHX FSHXX 
+ 587 + 181 + 303 + 43 
+ 488 + 144 + 233 + 12 
+ 258 + 151 + 142 + 39 
+ 96 + 21 + 79 + 8 
15 + 14 10 + 52 
X 
expressed as ng NIAMD rat LH RP-1/ml serum 
xx expressed as ng NIAMD rat FSH RP-1/ml serum 
while the doses of 0.5 ~g or of 0.05 ~g oestradiol suppres-
sed mean circulating LH levels to values respectively 
11% ~ 2 (S.D.) and 81% + 9 (S.D.) of castrate control 
levels (100% ~ 14 (S.D.)). Mean circulating FSH in the cas-
trates decreased to 28% ~ 1 (S.D.) and 62% + 12 (S.D.) of 
castrate control levels (100% + 6 (S.D.)) following daily 
administration of 5 or 0.5 vg oestradiol respectively. The 
dose of 0.05 vg oestradiol slightly augmented circulating 
FSH levels over FSH levels encountered in castrate controls 
receiving oil only. 
The effects of treatment with oestradiol on GnRF induced 
serum concentrations of LH and FSH in intact and gonadecto-
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Table 2 
Effect of treatment with various doses of oestradiol-176 (~g/100 g b.w./day for seven days 
s.c.) on increment of serum gonadotrophins following 500 ng intravenously administered 
synthetic GnRF in intact and gonadectomized, adult male rats (n ~ 3) 
Treatment 
Intact, 5 ~g oestradiol-176 
intact, 0.5 ug oestradiol-176 
intact, 0.05 ug oestradiol-176 
intact, sesame oil 
Castrate, 5 ug oestradiol-176 
castrate, 0. 5 ug oestradiol-176 
castrate, 0. 0 5 Ug oestradiol-176 
castrate, sesame oil 
X 
lncrement (mean! S.D.) in serum LH and FSH 15 min 
after injection of 500 ng GnRF in 0.1 rnl saline 
LHX FSHXX 
785 + 318xxx 596 + 38xxx 
357 + 106 405 + 228 
352 + 91 233 + 10 
338 + 12 251 + 133 
2,057 .±. 403xxxx 1 087 + 415xxxx 
' -
1,856 :':: 99 xxxx 960 + 254 xxxx 
1,038 :':: 234 643 + 232 
958 + 145 330 + 135 
XX 
expressed as ng NIAMD rat LH RP-1/rnl serum 
expressed as ng NIAMD rat FSH RP-1/ml serum 
XXX p < 0.05, compared with mean increment in sesame oil treated intact animals following 
GnRF 
xxxxp < 0.05, compared with mean increment in sesame oil treated castrated animals 
following GnRF 
mized male rats are summarized in Table 2. GnRF i.v. in a 
dose of 500 ng resulted in elevated levels of LH and FSH in 
castrates treated with sesame oil (Tables 2 and 3). Intra-
venous injection of saline in intact and castrated rats 
treated for seven days with sesame oil only gave slightly 
lower circulating gonadotrophin levels than those measured 
just before saline i.v. (data not shown). The increment in 
serum LH following GnRF i.v. in castrate controls was sig-
nificantly higher (P < 0.01) than in intact rats treated 
for seven days with sesame oil (Tables 2 and 3). Augmenta-
tion in serum FSH in castrated control rats was, however, 
not significantly higher compared with intact control rats 
given the same amount of GnRF i.v. (Tables 2 and 3). A 
higher (P < 0.05) LH and FSH increase was measured in 
intact rats treated with 5 ~g oestradiol compared with the 
increases observed in circulating gonadotrophins in oil 
treated intact rats 15 min subsequent to injection of 
500 ng GnRF i.v. (Table 2). Treatment with doses of 0.5 ~g 
and 0.05 ~g oestradiol had no influence on GnRF induced 
serum concentrations of LH and FSH in intact animals 
(Table 2). Augmented LH and FSH response (P < 0.05) to GnRF 
i.v. was, however, observed in castrates treated with 5 ~g 
or 0.5 ~g oestradiol, while treatment with the dose of 
0.05 ~g oestradiol did not affect gonadotrophin response in 
castrates following administration of GnRF i.v. (Table 2). 
5a-Dihydrotestosterone treated rats 
Circulating concentrations of LH in intact rats were 
depressed to undetectable values and to 56%+ 8 (S.D.) of 
intact control levels (100% ~ 34 (S.D.)) following daily 
administration of 5a-dihydrotestosterone in doses of 100 or 
10 ~g/100 g b.w. for seven days respectively. Treatment 
with 1 ~g 5a-dihydrotestosterone did not affect circulating 
LH levels and doses of 1 ~g and 10 ~g of this androgen were 
without effect on circulating FSH levels compared with 
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Table 3 
Effect of treatment with various doses of Sa-dihydrotestosterone (~g/100 g b.w./day for 
seven days s.c.) on increment of serum gonadotrophins following 500 ng intravenously admi-
nistered synthetic GnRF in intact and gonadectomized, adult male rats (n ~ 3) 
Increment (mean ~ S.D~) in serum LH and FSH 15 min 
after injection of 500 ng GnRF in 0.1 rnl saline 
Treatment LHX 
Intact, 100 ~g Sa-dihydrotestosterone 84 + 6xxx 
intact, 10 ~g Sa-dihydrotestosterone 240 + 62 
intact, 1 ~g Sa-dihydrotestosterone 297 + 137 
intact, sesame oil 465 + 178 
Castrate, 100 ~g sa-dihydrotestosterone 182 + 61 xxxx 
castrate, 10 ~g sa-dihydrotestosterone 587 + 58xxxx 
castrate, 1 ~g sa-dihydrotestosterone 1,132 ~ 516 
castrate, sesame oil 1,152 + 310 
X 
XX 
expressed as ng NIAMD rat LH RP-1/ml serum 
expressed as ng NIAMD rat FSH RP-1/ml serum 
XXX p < o.os, compared with mean increment in sesame oil treated 
GnRF 
FSHXX 
121 + 21 xxx 
265 + 42 
166 + 117 
262 + 59 
218 + 60 xxxx 
268 + 72 
438 + 192 
397 + 129 
intact animals following 
xxxxp < 0. 0 s, compared with mean increment in sesame oil treated castrated animals 
following GnRF 
intact controls receiving vehicle only. Only treatment with 
the dose of 100 vg 5a-dihydrotestosterone resulted in lower 
average serum FSH levels (69% ± 3 (S.D.)) compared with 
mean FSH levels in intact control rats injected with sesame 
oil (100%! 17 (S.D.)). 
In castrates, 100 vg Sa-dihydrotestosterone lowered cir-
culating LH to undetectable values and mean circulating FSH 
to 34% + 4 (S.D.) of castrate control levels (100%! 21 
(S.D.)). Daily administration of 10 or 1 vg 5a-dihydrotes-
tosterone/100 g b.w. for seven days did not change serum LH 
and FSH levels compared with castrate controls. 
Table 3 shows effects of intravenous administration of 
500 ng GnRF on serum levels of LH and FSH in normal and go-
nadectomized, adult male rats treated with various doses of 
Sa-dihydrotestosterone during the seven preceding days. 
Treatment of intact rats with 100 vg 5a-dihydrotestosterone 
resulted in a lower LH and FSH response (P < 0.05) to GnRF 
i.v. when compared with intact rats treated with sesame oil 
only (Table 3) . Pretreatment of intact rats with 10 vg or 
1 vg 5a-dihydrotestosterone had no significant effect on LH 
and FSH response to GnRF (Table 3). In castrates injected 
with 100 vg or 10 vg Sa-dihydrotestosterone, LH increment 
following GnRF i.v. was depressed (P < 0.05) as compared 
with oil treated control rats, while treatment with the 
dose of 1 ~g 5a-dihydrotestosterone was without effect on 
the LH response (Table 3). FSH response was inhibited 
{P < 0.05) in castrates pretreated with 100 vg 5a-dihydro-
testosterone, but treatment with doses of 10 vg or 1 vg of 
this androgen did not give such effects. 
D I S C U S S I 0 N 
Intravenous administration of GnRF resulted in elevated 
serum levels of LH and FSH in intact (Tables 1, 2 and 3) 
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and castrated {Tables 2 and 3) adult male rats. Furthermore, 
this gonadotrophin response was more pronounced in gonadec-
tomized than in normal animals 15 min after i.v. injection 
of the gonadotrophin releasing principle (Tables 2 and 3). 
Percentage increase relative to resting gonadotrophin 
levels was greater for serum LH than for serum FSH as 
measured 15 min following the same dose of GnRF. The syn-
thetic preparation of GnRF used exhibited higher LH and FSH 
releasing capacity than the one employed in a previous 
study (Verjans et al. 1974a). In that study, however, a 
different strain of rats was used. Both studies suffer cer-
tain shortcomings: handling of the animals, use of ether 
anaesthesia and frequent blood sampling. These conditions 
will influence circulating levels of LH and FSH (Krulich 
et al. 1974; Euker et al. 1975) and ether anaesthesia is 
known to depress testosterone secretion in rats (Bardin and 
Peterson 1967). Decapitation of intact rats exposed to 
ether vapour for 2 min results in slightly decreased LH, 
significantly increased FSH and unchanged testosterone 
serum concentrations compared with animals decapitated 
without ether anaesthesia (unpublished data). Such effects 
are not observed in castrated animals (unpublished data). 
The slightly lowered levels of LH and FSH found 15 min 
after 0.1 ml saline i.v. might therefore be caused by the 
standard procedure of animal treatment (Table 1). One may, 
moreover, question whether intact and short-term castrated 
rats really can be compared with regard to circulating go-
nadotrophin concentrations, owing to pleomorphism of rat 
FSH as observed in long-term castrated male rats 
(Bogdanove et al. 1974). At any rate, the circulating con-
centrations of the gonadotrophins are the ones reaching the 
target tissue(s). 
Provided that peripheral gonadotrophin concentrations 
are true indicators of pituitary production and secretion 
of these hormones and that clearance rates of these hor-
mones are not afflicted by the different treatments, it is 
abundantly clear from the present study that treatment with 
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high doses of Sa-dihydrotestosterone or oestradiol-17S, 
which will depress circulating LH and FSH concentrations in 
normal (Verjans et al. 1974b; Result section) and orchidec-
tomized (Swerdloff et al. 1972; Kalra et al. 1973; 
Verjans et al. 1974a; Result section) rats, will alter 
serum gonadotrophin response to the same high dose of the 
same gonadotrophin releasing principle (Tables 2 and 3). 
Serum levels of LH and FSH following GnRF i.v. are, how-
ever, different in rats after seven days treatment with 
either a non-aromatizable androgen or an oestrogen. Expo-
sure of intact and castrated male rats to high doses of 
Sa-dihydrotestosterone for seven days was associated with 
inhibited serum gonadotrophin response to exogenous GnRF 
i.v. (Table 3), while exposure to high doses of oestradiol-
176 during the same period of time markedly enhanced this 
response in both type of animals (Table 2) . 
It is now well established that rat testis tissue con-
tains measurable quantities of oestradiol-17S (de Jong 
et al. 1974) and of Sa-dihydrotestosterone (Folrnan et al. 
1972). The male gonad can also secrete these steroid hor-
mones and in the adult male rat mean plasma levels of 
oestradiol-176 and Sa-dihydrotestosterone are respectively 
2 (de Jong et al. 1973) and 350 (Coyotupa et al. 1973) pg 
per ml. Testicular steroids can pass the blood-brain 
barrier since retention of testosterone (Resko et al. 
1967), Sa-dihydrotestosterone (Perez-Palacios et al. 1973) 
or oestradiol-176 (Green et al. 1969) in the hypothalamic-
pituitary system can be recorded. Robel et al. (1973) 
showed that Sa-dihydrotestosterone is present in measurable 
quantities in hypothalamic and hypophyseal tissue of nor-
mal, adult male rats. Metabolism of radioactive androgens 
will occur in these tissues (Rommerts and van der Molen 
1971; Massa et al. 1972; Naftolin et al. 1972; Genet et al. 
1975). Sa-Reduction appears to be the predominant pathway 
for androgen metabolism in neuroendocrine cells (Naftolin 
and Ryan 1975) and oestradiol-17S is not likely to undergo 
biotransformation in the hypophysis and the hypothalamus 
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(Kato and Villee 1967; Kato 1975), 5~-Reduction of testos-
terone to s~-dihydrotestosterone is irreversible, but re-
duction of s~-dihydrotestosterone to s~-androstane-3a,178-
diol is reversible (Norna et al. 1975}. s~-Dihydrotestoste­
rone cannot be converted to an oestrogen {for review: 
Engel 1973). In addition, it has been demonstrated that the 
hypophysis and hypothalamus of male rats contain specific 
binding principles for oestradiol-178 {Kato et al. 1974; 
Kato 1975), testosterone (Jouan et al. 1971, 1973) and s~­
dihydrotestosterone (Kato and Onouchi 1973 a,b). Testoste-
rone is, however, quantitatively the main androgen in the 
peripheral circulation and thus probably the main precur-
sor for Sa-dihydrotestosterone and oestradiol-178 formation 
in the hypothalamic-pituitary system. Higher concentrations 
of testosterone than of s~-dihydrotestosterone are found in 
male hypothalamic and hypophyseal tissue (Robel et al. 
1973). The possibility must, however, not be overlooked 
that s~-dihydrotestosterone, its 3~- or 38-reduced metabo-
lites, or oestradiol-178, mediated by their specific recep-
tor binding molecules in the hypophysis and the hypothala-
mus (Kato and Onouchi 1973 a,b; Kato et al. 1974; Kato 
1975), may direct physiological regulatory events at these 
sites. 
Verjans et al. (1974a) reported decreased serum gonado-
trophin response to GnRF i.v. in castrates treated with the 
propionates of testosterone or s~-dihydrotestosterone corn-
pared with castrates treated with oestradiol benzoate. 
Debeljuk et al. (1972) found inhibitory effects of testos-
terone propionate injection on serum LH and FSH response 
following GnRF i.v. in intact animals, while 5~-dihydrotes­
tosterone administration suppressed only serum LH response 
following GnRF i.v. in normal and orchidectornized rats 
(Debeljuk et al. 1974). Schally et al. (1973b) observed 
that testosterone or s~-dihydrotestosterone in vitro inhi-
bited LH and FSH discharge from male pituitary tissue fol-
lowing GnRF addition in vitro. Administration of 100 ~g 
s~-androstane-3a,l78-diol/100 g b.w./day during seven days 
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to castrated male rats resulted in a diminished serum gona-
dotrophin response to 500 ng GnRF i.v., while administra-
tion of the same dose of 4-androstene-3~,176-diol to cas-
trates did not mimic this effect (unpublished data) . Fur-
thermore, we have shown previously that 5a-androstane-3a, 
17S-diol is at least as potent as 5a-dihydrotestosterone in 
curbing serum LH and FSH concentrations in orchidectomized, 
adult male rats (Verjans and Eik-Nes 1975a). 
It is therefore possible that testosterone, most likely 
after conversion to its potent Sa-reduced androstane meta-
bolites, modifies pituitary responsiveness to GnRF. This 
may mean that the anterior pituitary gland is the possible 
site of androgen regulatory effects on the hypothalamic-
pituitary axis, a view also shared by Mittler (1972), 
Schally et al. (1973b} and Kingsley and Bogdanove (1973}. 
We can, however, not exclude the possibility that in our 
experiments seven days treatment with this potent Sa-
reduced testosterone metabolite may act on endogenous GnRF 
production and/or secretion. Altered endogenous GnRF could 
have changed pituitary sensitivity to a high dose of exoge-
nous GnRF i.v. Low serum GnRF concentrations are found in 
adult male rats subsequent to hypophysectomy (Shin et al. 
1974) and no increase in such levels can be determined five 
or eight days following gonadectomy (Shin and Howitt 1975). 
Stimulating effects of testosterone on GnRF in castrates 
have been observed (Shin et al. 1974) indicating that in 
addition to the anterior pituitary gland, the hypothalamus 
is also involved in the action of androgens. We are apt to 
conclude from these data that the high circulating gonado-
trophin levels following orchidectomy may be induced by 
lack of testicular secretion products influencing release 
of LH and FSH by the hypophysis. Low doses of androgen in-
jected in castrates may stimulate GnRF release resulting 
in elevation of serum gonadotrophin concentrations over 
castr~te control levels (positive feedback) (Walsh et al. 
1973; Verjans et al. 1975). Injection of high androgen 
doses will inhibit pituitary release of gonadotrophins, and 
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for both - high and low doses of androgen - LH release is 
more sensitive than that of FSH. In this respect it is in-
teresting to note that Franchimont et al. (1975) observed a 
diminished response of serum FSH, but not of serum LH, to a 
gonadotrophin releasing preparation in intact and castrated, 
adult male rats pretreated with an inhibin-like factor iso-
lated from bull seminal plasma. In X-ray treated male rats 
with significant increase of serum FSH levels only, an ele-
vated response of serum FSH 1 but not of serum LH 1 can be 
observed 60 min after GnRF i.v. (Verjans and Eik-Nes 1975c). 
These data might indicate that inhibin 1 which may partly 
regulate FSH, possibly acts directly on the anterior hypo-
physis by modulating pituitary release of FSH only. 
In contrast to the androgen treatment used, exposure 
during seven days to high doses of oestradiol-17B 1 which 
also depressed basal gonadotrophin levels in normal and 
castrated rats, enhanced serum gonadotrophin response to 
GnRF i.v. in normal and gonadectomized rats (Table 2). In 
order to induce this potentiating effect 1 lower doses of 
oestradiol-17B were required in castrate than in normal 
animals (Table 2). Furthermore 1 it is known that treatment 
with oestradiol-17B results in decreased testicular and 
peripheral concentrations of testosterone in intact male 
rats (Verjans et al. 1974b). This latter effect may not 
only be caused by suppressed LH levels 1 but also by a 
direct testicular influence of oestradiol-17B. It has been 
demonstrated that oestrogen depresses testicular testoste-
rone formation by affecting enzymes involved in androgen 
biosynthesis (Samuels et al. 1969; Yanaihara et al. 1972) 
and that testicular interstitial tissue contains a specific 
receptor for oestradiol-17B (Brinkmann et al. 1972). In 
normal rats oestrogen treatment should result in low peri-
pheral concentrations of testosterone, thus removing andro-
gen inhibition of the hypothalamic-pituitary axis. The po-
tentiating effect of oestrogen on serum gonadotrophin res-
ponse following GnRF i.v. is 1 however, also observed in the 
castrate animal (Table 2). Augmentation of serum gonado-
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trophin 
to high 
response to GnRF i.v. in male castrates subjected 
doses of been reported before 
(Debeljuk et al. 
oestrogen has 
1973; Verjans et al. l974a). Eshkol et al. 
(1975) observed that exposure of male pituitary glands 
in vitro to low doses of oestradiol-17S caused higher LH 
and FSH response to GnRF. When, however, higher doses of 
oestradiol-17S were employed in these studies, inhibited LH 
and FSH response to GnRF occurred thus confirming the work 
in vitro by Schally et al. (1973b). It is difficult to corn-
pare data obtained in vivo with data obtained in vitro, but 
the anterior pituitary gland could be a possible feedback 
site of action of oestradiol-17S and it is also likely that 
oestradiol-17S can alter pituitary sensitivity to GnRF and 
thereby change pituitary release of gonadotrophins. In our 
experiments changes in endogenous GnRF production and/or 
secretion following seven days exposure to high doses of 
oestradiol-17S could have occurred. This may alter pituita-
ry responsiveness to a high dose of exogenous GnRF i.v. 
The fact that treatment with high doses of oestradiol-17S 
during seven days suppressed basal gonadotrophin concentra-
tions in the peripheral circulation, but enhanced circula-
ting gonadotrophin response to exogenous GnRF i.v. points 
to dual regulatory sites of oestrogen action in the hypo-
thalamic-pituitary axis. A hypothalamic site of inhibitory 
action of oestradiol-17S on GnRF production and/or secre-
tion is in this respect rather possible, though convincing 
evidence on this point is lacking. It is known that low 
doses of oestradiol-17S exert positive feedback effects on 
peripheral gonadotrophin levels in male castrates (Walsh 
et al. 1973; Kalra et al. 1973; Verjans et al. 1974a). Thus, 
low doses of oestradiol-17S administered to male castrates 
may render the anterior pituitary gland more sensitive to 
endogenous GnRF without affecting release or production of 
this material and may result in elevation of serum LH and 
FSH levels over castrate control levels (positive feedback). 
High doses of oestradiol-17a administered to castrated and 
normal animals may inhibit hypothalamic production and/or 
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release of GnRF. Such inhibition could render the anterior 
hypophysis more sensitive to high concentrations of exoge-
nous GnRF. It is a matter of speculation, however, whether 
a major physiological role can be assigned to the minute 
circulating oestradiol-176 concentrations in normal male 
rats with respect to regulation of pituitary gonadotrophins 
(Gay and Dever 1971; de Jong et al. 1975). 
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